
<html lang="en"     class="pb-page"  data-request-id="2613169d-5b6f-450a-9091-3a23edcf094c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm900367w;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2009.52.issue-14"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia" /></meta><meta name="dc.Creator" content="Weiguo  Liu" /></meta><meta name="dc.Creator" content="Kun  Liu" /></meta><meta name="dc.Creator" content="Harold B.  Wood" /></meta><meta name="dc.Creator" content="Margaret E.  McCann" /></meta><meta name="dc.Creator" content="Thomas W.  Doebber" /></meta><meta name="dc.Creator" content="Ching H.  Chang" /></meta><meta name="dc.Creator" content="Taro E.  Akiyama" /></meta><meta name="dc.Creator" content="Monica  Einstein" /></meta><meta name="dc.Creator" content="Joel P.  Berger" /></meta><meta name="dc.Creator" content="Peter T.  Meinke" /></meta><meta name="dc.Description" content="A series of 3-acylindole-1-benzylcarboxylic acids were designed and synthesized while searching for a PPARγ modulator with additional moderate intrinsic PPARα agonistic activity. 2-[3-[[3-(4-Chloro..." /></meta><meta name="Description" content="A series of 3-acylindole-1-benzylcarboxylic acids were designed and synthesized while searching for a PPARγ modulator with additional moderate intrinsic PPARα agonistic activity. 2-[3-[[3-(4-Chloro..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 16, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900367w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900367w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900367w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900367w" /></link>
        
    
    

<title>Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900367w" /></meta><meta property="og:title" content="Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0006.jpeg" /></meta><meta property="og:description" content="A series of 3-acylindole-1-benzylcarboxylic acids were designed and synthesized while searching for a PPARγ modulator with additional moderate intrinsic PPARα agonistic activity. 2-[3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl]phenoxy]-(2R)-butanoic acid (12d) was identified as such an agent which demonstrated potent efficacy in lowering both glucose and lipids in multiple animal models with significantly attenuated side effects such as fluid retention and heart weight gain associated with PPARγ full agonists. The moderate PPARα activity of 12d not only contributed to the agent’s ability to manage lipid profiles but also appears to have potentiated its PPARγ efficacy in lowering glucose levels in preclinical diabetic animal models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900367w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900367w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900367w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900367w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900367w&amp;href=/doi/10.1021/jm900367w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 4443-4453</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900319e" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900414x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weiguo++Liu">Weiguo Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kun++Liu">Kun Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harold+B.++Wood">Harold B. Wood</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Margaret+E.++McCann">Margaret E. McCann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+W.++Doebber">Thomas W. Doebber</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ching+H.++Chang">Ching H. Chang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Taro+E.++Akiyama">Taro E. Akiyama</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Einstein">Monica Einstein</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+P.++Berger">Joel P. Berger</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+T.++Meinke">Peter T. Meinke</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 732-594-2782. Fax: 732-594-9556. E-mail: <a href="/cdn-cgi/l/email-protection#4532202c22302a1a292c3005282037262e6b262a28"><span class="__cf_email__" data-cfemail="abdccec2ccdec4f4c7c2deebc6ced9c8c085c8c4c6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900367w&amp;href=/doi/10.1021%2Fjm900367w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 4443–4453</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 16, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 March 2009</li><li><span class="item_label"><b>Published</b> online</span>16 June 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900367w" title="DOI URL">https://doi.org/10.1021/jm900367w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4443%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWeiguo%2BLiu%252C%2BKun%2BLiu%252C%2BHarold%2BB.%2BWood%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D14%26contentID%3Djm900367w%26title%3DDiscovery%2Bof%2Ba%2BPeroxisome%2BProliferator%2BActivated%2BReceptor%2B%25CE%25B3%2B%2528PPAR%25CE%25B3%2529%2BModulator%2Bwith%2BBalanced%2BPPAR%25CE%25B1%2BActivity%2Bfor%2Bthe%2BTreatment%2Bof%2BType%2B2%2BDiabetes%2Band%2BDyslipidemia%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4453%26publicationDate%3DJuly%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900367w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2225</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900367w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Weiguo&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Kun&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Harold&quot;,&quot;last_name&quot;:&quot;B. Wood&quot;},{&quot;first_name&quot;:&quot;Margaret&quot;,&quot;last_name&quot;:&quot;E. McCann&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;W. Doebber&quot;},{&quot;first_name&quot;:&quot;Ching&quot;,&quot;last_name&quot;:&quot;H. Chang&quot;},{&quot;first_name&quot;:&quot;Taro&quot;,&quot;last_name&quot;:&quot;E. Akiyama&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Einstein&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;P. Berger&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;T. Meinke&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;4443-4453&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900367w&quot;},&quot;abstract&quot;:&quot;A series of 3-acylindole-1-benzylcarboxylic acids were designed and synthesized while searching for a PPARγ modulator with additional moderate intrinsic PPARα agonistic activity. 2-[3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl]phenoxy]-(2R)-butanoic acid (12d) was identified as such an agent which demonstrated potent efficacy in lowering both glucose and lipids in multiple animal models with significantly attenuated side effects such as fluid retention and heart weight gain associated with PPARγ full agonists. The moderate PPARα activity of 12d not only contributed to the agent’s ability to manage lipid profiles but also appears to have potentiated its PPARγ efficacy in lowering glucose levels in preclinical diabetic animal models.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900367w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900367w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900367w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900367w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900367w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900367w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900367w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900367w&amp;href=/doi/10.1021/jm900367w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900367w" /></input><a href="/doi/pdf/10.1021/jm900367w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900367w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900367w%26sid%3Dliteratum%253Aachs%26pmid%3D19530681%26genre%3Darticle%26aulast%3DLiu%26date%3D2009%26atitle%3DDiscovery%2Bof%2Ba%2BPeroxisome%2BProliferator%2BActivated%2BReceptor%2B%25CE%25B3%2B%2528PPAR%25CE%25B3%2529%2BModulator%2Bwith%2BBalanced%2BPPAR%25CE%25B1%2BActivity%2Bfor%2Bthe%2BTreatment%2Bof%2BType%2B2%2BDiabetes%2Band%2BDyslipidemia%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D14%26spage%3D4443%26epage%3D4453%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of 3-acylindole-1-benzylcarboxylic acids were designed and synthesized while searching for a PPARγ modulator with additional moderate intrinsic PPARα agonistic activity. 2-[3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy]-(2<i>R</i>)-butanoic acid (<b>12d</b>) was identified as such an agent which demonstrated potent efficacy in lowering both glucose and lipids in multiple animal models with significantly attenuated side effects such as fluid retention and heart weight gain associated with PPARγ full agonists. The moderate PPARα activity of <b>12d</b> not only contributed to the agent’s ability to manage lipid profiles but also appears to have potentiated its PPARγ efficacy in lowering glucose levels in preclinical diabetic animal models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Diabetes is a metabolic disorder afflicting about 5% of the population in the industrialized nations and is now rapidly expanding in the rest of the world, especially in those heavily populated developing countries such as China and India. Its growth rate is estimated to be 6% annually, reaching a potential total of 200−300 million cases in 2010.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Non-insulin dependent type 2 diabetes mellitus (T2DM<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: T2DM, type 2 diabetes mellitus; PPAR, peroxisome proliferator activated receptor; TG, triglyceride; LDL, low-density lipoprotein; SPPARγMs, selective peroxisome proliferator activated receptor γ modulators; LDA, lithium diisopropylamide; CYP, cytochrome P450; LXR, liver X receptor; RXR, retinoid X receptor; PXR, pregnane X receptor; GR, glucocorticoid receptor; ER, estrogen receptor; TR, thyroid homone receptor; TZD, thiazolidinedione; PV, plasma volume; HFD/STZ, high fat diet plus streptozotocin; BAT, brown adipose tissue.</p></div> accounts for more than 90% of the cases. It is characterized by insulin resistance in the liver and peripheral tissues and by pancreatic β-cell dysfunction. The underlying causes for T2DM are complex. Besides genetic and other pathological factors, the onset of T2DM has been clearly linked to lifestyle changes such as diet, exercise, and age and is increasingly accompanied by other metabolic disorders including obesity, dyslipidemia, and atherosclerosis. The combination of these risk factors, termed metabolic syndrome, significantly increases morbidity and mortality and is a major public health issue in the U.S. Over the years, several therapeutic agents for treating these disorders individually have been developed with varied success. There remains an urgent need for more comprehensive approaches for managing such complex diseases. For a diabetic patient with severe dyslipidemia, the increased incidence of atherosclerotic cardiovascular attack<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> may pose more of a threat than hyperglycemia.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Clinical intervention in such patients will have to include glycemic control as well as cardiovascular risk management. A single agent for treating both conditions simultaneously will not only fill an unmet medical need but also open up a new frontier in fighting metabolic syndrome.</div><div class="NLM_p">Peroxisome proliferator activated receptor (PPAR) belongs to a subfamily of ligand-activated nuclear hormone receptors<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> that are involved in regulating nutrient storage and catabolism.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> There are three PPAR subtypes, commonly designated as PPARα, PPARγ, and PPARδ(β).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Agonists of the α subtype have been shown to improve lipid profiles by lowering triglycerides (TG) and low density lipoprotein (LDL) and are therefore used to treat dyslipidemia.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The fibrates, which are weak PPARα agonists, have been used in the clinic for more than 20 years with a good safety profile.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The γ subtype has been studied extensively for its role in regulating glucose metabolism and insulin sensitivity.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> PPARγ full agonists, such as rosiglitazone and pioglitazone, have been developed and marketed for the treatment of T2DM.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> PPARα/γ dual agonists combining the features of both glucose and lipid lowering have been identified as potential therapeutic agents for diabetic hyperglycemia and dyslipidemia.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> However, despite extensive efforts from industry and academia,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> no such agents have advanced to the clinic. Mechanism-based side effects including weight gain, edema, and congestive heart failure, as well as recently reported possible bone fracture following rosiglitazone treatment, are among the major safety hurdles associated with PPARγ full agonists.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Lately, several reports in the literature,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> including work from our own laboratories,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> have demonstrated that selective PPARγ modulators (SPPARγMs) could bind to the receptor in a distinct mode relative to full agonists, providing a physical basis for different biological effects. As a result, such ligands act as partial agonists in transcriptional activity assays and induce an attenuated adipocyte gene signature in the gene chip study. In preclinical species, SPPARγMs were shown to retain antidiabetic efficacy comparable to full PPARγ agonists while displaying reduced PPARγ mechanism-based adverse effects. Over the years, several reports from our laboratories have described a variety of PPAR ligands including γ selective,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>α selective,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and α/γ dual agonists.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Recently, we reported the discovery of a new class of selective PPARγ modulators.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> These indolecarboxylic acids showed potent PPARγ activity in binding assays, partial agonism in cell-based transactivation assays, and good efficacy in lowering hyperglycemia in rodent models of diabetes. In contrast, all previous α/γ dual agents evaluated in preclinical and clinical settings were full PPARγ agonists that carry the aforementioned PPARγ adverse effects. Many of these dual agonists are also highly potent against PPARα, which may pose additional liabilities associated with full and potent PPARα activation.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Considering that fenofibrates are relatively weak PPARα agonists that possess a good efficacy and tolerability profile clinically, we sought to combine both features of a SPPARγM and a relatively weak PPARα agonist to generate a new type of PPARγ/α dual agonist with improved efficacy and safety profiles. We envisioned that such an agent would ideally be a highly potent PPARγ receptor binder with a differentiated partial activation profile for optimal glycemic control and minimal adverse effects. The PPARα activity would preferably be several orders of magnitude less potent, comparable to fenofibrates after adjusting for dosing levels needed for lipid modulation. Here, we describe the discovery process of <b>12d</b> and its in vitro and in vivo biological profiles as a PPARγ modulator or partial agonist with additional PPARα activity.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. 1-Benzoyl-3-benzylindolecarboxylic Acid vs 3-Acyl-1-benzylindolecarboxylic Acid</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the previous report,<a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> we described the SAR of 1-benzoyl-3-benzylindole carboxylic acid analogues (<b>1</b>) as SPPARγMs. Although potent, this class of compounds suffered a drawback of quick debenzoylation in vivo, resulting in lowered PK and high levels of circulating 3-benzylindole metabolites. To circumvent this issue, we transposed the 1- and 3-substituents to create the 3-acyl-1-benzylindolecarboxylic acid (<b>2</b>), which is superimposable to the original structure (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>). A series of such 3-acyl-1-benzylindolecarboxylic acids (<b>12</b>) were prepared following procedures as depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Starting from properly substituted phenylhydrazines (<b>3</b>) and thiosalicylic acid (<b>4</b>), classical Fisher indole cyclization produced two isomers of the indole-3-sulfides (<b>5</b> and <b>6)</b> which were separated by flash column chromatography. The desired isomer <b>6</b> was subjected to reductive cleavage of the sulfide bond to afford the parent indole core <b>7</b>. Friedel−Crafts acylation at C-3 of the indole <b>7</b> followed by N-alkylation gave the acylindole structural platform (<b>8</b>). The carboxylic acid moiety was introduced by O-alkylation after demethylation of the OMe group of <b>9</b> to expose the phenol functionality. Different substitutions on the indole, the benzoyl, and benzyl groups were explored, and the SAR is essentially identical to that of the earlier 1-benzoylindole series (<b>1</b>). Major chemistry efforts were then directed toward the introduction of chirality and different substitution patterns at the α-position of the carboxylic acids (<b>12</b>), which proved to be a very productive site for fine-tuning selectivity ratio between the γ/α receptors.</div><div class="NLM_p">O-Alkylations on intermediate <b>10</b> were carried out by Mitsunobu coupling with corresponding 2-hydroxylcarboxylic esters or through simple displacement reactions with 2-bromocarboxylic esters. Chirality was introduced by either starting with optically pure carboxylic esters or by resolution using chiral HPLC. Several noncommercially available chiral 2-bromocarboxylic esters were prepared starting with the corresponding chiral 2-aminocarboxylic acids via Sandmeyer’s reaction, followed by esterification. For the α,α-dialkylcarboxylic acid analogues <b>12i</b> and <b>12j</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), direct α-alkylation on the indolecarboxylic ester <b>11d</b> via lithium diisopropylamide (LDA) and iodomethane resulted in methylation of the 2-methyl group on the indole core. To avoid this side reaction, 3-methylphenol (<b>13</b>) was used as the starting material. Attachment reaction with ethyl 2-bromobutyrate (<b>14</b>) followed by α-alkylation with LDA and iodomethane gave the α,α-dialkylcarboxylic ester <b>16</b>. This intermediate was converted to the benzyl bromide <b>17</b> by free radical bromination with <i>N</i>-bromosuccinamide (NBS) and then attached to the indole <b>8</b> to give the racemic carboxylic ester, which was resolved by chiral HPLC and hydrolyzed to afford acids <b>12i</b> and <b>12j</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). A separate manuscript describing an improved synthesis of <b>12d</b> on a 3 kg scale has been accepted for publication.<a onclick="showRef(event, 'cit22a'); return false;" href="javascript:void(0);" class="ref cit22a">(22a)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AcOH, 110 °C, flash SiO<sub>2</sub> column separation to obtain <b>6</b>; (b) TFA, 50 °C; (c) ZnCl<sub>2</sub>, EtMgCl, CH<sub>2</sub>Cl<sub>2</sub>, AlCl<sub>3,</sub> room temp; (d) Cs<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (e) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (f) PPh<sub>3</sub>, DIAD, THF, 0 °C, X = OH; or Cs<sub>2</sub>CO<sub>3</sub>, DMF, room temp, X = Br; (g) NaOH, MeOH, room temp.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (b) LDA, MeI, THF, −78 °C; (c) NBS, AIBN, CCl<sub>4</sub>, reflux; (d) Ce<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (e) chiral HPLC resolution; (f) NaOH, MeOH, room temp.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Earlier SAR efforts established that the 3-acylindole series exhibited slightly enhanced PPARα activity relative to the 1-benzoylindole series. Extensive SAR exploration followed, with variations of substitutions on the indole ring, the acyl group, and the aromatic ring of the 1-benzyl substitution. Several hundred analogues were prepared, and many of them are potent PPARγ selective modulators which will be the subject of a separate publication.<a onclick="showRef(event, 'cit22b'); return false;" href="javascript:void(0);" class="ref cit22b">(22b)</a> Among all the permutations we explored with this chemotype, the only modification that significantly affects the selectivity and activity ratios between α and γ receptors is at the position α to the carboxylic acid. We herein focus the discussion only on a few selected analogues varying the α substituent with the rest of the structure optimized for PPARγ activity. The 3-acylindolecarboxylic acids described herein are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Their biological activities are evaluated on two criteria: their affinity to PPARγ and α receptors (IC<sub>50</sub>)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and their agonist activity in a PPAR-GAL4 chimeric transactivation assay in COS-1 cells in terms of potency (EC<sub>50</sub>) and maximum activation (Max%) relative to rosiglitazone for γ agonism.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> All compounds with α agonism have similar activation levels as WY14643, a PPARα full agonist control.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Compound <b>1</b> is a typical 1-benzoyl-3-benzylindolecarboxylic acid type of PPARγ selective modulator with high binding affinity to the γ receptor and potent EC<sub>50</sub> activity in the cell based transactivation assay with 30% of maximum activation. Its PPARα receptor activity is minimal in both the binding and transactivation assays. Compound <b>2</b> is the corresponding 3-acyl-1-benzylindolecarboxylic acid equivalent. There is little change in PPARγ potency and maximum activation. But a slight increase of potency on the mouse α receptor was detected in the transactivation assay. Introduction of a methyl substitution at α-position to the carboxylic acid significantly increases the PPARα activity, while the PPARγ potency remains unaffected. Interestingly, this increase in PPARα activity can be separated within the same molecule by separating the two stereoisomers generated by the substitution. While compound <b>12a</b>, the (<i>S</i>)-enantiomer, remains a highly potent and highly selective PPARγ modulator, compound <b>12b</b>, the (<i>R</i>)-enantiomer, carried all the activity toward the α receptor with only a slight decrease in potency for the γ receptor. This was a consistent pattern for the (<i>R</i>)-enantiomers of the series. Generally, increasing the size of the substituents increases the α potency. Compound <b>12c</b>, the (<i>S</i>)-enantiomer of the ethyl-substituted analogue, is a selective PPARγ modulater, while its (<i>R</i>)-enantiomer, compound <b>12d</b>, has significant PPARα activity in addition to its potent PPARγ activity. The propyl-substituted analogues <b>12e</b> and <b>12f</b> are very similar to their ethyl-substituted counterparts with small increases of α activity on the mouse receptor. With further increases in substituent size, PPARα activity starts to manifest in the (<i>S</i>)-enantiomer. As a result, compound <b>12g</b>, the (<i>S</i>)-enantiomer of the isopropyl analogue, bears weak activity toward the PPARα receptor in the transactivation assay. The corresponding (<i>R</i>)-enantiomer, compound <b>12h</b>, becomes a potent PPARα/γ dual agonist with EC<sub>50</sub> = 2 nM on both receptors in the same assay. The α,α-disubstituted carboxylic acids exemplified by <b>12i</b>−<b>j</b> are generally γ weighed γ/α dual agonists which have equal distribution of selectivity in their stereoisomers. The cyclobutyl substituted analogue <b>12k</b> shows balanced α activities toward both mouse and human receptors with PPARγ activities slightly weaker compared to that of other analogues. It is important to note that all the compounds in this series demonstrated a high degree of selectivity over PPARδ subtype. No activity was observed for this receptor at the highest concentration tested (50 μM) in the binding assay.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro and in Vivo Activities of 3-Acylindole-1-benzylcarboxylic Acids</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th align="left"> </th><th align="left"> </th><th class="rowsep1" colspan="2" align="center" char=".">SPA IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1" colspan="3" align="center">TA EC<sub>50</sub> (nM) (max)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="rowsep1" colspan="2" align="center" char=".">db/db (10 mpk)</th><th align="center" char="."> </th></tr><tr valign="top"><th align="center">compd</th><th align="center">R<sub>1</sub></th><th align="center">R<sub>2</sub></th><th align="center" char=".">hPPARγ</th><th align="center" char=".">hPPARα</th><th align="center">hPPARγ</th><th align="center" char=".">hPPARα</th><th align="center" char=".">mPPARα</th><th align="center" char=".">−Glu (%)</th><th align="center" char=".">−TG (%)</th><th align="center" char=".">rat PK (2 mpk) (po) AUC (μM·h)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left"> </td><td align="left"> </td><td align="char" char=".">1</td><td align="char" char=".">>15000</td><td align="left">3 (30%)</td><td align="char" char=".">>3000</td><td align="char" char=".">>3000</td><td align="char" char="."> </td><td align="char" char="."> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left"> </td><td align="left"> </td><td align="char" char=".">2</td><td align="char" char=".">>15000</td><td align="left">2 (20%)</td><td align="char" char=".">>3000</td><td align="char" char=".">350</td><td align="char" char="."> </td><td align="char" char="."> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>12a</b></td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">1</td><td align="center" char=".">>15000 <a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td align="left">1 (30%)</td><td align="char" char=".">4890</td><td align="char" char=".">>3000</td><td align="char" char=".">53</td><td align="char" char=".">4</td><td align="char" char=".">0.6</td></tr><tr valign="top"><td align="left"><b>12b</b></td><td align="left">H</td><td align="left">Me</td><td align="char" char=".">11</td><td align="center" char=".">>15000<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td align="left">4 (50%)</td><td align="char" char=".">320</td><td align="char" char=".">28</td><td align="char" char=".">105</td><td align="char" char=".">90</td><td align="char" char=".">1.1</td></tr><tr valign="top"><td align="left"><b>12c</b></td><td align="left">Et</td><td align="left">H</td><td align="char" char=".">4</td><td align="center" char=".">>15000<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td align="left">6 (20%)</td><td align="char" char=".">500</td><td align="char" char=".">>3000</td><td align="char" char=".">22</td><td align="char" char=".">7</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>12d</b></td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">9</td><td align="char" char=".">2624</td><td align="left">2 (48%)</td><td align="char" char=".">230</td><td align="char" char=".">120</td><td align="char" char=".">101</td><td align="char" char=".">84</td><td align="char" char=".">1.5</td></tr><tr valign="top"><td align="left"><b>12e</b></td><td align="left">Pr</td><td align="left">H</td><td align="char" char=".">8</td><td align="char" char=".">>50000</td><td align="left">1 (27%)</td><td align="char" char=".">>3000</td><td align="char" char=".">>3000</td><td align="char" char=".">22</td><td align="char" char=".">8</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left"><b>12f</b></td><td align="left">H</td><td align="left">Pr</td><td align="char" char=".">12</td><td align="center" char=".">>15000<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td align="left">10 (51%)</td><td align="char" char=".">380</td><td align="char" char=".">110</td><td align="char" char=".">94</td><td align="char" char=".">80</td><td align="char" char=".">1.7</td></tr><tr valign="top"><td align="left"><b>12g</b></td><td align="left">i-Pr</td><td align="left">H</td><td align="char" char=".">17</td><td align="char" char=".">2981</td><td align="left">21 (24%)</td><td align="char" char=".">370</td><td align="char" char=".">360</td><td align="char" char=".">76</td><td align="char" char=".">37</td><td align="char" char=".">1.5</td></tr><tr valign="top"><td align="left"><b>12h</b></td><td align="left">H</td><td align="left">i-Pr</td><td align="char" char=".">10</td><td align="char" char=".">491</td><td align="left">2 (55%)</td><td align="char" char=".">2</td><td align="char" char=".">40</td><td align="char" char=".">101</td><td align="char" char=".">87</td><td align="char" char=".">3.5</td></tr><tr valign="top"><td align="left"><b>12i</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td align="left">Et</td><td align="left">Me</td><td align="char" char=".">9</td><td align="char" char=".">87</td><td align="left">2 (41%)</td><td align="char" char=".">107</td><td align="char" char=".">>1000</td><td align="char" char=".">71</td><td align="char" char=".">51</td><td align="char" char=".">1.3</td></tr><tr valign="top"><td align="left"><b>12j</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td align="left">Me</td><td align="left">Et</td><td align="char" char=".">5</td><td align="char" char=".">764</td><td align="left">2 (27%)</td><td align="char" char=".">129</td><td align="char" char=".">>1000</td><td align="char" char=".">45</td><td align="char" char=".">3</td><td align="char" char=".">2.8</td></tr><tr valign="top"><td align="left"><b>12k</b></td><td colspan="2" align="left">cyclobutyl</td><td align="char" char=".">16</td><td align="char" char=".">1081</td><td align="center">12 (35%)</td><td align="center" char=".">185</td><td align="char" char=".">150</td><td align="char" char="."> </td><td align="char" char="."> </td><td align="char" char="."> </td></tr><tr valign="top"><td colspan="3" align="left">rosiglitazone</td><td align="char" char=".">200</td><td align="center" char=".">>50000</td><td align="left">20 (100%)</td><td align="char" char=".">>3000</td><td align="center" char=".">>3000</td><td align="char" char=".">76</td><td align="char" char=".">71</td><td align="char" char=".">16.4</td></tr><tr valign="top"><td colspan="3" align="left">fenofibrate</td><td align="char" char=".">>5000</td><td align="center" char=".">1000</td><td align="center">>5000</td><td align="char" char=".">2000</td><td align="char" char="."> </td><td align="char" char="."> </td><td align="char" char="."> </td><td align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">SPA = scintillation proximity assay. Mean value of three determinations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">TA = transactivation assay. Rosiglitazone TA response set to 100%. Mean value of three determinations.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Absolute configuration undetermined.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Above sensitivity range due to weaker activity.</p></div></div></div><div class="NLM_p">In vivo efficacy of selected analogues was evaluated using db/db mice by daily oral administration of the test compounds for 10 days.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> On the 11th day, blood glucose (Glu) and triglyceride (TG) levels from test animals were measured vs those from the vehicle control. All compounds were dosed at 10 mpk with rosiglitazone (10 mpk) as positive control. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, a clear relationship between PPARα agonism and its efficacy in glucose and TG lowering in db/db mice is established. The highly potent PPARγ selective agonists <b>12a</b>,<b>c</b>,<b>e</b> exhibited modest efficacy (22−53%) in glucose lowering and essentially no effects on TG levels. Their modest glucose-lowering efficacy relative to the selective PPARγ full agonist, rosiglitazone (−76%), is likely due to partial activation of the γ receptor and lower blood exposures. However, <b>12b</b>,<b>d</b>,<b>f</b>, the enantiomers of <b>12a</b>,<b>c</b>,<b>e</b>, showed robust glucose (94−105%) and TG (80−90%) lowering in the db/db study. The only apparent difference between these enantiomers was their intrinsic PPARα activity. For compounds <b>12g</b> and <b>12h</b>, both (<i>S</i>)- and (<i>R</i>)-enantiomers carried a certain amount of PPARα agonist activity, and therefore, both showed good in vivo efficacy regarding Glu and TG lowering. However, the (<i>R</i>)-enantiomer (<b>12h</b>) was a much more potent PPARα agonist and was much more efficacious than its (<i>S</i>)-enantiomer (<b>12g</b>). The α,α-disubstituted analogues (<b>12i</b>−<b>j</b>) had moderate PPARα activity and thus moderate efficacy in Glu and TG lowering. Further comparison of PK profiles of these (<i>R</i>)-enantiomers with their (<i>S</i>)-enantiomer counterparts (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) indicated that they have similar blood exposure levels, eliminating the possibility that elevated drug levels contributed to the increased efficacy of the former ligands. The apparent contribution of PPARα to the observed hypoglycemic effect is consistent with reports of insulin sensitization by PPARα selective agonists in rodents.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Recently, PPARα agonists have been reported to demonstrate insulin sensitizing activity in nonrodent models of insulin resistance.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The additional contribution of PPARα agonism to the hypoglycemic effect of PPARγ partial agonism may provide these unique PPARα/γ dual ligands with enhanced clinical efficacy, although this hypothesis remains to be proven in human trials.</div><div class="NLM_p">One important criterion for selecting a candidate for further preclinical development in this project was the proper balance between PPARγ and PPARα activity within one molecule. Considering the partial PPARγ activation of this class of compounds, we targeted a candidate to be a highly potent PPARγ agonist with maximum activation in the range of 50% relative to the full agonists. Most of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> have PPARγ potency that is 10- to 20-fold greater than that of rosiglitazone but also showed significantly lower drug exposures in rat PK, about 10−20% to that of rosiglitazone. After adjustment of potency and exposure, the estimated dosing levels of these compounds in humans are expected to be similar to that of rosiglitazone, which is 2−8 mg q.d.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In contrast, the clinical dose of fenofibrate, which is a weak PPARα agonist with EC<sub>50</sub> = 2−4 μM in our transactivation assay, is in the range of 100−150 mg q.d.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Achieving the same PPARα agonist effects as fenofibrate at a dose level of 2−8 mg would require the selected compound to have an EC<sub>50</sub> of around 200 nM in our PPARα transactivation assay (see later discussions for further correlation). Among the four most efficacious compounds (<b>12b</b>,<b>d</b>,<b>f</b>,<b>h</b>) in our in vivo efficacy studies, the functional activity of <b>12h</b> on the PPARα receptor was deemed too potent (2 nM) in our selection criteria, while the α potency of <b>12f</b> was insufficient. </div><div class="NLM_p">It has been demonstrated that PPARα agonists can exhibit differential species-dependent transactivation profiles.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> It is desirable to identify a compound with relatively similar PPARα potency in the various species used in preclinical efficacy and safety studies as well as in man. Thus, transactivation assays were conducted using chimeric PPARα receptors derived from a variety of appropriate species. The results indicated that compound <b>12b</b> had very different potency on human vs mouse α receptors, while <b>12d</b> exhibited comparable agonist activity toward mouse, hamster, dog, and human PPARα receptors with EC<sub>50</sub> values of 0.12, 0.46, 0.55, and 0.23 μM, respectively. In the screen of a panel of cytochrome P450 (CYP) isozymes for potential inhibition, <b>12d</b> gave IC<sub>50</sub> values of 91, 24, 40, 7, and 10 μM, respectively, for 2C19, 4A4, 1A2, 2D6, and 2C9, a significant improvement from some of the indole analogues published earlier.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Furthermore, compound <b>12d</b> demonstrated a high degree of selectivity against other members of the nuclear receptor family. In nuclear receptor counterscreens, compound <b>12d</b> was negative in binding and/or activation assays of LXRα, LXRβ, RXRα, PXR, GR, ERα, ERβ, TRα, and TRβ at concentrations up to 10 μM. On the basis of this attractive profile, compound <b>12d</b> was selected for further evaluation.</div><div class="NLM_p">Compound <b>12d</b> was assessed for its ability to lower plasma levels of glucose, TG, or insulin in db/db mouse,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> ob/ob mouse,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and HFD/STZ mouse models.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In several independent 12-day db/db studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), <b>12d</b> consistently produced dose-dependent corrections of glucose (78−101%) and TG levels (75−85%) in a dosing range of 1−10 mpk. As a positive control in these experiments, rosiglitazone at 10 mpk lowered glucose levels by an average of 76% and TG by 71%. Measurements of systemic drug exposure for <b>12d</b> showed <i>C</i><sub>max</sub> and AUC values of 1.5/5.4/9.6 μM and 1.9/6.4/9.6 μM·h, respectively, at dosages of 1/3/10 mpk. In contrast, drug levels of rosiglitazone in this assay were measured to be much higher, with <i>C</i><sub>max</sub> of 68 μM and AUC of 317 μM·h at a dosage of 10 mpk. Thus, <b>12d</b> produced substantial efficacy at drug levels that were lower than those typically observed with rosiglitazone. In the same experiment, pioglitazone at 10 mpk lowered glucose level by 53% and TG by 65% with a systemic exposure of 180 μM·h. In two independent ob/ob studies, <b>12d</b> lowered insulin levels by 67% at 3 mpk and 89% at 10 mpk while rosiglitazone treatment at 1 mpk led to a corresponding insulin reduction of 50% (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In the more stringent HFD/STZ mouse model, <b>12d</b> produced glucose corrections of 75% and 103% at dosages of 5 and 30 mpk while rosiglitazone lowered glucose by 36% and 45%, respectively, at the same dosing levels (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). These results clearly demonstrate the superior antihyperglycemic and antidyslipidemic efficacy of compound <b>12d</b> in multiple animal models vs TZDs currently available in the clinic.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vivo Efficacy of Compound <b>12d</b> in db/db Mice<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center" char=".">dose (mpk)</th><th align="center" char=".">glucose correction (%)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th align="center" char=".">TG correction (%)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th align="center"><i>C</i><sub>max</sub> (μM)/AUC (μM·h)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">1</td><td align="char" char=".">78</td><td align="char" char=".">75</td><td align="char">1.5/1.9</td></tr><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">3</td><td align="char" char=".">98</td><td align="char" char=".">85</td><td align="char">5.4/6.4</td></tr><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">10</td><td align="char" char=".">101</td><td align="char" char=".">82</td><td align="char">9.6/9.6</td></tr><tr valign="top"><td align="left">rosiglitazone</td><td align="char" char=".">10</td><td align="char" char=".">76</td><td align="char" char=".">71</td><td align="char">68/317</td></tr><tr valign="top"><td align="left">pioglitazone</td><td align="char" char=".">10</td><td align="char" char=".">53</td><td align="char" char=".">65</td><td align="char">_/180</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Male db/db mice and lean mice were dosed daily for 11 days by gavage with vehicle or the indicated doses of test compounds. Glucose and triglyceride corrections were calculated as percent correction of vehicle control.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Mean value (<i>n</i> = 7). <i>P</i> < 0.01 vs vehicle control.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Mean value (<i>n</i> = 4).</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vivo Efficacy of Compound <b>12d</b> in ob/ob Mice<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center" char=".">dose (mpk)</th><th align="center" char=".">glucose correction (%)</th><th align="center" char=".">TG correction (%)</th><th align="center" char=".">insulin correction (%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">3</td><td align="char" char=".">21</td><td align="char" char=".">27</td><td align="char" char=".">67</td></tr><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">10</td><td align="char" char=".">34</td><td align="char" char=".">50</td><td align="char" char=".">89</td></tr><tr valign="top"><td align="left">rosiglitazone</td><td align="char" char=".">1</td><td align="char" char=".">15</td><td align="char" char=".">45</td><td align="char" char=".">50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Female ob/ob mice and lean mice were dosed daily for 5 days by gavage with vehicle or the indicated doses of test compounds. Glucose, triglyceride, and insulin corrections were calculated as percent correction of vehicle control. Each data point represents the mean value of five individual mice.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vivo Efficacy of Compound <b>12d</b> in HFD/STZ Mouse Model<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center" char=".">dose (mpk)</th><th align="center" char=".">glucose correction (%)</th><th align="center" char=".">AUC (μM·h)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">5</td><td align="char" char=".">75</td><td align="char" char=".">2.7</td></tr><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">30</td><td align="char" char=".">103</td><td align="char" char=".">8.2</td></tr><tr valign="top"><td align="left">rosiglitazone</td><td align="char" char=".">5</td><td align="char" char=".">36</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left">rosiglitazone</td><td align="char" char=".">30</td><td align="char" char=".">45</td><td align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Male HFD/STZ mice were dosed daily for 12 days by gavage with vehicle or the indicated doses of test compounds. Glucose correction was calculated as percent correction of vehicle control. Each data point represents the mean value of five individual mice.</p></div></div></div><div class="NLM_p">A 7-day study was conducted in obese, insulin resistant Zucker fa/fa rats,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> a preclinical model we use to directly compare the insulin sensitizing efficacy vs the mechanism-based side effects of PPARγ ligands. The plasma volume (PV) and heart weight of test animals were measured as well as their insulin levels and lipid profiles. In this study, <b>12d</b> (0.03, 0.3, 3.0, 15 mpk) was compared to rosiglitazone (1.0, 10, and 100 mpk). Both compounds substantially lowered elevated levels of free fatty acids, insulin, and triglycerides, indicating significant insulin sensitizing activity. However, efficacy was achieved with lower exposure of <b>12d</b> (insulin lowering ED<sub>50</sub> = 10 μM·h) than rosiglitazone (insulin lowering ED<sub>50</sub> = 125 μM·h). Importantly, while rosiglitazone produced clear dose responsive increases in plasma volume and heart weight at dosages of ≥10 mpk, no significant increase in heart weight was seen with <b>12d</b>; and at 15 mpk of <b>12d</b> (1060 μM·h), only a slight increase in plasma volume was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Evaluation of compound <b>12d</b> in fa/fa Zucker rat for plasma volume and cardiac effects. Animals (<i>n</i> = 8) were treated daily for 7 days with vehicle, rosiglitazone (1, 10, and 100 mpk), or <b>12d</b> (0.03, 0.3, 3, 15 mpk). Circulating drug and insulin levels, plasma volume, and heart weight were determined as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. The drug exposure levels that caused a 50% reduction in plasma insulin (ED<sub>50</sub>) for rosiglitazone and <b>12d</b> were 125 and 10 μM·h, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In additional studies, the ability of <b>12d</b> to improve serum lipid profiles was assessed in both hamster<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and dog<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> efficacy models. In a 9-day study conducted in Syrian hamsters, <b>12d</b> produced substantial dose-proportional decreases in total cholesterol (22−51%) and triglycerides (10−57%) at dosages of 0.3−3 mpk. In the same study, fenofibrate (100 mpk) served as a positive control and lowered cholesterol (23%) and TG (34%). Systemic exposures from an independent 9-day dosing experiment in hamsters gave <i>C</i><sub>max</sub> and AUC values of 0.02/0.07/0.6 μM and 0.13/0.55/2.11 μM·h, respectively, at dosages of 0.3/1/3 mpk. The hamster AUC for fenofibrate at 100 mpk averaged 1800 μM·h (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Thus, by exposure-based comparisons, <b>12d</b> was substantially more potent (>1000-fold) than fenofibrate in this assay and also achieved a maximal efficacy that exceeded the fenofibrate effects. In a 14-day male Beagle dog study, low dosages of <b>12d</b> were associated with significant lipid lowering. The observed total cholesterol lowering in dogs was 12.8% and 26% at 1 and 3 mpk. In this same study, fenofibrate at 50 mpk lowered total cholesterol by 17%. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, the net lipid lowering by <b>12d</b> at 1−3 mpk was similar, or superior, to the efficacy of 50 mpk fenofibrate. If this result is translated to human, to achieve the same clinical efficacy of 150 mg fenofibrate would require 3−9 mg of <b>12d</b>, which is right in the range of expected clinical dose for <b>12d</b> based on its PPARγ instigated antidiabetic effect. Compound <b>12d</b> was also compared with simvastatin in the dog lipid model. Simvastatin (4 mpk) lowered cholesterol to a lesser extent than 3 mpk <b>12d</b>. Coadministration of <b>12d</b> (3 mpk) with simvastatin (4 mpk) produced additive effects (cholesterol lowering of 36.4%) vs simvastatin alone (18.4%). Drug exposure measurements of <b>12d</b> at 1 and 3 mpk showed <i>C</i><sub>max</sub> of 1.03 and 18.58 μM and AUC of 5.41 and 21.4 μM·h, respectively. Exposure values for fenofibrate in this assay at 50 mkd were higher (<i>C</i><sub>max</sub> = 15 μM, AUC = 117 μM·h). Drug levels of <b>12d</b>, simvastatin, and simvastatin acid were unaffected by coadministration (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo Efficacy of Compound <b>12d</b> in Lipid Hamster Model<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center" char=".">dose (mpk)</th><th align="center" char=".">cholesterol correction (%)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th align="center" char=".">triglyceride correction (%)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th align="center">hamster-PK <i>C</i><sub>max</sub> (μM)/AUC (μM·h)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">0.3</td><td align="char" char=".">21.9</td><td align="char" char=".">10.1</td><td align="char">0.02/0.13</td></tr><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">1</td><td align="char" char=".">33.9</td><td align="char" char=".">30.7</td><td align="char">0.07/0.55</td></tr><tr valign="top"><td align="left"><b>12d</b></td><td align="char" char=".">3</td><td align="char" char=".">51.4</td><td align="char" char=".">56.9</td><td align="char">0.6/2.11</td></tr><tr valign="top"><td align="left">fenofibrate</td><td align="char" char=".">100</td><td align="char" char=".">22.7</td><td align="char" char=".">33.7</td><td align="char">−/1800</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Male golden Syrian hamsters fed a normal rodent chow were orally dosed daily for 9 days by gavage with vehicle or the indicated doses of test compounds. Glucose and triglyceride corrections were calculated as percent correction of vehicle control.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Mean value (<i>n</i> = 10). <i>P</i> < 0.01 vs vehicle control.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Mean value (<i>n</i> = 4).</p></div></div></div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Percentage reduction of serum total cholesterol levels in mature beagle dogs. Dogs were housed individually and dosed daily by oral gavage with <b>12d</b>, simvastatin (Simva), fenofibrate, or vehicle, respectively. Serum cholesterol reductions were calculated as percent correction of vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To evaluate the typical PPARγ and PPARα agonist-mediated side effects, <b>12d</b> was compared head-to-head with both the full PPARγ agonist rosiglitazone and the PPARα ligand fenofibrate in a 2-week normal Sprague−Dawley (SD) rat tolerability study. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, typical effects associated with PPARγ activation such as brown adipose tissue (BAT) proliferation<a onclick="showRef(event, 'cit35a'); return false;" href="javascript:void(0);" class="ref cit35a">(35a)</a> and heart weight increases<a onclick="showRef(event, 'cit35b'); return false;" href="javascript:void(0);" class="ref cit35b">(35b)</a> were observed with rosiglitazone but not or in less extent with <b>12d</b>. For example, rosiglitazone increased heart weight by 25% and BAT depot mass by 260% while <b>12d</b> only increased these two parameters by 1% and 32%, respectively. In contrast, the PPARα driven liver signatures<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> such as increased liver weight and albumin/globulin and bilirubin levels were observed with both fenofibrate and <b>12d</b> on a similar scale. These findings are consistent with the profile of <b>12d</b> as a PPARγ partial agonist with additional PPARα full agonistic activity. Overall, <b>12d</b> was well tolerated in this experiment and there were no significant findings other than those described above.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Two-Week SD Rat Tolerability Study Results of <b>12d</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="colsep1" colspan="3" align="center">compd</th></tr><tr valign="top"><th align="center">parameter</th><th align="center"><b>12d</b></th><th align="center">rosiglitazone</th><th align="center" char=".">fenofibrate</th></tr></thead><tbody><tr valign="top"><td align="left">dose (mpk)</td><td align="char">60</td><td align="char">150</td><td align="char" char=".">300</td></tr><tr valign="top"><td align="left">AUC (μM·h)</td><td align="char">40</td><td align="char">600−1650</td><td align="char" char=".">5600</td></tr><tr valign="top"><td align="left">heart weight (%)</td><td align="char">1</td><td align="char">25</td><td align="char" char=".">3</td></tr><tr valign="top"><td align="left">BAT weight (%)</td><td align="char">32</td><td align="char">260</td><td align="char" char=".">5</td></tr><tr valign="top"><td align="left">hematocrit</td><td align="char">−8%</td><td align="char">−11%</td><td align="char" char=".">−10</td></tr><tr valign="top"><td align="left">liver weight (%)</td><td align="char">127</td><td align="char">17</td><td align="char" char=".">111</td></tr><tr valign="top"><td align="left">albumin/globulin (%)</td><td align="char">45</td><td align="char">−4</td><td align="char" char=".">95</td></tr><tr valign="top"><td align="left">bilirubin (%)</td><td align="char">48</td><td align="char">16</td><td align="char" char=".">40</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Male normal rat fed a rodent chow with vehicle or test compounds at the indicated doses for 2 weeks. Changes in serum chemistry and organ weight were calculated as percent change of vehicle control. For details, see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, compound <b>12d</b> is a potent PPARγ partial agonist possessing additional modest PPARα activity. Its glucose and insulin lowering activity was similar or superior to that of rosiglitazone in rodent models of T2DM but at significantly lower plasma levels. Potent lipid-modulating efficacy was demonstrated in hamster and dog. An improved therapeutic window was noted with <b>12d</b> in insulin resistant rat studies in which plasma volume expansion and cardiac enlargement were diminished vs that caused by less efficacious doses of rosiglitazone. Unlike the marketed thiazolidinediones, <b>12d</b> is a PPARγ modulator (PPARγM). This designation is based on the partial agonism observed in cell-based functional assays and mutagenesis studies<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> plus the results obtained in our in vivo efficacy studies. The additional PPARα activity of <b>12d</b> not only contributed to the agent’s ability to manage lipid profiles but also appear to have potentiated its PPARγ efficacy in lowering glucose levels in db/db mice. Its relative potencies on PPARγ and PPARα receptors are proportional for projected clinical applications. These unique biological properties of compound <b>12d</b> as a PPARγM with additional modest PPARα activities make it an attractive candidate for a novel therapeutic agent for the treatment of T2DM and dyeslipidemia.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04823" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04823" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vitro Assays</h3><div class="NLM_p last">Activities of compounds were evaluated for both binding affinity and functional activity. Binding affinities for the PPARs were measured in a scintillation proximity assay (SPA). Selected compounds from the binding assay were then evaluated for their potencies of PPAR gene activation in cell-based transcription assays using GAL4-PPAR chimeric receptors as previously described.<a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> All results were produced in triplicate, and mean values are reported.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo db/db Mouse Studies</h3><div class="NLM_p last">Male db/db (C57BLKS/J-m +/+Leprdb) mice at 12−13 weeks of age and nondiabetic db/+ (lean) mice from Jackson Laboratories were housed seven mice per cage and fed a rodent chow with free access to water. Mice (seven per group) received a once daily oral dosing of test compounds with vehicle (0.25% methylcellulose) by oral gavage for 11 days. Blood was collected from the tail immediately prior to the next dosing at days 0, 4, 7, and 11 for measurement of the plasma glucose levels.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo ob/ob Mouse Studies</h3><div class="NLM_p last">Female ob/ob mice from Jackson Laboratories (∼8 weeks old; body weight ∼50 g; food P5008) were fasted for 5 h after which time a baseline blood sample for determination of glucose and insulin was collected into a heparinized capillary tube. Animals were subsequently assigned to treatment groups (<i>n</i> = 5/group) such that baseline glucose values were equivalent between groups. Mice were administered compounds in a volume (0.5 mL/animal) of vehicle (0.25% methylcellulose) by oral gavage for 5 consecutive days. One hour prior to the last day of dosing food was removed from all animals’ cages. Four hours after the last dose of compound the animals were euthanized via carbon dioxide inhalation and a terminal blood sample was collected by cardiac puncture. Sera prepared from the blood samples were used for the determination of glucose (using a Sigma glucose (Tinder) 100 assay kit) and insulin (using a Linco rat insulin radioimmunoassay kit).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo HFD-STZ Mice Studies</h3><div class="NLM_p last">Male mice were fed high fat diet (HFD) for 3 weeks and then injected with a single dose (90 mg/kg) of streptozotocin (STZ) and fed HFD for an additional 3 weeks. Animals were subsequently assigned to treatment groups (<i>n</i> = 5/group) and were administered compounds in a volume (0.5 mL/animal) of vehicle (0.25% methylcellulose) by oral gavage for 12 consecutive days. Animals were then euthanized via carbon dioxide inhalation and a terminal blood sample was collected by cardiac puncture. Sera prepared from the blood samples were used for the determination of glucose.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Hamster Lipid Studies</h3><div class="NLM_p last">Golden Syrian hamsters weighing between 120 and 150 g were purchased from Charles River Laboratories and used for the experiments. Hamsters were housed in boxes (five per box) and fed a normal rodent chow with free access to water. Hamsters (10 for each group) were orally dosed with compounds (suspended in 0.5% methylcellulose) for 9 days. On the morning of the 10th day, hamsters were euthanized with carbon dioxide, and blood samples were obtained via heart puncture. Serum cholesterol and triglyceride levels were determined from the samples.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Dog Lipid Studies</h3><div class="NLM_p last">Mature male beagle dogs weighing between 12 and 18 kg were purchased from Marshall Farm, PA. They were housed individually and fed a cholesterol-free chow diet with free access to water. Prior to starting experiments, the dogs (five for each group) were bled weekly from the jugular vein and their serum cholesterol levels were determined. Test compounds were suspended in 0.5% methylcellulose and administered orally to the dogs daily for 2 weeks. Blood samples were taken during and after the dosing periods, and serum cholesterol levels were determined.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Obese Zucker fa/fa Rat Studies</h3><div class="NLM_p">Nine to ten week old male Zucker fa/fa rats (Charles River Laboratories, Wilmington, MA) were housed two animals per cage and were provided food (Harlan Teklad diet no. 7012, Madison, WI) and water ad libitum. Animals were housed in a temperature-, humidity-, and light-controlled room (21−23 °C, 47−65%, 12−12 h light−dark cycle, <i>n</i> = 8/group). Following 7 days of acclimation, rats were treated once daily for 7 days by oral gavage with test comopunds (0.25% methylcellulose, 10 mL/kg).</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Evaluation of Insulin Sensitization</h4><div class="NLM_p last">Tail nick blood samples were collected one day before the start of dosing and one day after the seventh dose, and plasma glucose (Sigma glucose Trinder assay kit, St. Louis, MO), insulin (rat insulin RIA from American Laboratory Products Company, Windham, NH), and free fatty acids (FFA) and triglyceride (both from Roche Diagnostics, Basel, Switzerland) concentrations were determined.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Bioelectrical Impedance Analysis for Determination of Extracellular Fluid Volume</h4><div class="NLM_p last">Twenty-four hours following the final dose, rats were anesthetized with ketamine (85 mg/kg, im) and xylazine (10 mg/kg, im). Animals were positioned on a nonconductive surface in dorso-lateral recumbency, and extracellular fluid volume was determined by bioelectrical impedance analysis, following procedures described by the manufacturer (Hydra ECF/ICF impedance analyzer model 4, Xitron, San Diego, CA). A tetrapolar impedance monitor was used to measure impedance, and hence the total body water, over a frequency range of 5 kHz to 1 MHz. Source electrodes (1 cm × 26G stainless steel needles) were inserted 5 mm subcutaneously. Detector electrodes were inserted along the midline at the anterior point of the sternum and the anterior point of the penis. The distance between electrodes was measured and included for data modeling.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Plasma Volume Measurement</h4><div class="NLM_p last">After determination of extracellular fluid volume, plasma volume was measured in anesthetized animals using a dye dilution technique following methods described by Belcher and Harriss<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> with minor modifications. Evans blue dye solution (25 mg/mL in physiological saline) was filtered through a 0.22 μm filter prior to injection into a femoral vein. Twenty minutes after injection, a heparinized blood sample (2 mL) was withdrawn from the descending aorta. Plasma was separated by centrifugation of the blood at 1100<i>g</i> for 15 min; samples were kept at −80 °C until assayed. Absorbance of the thawed plasma was read at 620 nm, and plasma Evans blue dye concentrations were calculated according to a standard curve generated by a serial dilution of the 25 mg/mL Evans blue dye−saline solution. Plasma volume was calculated by using the dilution factors of Evans blue as shown below.<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/jm-2009-00367w_m001.gif" alt="" /></img></span></div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Heart Weight Measurements</h4><div class="NLM_p last">Animals were then euthanized by pneumothorax and exsanguination, and the heart was excised, blotted, and weighed.</div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Rat Tolerability Studies</h3><div class="NLM_p last">Male Sprague−Dawley rats weighing about 200 g from Charles River were housed three rats per cage and provided free access to water and rodent chow. Rats (<i>n</i> = 6) were orally dosed once daily by gavage with vehicle or test compounds at indicated doses in 0.5% methylcellulose for 14 days. Animals were euthanized via carbon dioxide 24 h following the last dose, and the indicated tissue and organs were removed and weighed. Blood samples were drawn via heart puncture and assayed for serum chemistry.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Pharmacokinetic Studies</h3><div class="NLM_p last">For the determination of the exposure of the testing compounds in animals, blood samples were taken at specified intervals. The plasma was separated, acidified by the addition of 0.5 M formate buffer, pH 3.0 (0.3 mL of formate buffer per mL plasma), and stored at −70 °C prior to extraction and analysis. Concentrations of the testing compounds were determined following protein precipitation with acetonitrile. Calibration curves were constructed using plasma of control animals by addition of known quantities of the testing compounds as an internal standard. Quantitative analyses were carried out by LC−MS−MS using a PE Sciex API 3000 triple quadrupole mass spectrometer. Plasma concentrations and PK parameters were determined using Watson software.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthetic Materials and Methods</h3><div class="NLM_p last">Reagents and solvents were obtained from commercial suppliers and were used without further purification. Flash chromatography was performed using E. Merck silica gel (230−400 mesh). <sup>1</sup>HNMR spectra were recorded in the deuterated solvents specified on a Varian Unity INOVA 500 MHz instrument. Chemical shifts are reported in ppm in the indicated solvent with TMS as internal standard. LC-MS was measured using HP1100 and Micromass ZQ instruments. Elemental analyses were obtained from Robertson Microlit Laboratories.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-[[2-Methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-3-yl]thio]benzoic Acid (<b>6</b>)</h3><div class="NLM_p last">A suspension of [3-(trifluoromethoxy)phenyl]hydrazine hydrochloride (<b>3</b>) (29.4 g, 130 mmol) and 2-[(2-oxopropyl)thio]benzoic acid (<b>4</b>) (27 g, 130 mmol) in glacial acidic acid (250 mL) was heated to 118 °C . The mixture turned to a clear solution. Upon further heating for 45 min, the solution was concentrated to dryness under vacuum and the residue was purified by silica gel (500 g) chromatography eluting with a 9:1 mixture of hexane:ethyl acetate. Fractions containing the first spot were combined and concentrated to obtain a total of 15 g (31% yield) of the title compound as a yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>,) δ: 6.56 (d, 1H), 6.97 (d, 1H), 7.10 (t, 1H), 7.24 (t, 1H), 7.29 (d, 1H), 7.37 (s, 1H), 7.93 (d, 1H), 12.3 (s, 1H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 368.05 [M + H]<sup>+</sup>. The later fractions containing regioisomer <b>5</b> were not further isolated.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl-6-trifluoromethoxyindole (<b>7</b>)</h3><div class="NLM_p last">The indolylthiobenzoic acid (<b>6</b>) (12.3 g, 33.5 mmol) and thiosalicylic acid (10.3 g, 67 mmol) were suspended in trifluoroacidic acid (150 mL). The mixture was degassed and then heated under nitrogen at 50 °C for 3 h. The mixture was cooled to room temperature and concentrated to dryness. The residue was triturated in diethyl ether (200 mL), filtered, and washed with diethyl ether repeatedly (3 × 50 mL). The combined filtrates were washed consecutively with 1 N NaOH, 15% Cs<sub>2</sub>CO<sub>3</sub>, and brine, dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was recrystallized in ethanol/water to obtain 5.2 g (71% yield) of the title product as a while solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>,) δ: 12.20 (s, 1H), 7.87 (d, 1H), 7.17 (s, 1H), 6.99 (d, 1H), 6.26 (s, 1H), 2.46 (s, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. HRMS: <i>m</i>/<i>z</i> 216.0628 [M + H], calculated (M + 1) 216.0636.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(4-Chlorobenzoyl)-2-methyl-6-trifluoromethoxy-1<i>H</i>-indole (<b>8</b>)</h3><div class="NLM_p last">Methyl-6-trifluoromethoxyindole (<b>7</b>) (1.88 g, 8.74 mmol) was dissolved in anhydrous dichloromethane (40 mL). To this solution, was added zinc chloride (ZnCl<sub>2</sub>, 2.5 g, 18.4 mmol) followed by 3 M ethylmagnesium bromide solution (3.2 mL, 9.6 mmol) in diethyl ether. The mixture was stirred at room temperature under nitrogen for 1 h. 4-Chlorobenzoic chloride (2.0 g, 11.4 mmol) was added. After continued stirring for 40 min, aluminum chloride (AlCl<sub>3</sub>, 0.58 g, 3.43 mmol) was added. The mixture was stirred for another 3 h and concentrated to dryness. The residue was taken up in ethyl acetate, washed consecutively with saturated NH<sub>4</sub>Cl, NaHCO<sub>3</sub>, and brine, dried on MgSO<sub>4</sub>, and concentrated to dryness. The residue was recrystallized in hexane/ethyl acetate to obtain 2.5 g (82% yield) of the title product as a pale-yellow solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.20 (s, 1H), 7.87 (d, 1H), 7.64 (d, 2H), 7.57 (d, 2H), 7.51 (d, 1H), 7.36 (s, 1H) 2.38 (s, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 354.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]anisole (<b>9</b>)</h3><div class="NLM_p last">A suspension of 3-(4-chlorobenzoyl)-2-methyl-6-trifluoromethoxy-1<i>H</i>-indole (<b>8</b>) (2.5 g, 6.9 mmol), 3-methoxybenzyl bromide (1.4 g, 6.9 mmol), and cesium carbonate (Cs<sub>2</sub>CO<sub>3</sub>, 5.5 g, 17.5 mmol) in anhydrous DMF (20 mL) was stirred at room temperature under nitrogen for 4 h. The mixture was diluted with water (40 mL), stirred in an ice bath for 2 h, and filtered. The solid was washed with water and dried in air to obtain 2.6 g (78% yield) of the title product as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.75 (dd, 2H), 7.49 (dd, 2H), 7.35 (d, 1H), 7.26 (t, 1H), 7.17 (s, 1H), 7.01 (d, 1H), 6.84 (d, 1H), 6.61 (d, 1H), 6.59 (s, 1H), 5.36 (s, 2H), 3.78 (s, 3H), 2.57 (s, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 474.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenol (<b>10</b>)</h3><div class="NLM_p last">A solution of 3-[[3-(4-chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]anisole (<b>9</b>) (2.0 g, 5.7 mmol) in anhydrous dichloromethane was cooled to 0 °C in an ice batch. A solution of boron tribromide (BBr<sub>3</sub>, 1.0 M in CH<sub>2</sub>Cl<sub>2</sub>, 15 mL, 15 mmol) was added. The reaction mixture was warmed to room temperature and stirred overnight. It was then diluted with dichloromethane, washed with saturated sodium bicarbonate solution, brine, and concentrated to dryness. The residue was chromatographed on silica gel column, eluting with 2:1 hexane/ethyl acetate to obtain 2.5 g (93% yield) of the title compound. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ: 7.71 (dd, 2H), 7.53 (dd, 2H), 7.41 (d, 1H), 7.35 (s, 1H), 7.15 (t, 1H), 7.02 (d, 1H), 6.69 (d, 1H), 6.57 (d, 1H), 6.40 (s, 1H), 5.46 (s, 2H), 2.48 (s, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 460.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-[3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy]acetic Acid (<b>2</b>)</h3><div class="NLM_p last">A solution of 3-[[3-(4-chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenol (<b>10</b>) (150 mg, 0.32 mmol), ethyl 2-bromoacetate (52 mg, 0.32 mmol), and cesium carbonate (Cs<sub>2</sub>CO<sub>3</sub>, 208 mg, 0.64 mmol) in anhydrous DMF (2 mL) was stirred at room temperature overnight. The reaction mixture was diluted with water (5 mL) and extracted with ethyl acetate. The combined organic extract was concentrated to dryness. The residue was hydrolyzed by sodium hydroxide (NaOH, 5.0 M, 0.5 mL) in a mixture of tetrahydrofuran, methanol, and water (3:1:1, 2.5 mL) at room temperature overnight. The reaction mixture was then concentrated to dryness and purified by reverse phase HPLC to give the title product. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ: 7.74 (d, 2H), 7.46 (d, 2H), 7.34 (d, 1H), 7.25 (d, 1H), 7.18 (s, 1H), 7.05 (d, 1H), 6.83 (d, 1H), 6.73 (d, 1H), 6.44 (s, 1H), 5.36 (dd, 2H), 4.08 (s, 1H), 2.51 (s, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 518.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (2<i>S</i>)- and (2<i>R</i>)-2-[3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy]propanoic Acid (<b>12a</b> and <b>12b</b>)</h3><div class="NLM_p last">A solution 3-[[3-(4-chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenol <b>(10)</b> (150 mg, 0.32 mmol) and (<i>R</i>)-isobutyl lactate (48 mg, 0.32 mmol) in anhydrous dichloromethane (15 mL) was cooled to 0 °C. Triphenylphosphine (PPh<sub>3</sub>, 84 mg, 0.32 mmol) was then added followed by diisopropylazodicarboxylate (DIAD, 64 mg, 0.32 mmol). The reaction mixture was stirred at room temperature overnight, diluted with dichloromethane, washed with water and brine, and concentrated to dryness. The residue was purified by silica gel column chromatography, eluting with 8:1 hexane/ethyl acetate to obtain 121 mg (60% yield) of the isobutyl ester of the title product (<b>11a</b>, R<sub>4</sub> = isobutyl), which was hydrolyzed by sodium hydroxide (NaOH, 5.0 M, 0.5 mL) in a mixture of tetrahydrofuran, methanol, and water (3:1:1, 2.5 mL) to afford the title compound (<b>12a</b>). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ: 7.76 (d, 2H), 7.48 (d, 2H), 7.34 (d, 1H), 7.26 (d, 1H), 7.16 (s, 1H), 7.02 (d, 1H), 6.82 (d, 1H), 6.72 (d, 1H), 6.44 (s, 1H), 5.36 (dd, 2H), 4.64 (q, 1H), 2.51 (s, 3H), 1.62 (d, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 532.1 [M + H]<sup>+</sup>. (2<i>R</i>)-2-[3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy]propanoic acid (<b>12b</b>) was synthesized following the same procedure using (<i>S</i>)-isobutyl lactate as starting material. Enantiomeric purities of the products are greater than 95% ee based on analytical chiral HPLC analysis (Chiracel OD, 10% ethanol in heptane.)</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (2<i>S</i>)- and (2<i>R</i>)-2-{3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy}butanoic Acid (<b>12c</b> and <b>12d</b>)</h3><div class="NLM_p">A solution of 3-[[3-(4-chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenol (<b>10</b>) (150 mg, 0.32 mmol), freshly prepared methyl 2(<i>S</i>)-bromobutyrate (62 mg, 0.32 mmol; for preparation, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), and cesium carbonate (Cs<sub>2</sub>CO<sub>3</sub>, 208 mg, 0.64 mmol) in anhydrous DMF (2 mL) was stirred at room temperature overnight. The reaction mixture was diluted with water (5 mL) and extracted with ethyl acetate. The combined organic extract was concentrated to dryness. The residue was purified by reverse phase HPLC to obtain 180 mg (98% yield) of methyl (2<i>R</i>)-2-{3-[[3-(4-chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy}butyrate (<b>11d</b>, R<sub>4</sub> = Me). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ: 7.76 (d, 2H), 7.48 (d, 2H), 7.36 (d, 1H), 7.25 (t, 1H), 7.15 (s, 1H), 7.02 (d, 1H), 6.79 (d, 1H), 6.67 (d, 1H), 6.56 (s, 1H), 5.35 (s, 2H), 4.49 (t, 1H), 4.01 (s, 3H), 2.55 (s, 3H), 1.97 (m, 2H), 1.08 (t, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 574.1 [M + H]<sup>+</sup>. This ester which had an enantiomeric purity of 70% by chiral HPLC analysis was further enriched to 96% ee by preparative chiral HPLC purification.</div><div class="NLM_p">For analysis of enantiomeric purities of the product, a 10 μL sample solution of approximately 1.0 mg/mL concentration was injected onto a Chiracel OD analytical column (4.6 mm × 50 mm, 10 μm). The column was then eluted with an isocratic solvent system consisting of 10% ethanol in heptane at a flow rate of 0.75 mL/min. Peaks were recorded at a wavelength of 220 μm with a UV detector. Under these conditions, the retention time of the <i>S</i> enantiomer is approximately 10 min while the retention time of the <i>R</i> enantiomer is about 16 min. Enantiomeric excess (% ee) is calculated as area under the curve of the <i>S</i> enantiomer minus area under the curve of the <i>R</i> enantiomer and divided by the sum of the two areas.</div><div class="NLM_p last">For preparative purpose, the Chiracel OD Semi-Prep column (20 mm × 250 mm, 10 μm) was used. A 1.8 mL sample solution of approximately 40 mg/mL concentration was injected. The column was then eluted with an isocratic solvent system consisting of 10% ethanol in heptane at a flow rate of 9.0 mL/min. Peaks detected above 0.5 mV threshold at a wavelength of 254 μm were collected with a Gilson fraction collector. Fractions containing the <i>S</i> enantiomer were collected between 15 and 18 min after injection, while those containing the <i>R</i> enantiomer were collected at about 20−25 min. Repeated injections resulted in continuous separation of the two enantiomers. Fractions containing the separated enantiomers were then combined and concentrated to obtain the optically pure enantiomers of <b>11c</b> and <b>11d</b>. Enantiomeric purity of the product ranges from 96% ee based on analytical chiral HPLC analysis (Chiracel OD, 10% ethanol in heptane). Each enantiomer was hydrolyzed by sodium hydroxide to give the title compounds <b>12c</b> and <b>12d</b> as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 7.77 (d, 2H), 7.48 (d, 2H), 7.35 (d, 1H), 7.27 (d, 1H), 7.17 (s, 1H), 7.02 (d, 1H), 6.84 (d, 1H), 6.73 (d, 1H), 6.38 (s, 1H), 5.36 (q, 2H), 4.44 (t, 1H), 2.49 (s, 3H), 1.98 (m, 2H), 1.07 (t, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 546.1 [M + H]<sup>+</sup>. Enantiomeric purity of the product ranges from 96 to 98% ee (enantiomeric purity was determined by converting the acid back to the methyl ester followed by chiral HPLC analysis).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (2<i>S</i>)- and (2<i>R</i>)-2-{3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy}pentanoic Acid (<b>12e</b> and <b>12f</b>)</h3><div class="NLM_p last"><b>12e</b> and <b>12f</b> were prepared by the same procedure as for <b>12c</b> and <b>12d</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ: 7.76 (d, 2H), 7.47 (d, 2H), 7.34 (d, 1H), 7.25 (t, 1H), 7.15 (s, 1H), 7.01 (d, 1H), 6.81 (d, 1H), 6.68 (d, 1H), 6.49 (s, 1H), 5.35 (q, 2H), 4.52 (q, 1H), 2.51 (s, 3H), 1.91 (m, 2H), 1.54 (m, 2H), 0.96 (t, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 560.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (2<i>S</i>)- and (2<i>R</i>)-2-{3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy}isobutyric Acid (<b>12g</b> and <b>12h</b>)</h3><div class="NLM_p last"><b>12g</b> and <b>12h</b> were prepared by the same procedure as for <b>12c</b> and <b>12d</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ: 7.76 (d, 2H), 7.47 (d, 2H), 7.35 (d, 1H), 7.26 (t, 1H), 7.16 (s, 1H), 7.02 (d, 1H), 6.84 (d, 1H), 6.68 (d, 1H), 6.49 (s, 1H), 5.35 (q, 2H), 4.29 (d, 1H), 2.51 (s, 3H), 2.29 (m, 1H), 1.08 (d, 6H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 560.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (+)- and (−)-2-{3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy}-2-methylbutanoic Acid (<b>12i</b> and <b>12j</b>)</h3><div class="NLM_p last">A solution of 3-methylphenol (<b>13</b>) (0.5 g, 4.63 mmol), ethyl 2-bromobutyrate (<b>14</b>) (1.35 g, 6.95 mmol), and cesium carbonate (Cs<sub>2</sub>CO<sub>3</sub>, 3 g, 9.26 mmol) in anhydrous DMF (10 mL) was stirred at room temperature overnight. The reaction mixture was diluted with water (20 mL) and extracted with ethyl acetate. The combined organic extract was concentrated to dryness and the residue was purified by silica gel chromatography, eluting with a 9:1 mixture of hexane/ethyl acetate to give 0.6 g of <b>15</b> (59% yield). To a solution of <b>15</b> (0.6 g, 2.7 mmol) in anhydrous THF cooled to −78 °C in an acetone/dry ice bath under nitrogen was added 2.0 M solution of lithium diisopropylamide (LDA) in heptane (4.0 mL, 8.1 mmol), followed 40 min later by iodomethane (0.77 g, 5.4 mmol). The reaction mixture was stirred at −78 °C for 4 h, warmed to room temperature, and treated with saturated NH<sub>4</sub>Cl solution. The organic extract was concentrated to dryness and purified by silica gel chromatography, eluting with a 9:1 mixture of hexane/ethyl acetate to give 0.4 g of <b>16</b> (62% yield). A solution of <b>16</b> (0.4 g, 1.68 mmol), <i>N</i>-bromosuccinamide (0.36 g, 2.0 mmol), and 2,2′-azobisisobutyronitrile (AIBN, catalytic) in CCl<sub>4</sub> was refluxed at 78 °C for 3 h. The reaction mixture was cooled to room temperature, concentrated to dryness, and purified by silica gel chromatography, eluting with a 9:1 mixture of hexane/ethyl acetate to give 0.44 g of <b>17</b> (83% yield). A solution of <b>17</b> (44 mg, 0.14 mmol), 3-(4-chlorobenzoyl)-2-methyl-6-trifluoromethoxy-1<i>H</i>-indole <b>(8)</b> (50 mg, 0.14 mmol), and cesium carbonate (Cs<sub>2</sub>CO<sub>3</sub>, 140 mg, 0.42 mmol) in anhydrous DMF (2 mL) was stirred at room temperature overnight. The reaction mixture was diluted with water (5 mL) and extracted with ethyl acetate. The combined organic extract was concentrated to dryness. The residue was purified by preparative TLC to obtain 77 mg (92% yield) of racemic ethyl 2-{3-[[3-(4-chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy}-2-methyl butanoate. This racemic mixture was resolved by preparative chiral HPLC, affording enantiomerically pure <b>11i</b> (R<sub>4</sub> = Et) (99% ee) and <b>11j</b> (R<sub>4</sub> = Et) (96% ee), which were hydroxylized by sodium hydroxide to give the title products <b>12i</b> and <b>12j</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ: 7.82 (d, 2H), 7.49 (d, 2H), 7.37 (d, 1H), 7.28 (t, 1H), 7.15 (s, 1H), 7.04 (d, 1H), 6.86 (m, 2H), 6.05 (s, 1H), 5.38 (q, 2H), 2.48 (s, 3H), 1.84 (m, 2H), 1.29 (s, 3H), 0.94 (t, 3H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 560.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-{3-[[3-(4-Chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenoxy}-1-cyclobutanecarboxylic Acid (<b>12k</b>)</h3><div class="NLM_p last">A solution of 3-[[3-(4-chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]methyl]phenol (<b>10</b>) (20 mg, 0.043 mmol), ethyl 1-bromocyclobutanecarboxylate (12 mg, 0.05 mmol), and cesium carbonate (Cs<sub>2</sub>CO<sub>3</sub>, 32 mg, 0.1 mmol) in anhydrous DMF (1 mL) was stirred at room temperature overnight. The reaction mixture was diluted with water (1 mL) and extracted with ethyl acetate. The combined organic extract was concentrated to dryness. The residue was hydrolyzed by sodium hydroxide (0.5 mL, 5.0M) in a mixture of tetrahydrofuran, methanol, and water (2 mL, 3:1:1) at room temperature overnight. The reaction mixture was then concentrated to dryness and purified by reverse phase HPLC to give the title product. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ: 7.78 (d, 2H), 7.48 (d, 2H), 7.35 (d, 1H), 7.25 (t, 1H), 7.15 (s, 1H), 7.02 (d, 1H), 6.75 (d, 1H), 6.66 (d, 1H), 6.02 (s, 1H), 5.34 (s, 2H), 2.51 (m, 2H), 2.34 (m, 2H), 1.95 (m, 2H). LC−MS (ESI): >97% purity at λ 220 and 254 nm. MS: <i>m</i>/<i>z</i> 558.1 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/jm900367w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures for synthesis of 2-bromoamino acids; elemental analysis results of <b>12c</b>, <b>12d</b>, <b>12g</b>, and <b>12h</b>; spectral data of compounds <b>15</b>, <b>16</b>, and <b>17</b>; and chiral HPLC traces of selected compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900367w/suppl_file/jm900367w_si_001.pdf">jm900367w_si_001.pdf (372.56 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900367w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiguo Liu</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cbbcaea2acbea494a7a2be8ba6aeb9a8a0e5a8a4a6"><span class="__cf_email__" data-cfemail="6611030f011309390a0f13260b0314050d4805090b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kun Liu</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harold B. Wood</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margaret E. McCann</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas W. Doebber</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ching H. Chang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taro E. Akiyama</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Einstein</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel P. Berger</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter T. Meinke</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge the technical assistance from Margaret Wu, Neelam Sharma, and Roger Meurer.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This manuscript was released ASAP on June 16, 2009, with an error in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The correct version was posted on June 23, 2009.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kopelman, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitman, G. A.</span><span> </span><span class="NLM_article-title">Diabetes, exploding type II</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">SIV5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=SIV5&issue=Suppl.+4&author=P.+G.+Kopelmanauthor=G.+A.+Hitman&title=Diabetes%2C+exploding+type+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopelman%26aufirst%3DP.%2BG.%26aulast%3DHitman%26aufirst%3DG.%2BA.%26atitle%3DDiabetes%252C%2520exploding%2520type%2520II%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26issue%3DSuppl.%25204%26spage%3DSIV5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Amos, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmet, P.</span><span> </span><span class="NLM_article-title">The rising global burden of diabetes and its complications: estimates and projections by 2010</span> <span class="citation_source-journal">Diabet. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 5</span><span class="NLM_x">) </span> <span class="NLM_fpage">S5</span><span class="NLM_x">–</span> <span class="NLM_lpage">S85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=S5-S85&issue=Suppl.+5&author=A.+F.+Amosauthor=D.+J.+McCarthyauthor=P.+Zimmet&title=The+rising+global+burden+of+diabetes+and+its+complications%3A+estimates+and+projections+by+2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmos%26aufirst%3DA.%2BF.%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DZimmet%26aufirst%3DP.%26atitle%3DThe%2520rising%2520global%2520burden%2520of%2520diabetes%2520and%2520its%2520complications%253A%2520estimates%2520and%2520projections%2520by%25202010%26jtitle%3DDiabet.%2520Med.%26date%3D1997%26volume%3D14%26issue%3DSuppl.%25205%26spage%3DS5%26epage%3DS85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronnemaa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyorala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakso, M.</span><span> </span><span class="NLM_article-title">Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with or without prior myocardial infarction</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1056%2FNEJM199807233390404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=9673301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A280%3ADyaK1czivVKgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=229-234&author=S.+M.+Haffnerauthor=S.+Lehtoauthor=T.+Ronnemaaauthor=K.+Pyoralaauthor=M.+Laakso&title=Mortality+from+coronary+heart+disease+in+subjects+with+type+2+diabetes+and+in+non-diabetic+subjects+with+or+without+prior+myocardial+infarction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction</span></div><div class="casAuthors">Haffner S M; Lehto S; Ronnemaa T; Pyorala K; Laakso M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-34</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Type 2 (non-insulin-dependent) diabetes is associated with a marked increase in the risk of coronary heart disease.  It has been debated whether patients with diabetes who have not had myocardial infarctions should be treated as aggressively for cardiovascular risk factors as patients who have had myocardial infarctions.  METHODS:  To address this issue, we compared the seven-year incidence of myocardial infarction (fatal and nonfatal) among 1373 nondiabetic subjects with the incidence among 1059 diabetic subjects, all from a Finnish population-based study.  RESULTS:  The seven-year incidence rates of myocardial infarction in nondiabetic subjects with and without prior myocardial infarction at base line were 18.8 percent and 3.5 percent, respectively (P<0.001).  The seven-year incidence rates of myocardial infarction in diabetic subjects with and without prior myocardial infarction at base line were 45.0 percent and 20.2 percent, respectively (P<0.001).  The hazard ratio for death from coronary heart disease for diabetic subjects without prior myocardial infarction as compared with nondiabetic subjects with prior myocardial infarction was not significantly different from 1.0 (hazard ratio, 1.4; 95 percent confidence interval, 0.7 to 2.6) after adjustment for age and sex, suggesting similar risks of infarction in the two groups.  After further adjustment for total cholesterol, hypertension, and smoking, this hazard ratio remained close to 1.0 (hazard ratio, 1.2; 95 percent confidence interval, 0.6 to 2.4).  CONCLUSIONS:  Our data suggest that diabetic patients without previous myocardial infarction have as high a risk of myocardial infarction as nondiabetic patients with previous myocardial infarction.  These data provide a rationale for treating cardiovascular risk factors in diabetic patients as aggressively as in nondiabetic patients with prior myocardial infarction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqrTVfkG4mzSM8MEzWGjS9fW6udTcc2eaXG5ZIms2v1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czivVKgsg%253D%253D&md5=b11e317a0a8cb2eaf90f80a72e746416</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJM199807233390404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199807233390404%26sid%3Dliteratum%253Aachs%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DLehto%26aufirst%3DS.%26aulast%3DRonnemaa%26aufirst%3DT.%26aulast%3DPyorala%26aufirst%3DK.%26aulast%3DLaakso%26aufirst%3DM.%26atitle%3DMortality%2520from%2520coronary%2520heart%2520disease%2520in%2520subjects%2520with%2520type%25202%2520diabetes%2520and%2520in%2520non-diabetic%2520subjects%2520with%2520or%2520without%2520prior%2520myocardial%2520infarction%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D229%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">UKPDS.</span><span> </span><span class="NLM_article-title">UK prospective diabetes study 33: intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications with type 2 diabetes</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=837-853&author=UKPDS.&title=UK+prospective+diabetes+study+33%3A+intensive+blood+glucose+control+with+sulfonylureas+or+insulin+compared+with+conventional+treatment+and+risk+of+complications+with+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DUK%2520prospective%2520diabetes%2520study%252033%253A%2520intensive%2520blood%2520glucose%2520control%2520with%2520sulfonylureas%2520or%2520insulin%2520compared%2520with%2520conventional%2520treatment%2520and%2520risk%2520of%2520complications%2520with%2520type%25202%2520diabetes%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26spage%3D837%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternbach, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, B. R.</span><span> </span><span class="NLM_article-title">The PPARs: from orphan receptor to drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990554g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=527-550&author=T.+M.+Willsonauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=B.+R.+Henke&title=The+PPARs%3A+from+orphan+receptor+to+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm990554g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990554g%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DHenke%26aufirst%3DB.%2BR.%26atitle%3DThe%2520PPARs%253A%2520from%2520orphan%2520receptor%2520to%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D527%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kersten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desvergne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahli, W.</span><span> </span><span class="NLM_article-title">Roles of PPARs in health and disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1038%2F35013000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=10839530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=421-424&author=S.+Kerstenauthor=B.+Desvergneauthor=W.+Wahli&title=Roles+of+PPARs+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of PPARs in health and disease</span></div><div class="casAuthors">Kersten, Sander; Desvergne, Beatrice; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6785</span>),
    <span class="NLM_cas:pages">421-424</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 30 refs.  In developed societies, chronic diseases such as diabetes, obesity, atherosclerosis and cancer are responsible for most deaths.  These ailments have complex causes involving genetic, environmental and nutritional factors.  There is evidence that a group of closely related nuclear receptors, called peroxisome proliferator-activated receptors (PPARs), may be involved in these diseases.  This, together with the fact that PPAR activity can be modulated by drugs such as thiazolidinediones and fibrates, has instigated a huge research effort into PPARs.  Here the authors present the latest developments in the PPAR field, with particular emphasis on the physiol. function of PPARs during various nutritional states, and the possible role of PPARs in several chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PXJCpyB84rVg90H21EOLACvtfcHk0liYPNmQ_O0zug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslymsb4%253D&md5=239dd875e8860da8fa12d6a0e0fc0dfd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F35013000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35013000%26sid%3Dliteratum%253Aachs%26aulast%3DKersten%26aufirst%3DS.%26aulast%3DDesvergne%26aufirst%3DB.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DRoles%2520of%2520PPARs%2520in%2520health%2520and%2520disease%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D421%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span>Nuclear Receptors Nomenclature Committee, 1999. <span> </span><span class="NLM_article-title">A unified nomenclature system for the nuclear receptor superfamily</span>.  <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span>− <span class="NLM_lpage">163</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nuclear+Receptors+Nomenclature+Committee%2C+1999.+A+unified+nomenclature+system+for+the+nuclear+receptor+superfamily.+Cell+1999%2C+97%2C+161%E2%88%92163."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520unified%2520nomenclature%2520system%2520for%2520the%2520nuclear%2520receptor%2520superfamily%26jtitle%3DCell%26date%3D1999%26volume%3D97%26spage%3D161%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallongeville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoonjans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitersdorf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruchart, J. C.</span><span> </span><span class="NLM_article-title">Mechanism of action of fibrates on lipid and lipoprotein metabolism</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">2088</span><span class="NLM_x">–</span> <span class="NLM_lpage">2093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1161%2F01.CIR.98.19.2088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=9808609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFCisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1998&pages=2088-2093&author=B.+Staelsauthor=J.+Dallongevilleauthor=J.+Auwerxauthor=K.+Schoonjansauthor=E.+Leitersdorfauthor=J.+C.+Fruchart&title=Mechanism+of+action+of+fibrates+on+lipid+and+lipoprotein+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of fibrates on lipid and lipoprotein metabolism</span></div><div class="casAuthors">Staels, Bart; Dallongeville, Jean; Auwerx, Johan; Schoonjans, Kristina; Leitersdorf, Eran; Fruchart, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2088-2093</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 78 refs.  Treatment with fibrates, a widely used class of lipid-modifying agents, results in a substantial decrease in plasma triglycerides and is usually assocd. with a moderate decrease in LDL cholesterol and an increase in HDL cholesterol concns.  Recent investigations indicate that the effects of fibrates are mediated, at least in part, through alterations in transcription of genes encoding for proteins that control lipoprotein metab.  Fibrates activate specific transcription factors belonging to the nuclear hormone receptor superfamily, termed peroxisome proliferator-activated receptors (PPARs).  The PPAR-α form mediates fibrate action on HDL cholesterol levels via transcriptional induction of synthesis of the major HDL apolipoproteins, apoA-I and apoA-II.  Fibrates lower hepatic apoC-III prodn. and increase lipoprotein lipase-mediated lipolysis via PPAR.  Fibrates stimulate cellular fatty acid uptake, conversion to acyl-CoA derivs., and catabolism by the β-oxidn. pathways, which, combined with a redn. in fatty acid and triglyceride synthesis, results in a decrease in VLDL prodn.  In summary, both enhanced catabolism of triglyceride-rich particles and reduced secretion of VLDL underlie the hypotriglyceridemic effect of fibrates, whereas their effect on HDL metab. is assocd. with changes in HDL apolipoprotein expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohY0hG-dzaaLVg90H21EOLACvtfcHk0lh7js8kQ6FbAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFCisr8%253D&md5=79c83a6524388cfa813c633fdbffc720</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.98.19.2088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.98.19.2088%26sid%3Dliteratum%253Aachs%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDallongeville%26aufirst%3DJ.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DLeitersdorf%26aufirst%3DE.%26aulast%3DFruchart%26aufirst%3DJ.%2BC.%26atitle%3DMechanism%2520of%2520action%2520of%2520fibrates%2520on%2520lipid%2520and%2520lipoprotein%2520metabolism%26jtitle%3DCirculation%26date%3D1998%26volume%3D98%26spage%3D2088%26epage%3D2093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schoonjans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span> </span><span class="NLM_article-title">Role of the peroxisome proliferators-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=907-925&author=K.+Schoonjansauthor=B.+Staelsauthor=J.+Auwerx&title=Role+of+the+peroxisome+proliferators-activated+receptor+%28PPAR%29+in+mediating+the+effects+of+fibrates+and+fatty+acids+on+gene+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DRole%2520of%2520the%2520peroxisome%2520proliferators-activated%2520receptor%2520%2528PPAR%2529%2520in%2520mediating%2520the%2520effects%2520of%2520fibrates%2520and%2520fatty%2520acids%2520on%2520gene%2520expression%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1996%26volume%3D37%26spage%3D907%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Steiner, G.</span><span> </span><span class="NLM_article-title">Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=905-910&author=G.+Steiner&title=Effect+of+fenofibrate+on+progression+of+coronary-artery+disease+in+type+2+diabetes%3A+the+Diabetes+Atherosclerosis+Intervention+Study%2C+a+randomised+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteiner%26aufirst%3DG.%26atitle%3DEffect%2520of%2520fenofibrate%2520on%2520progression%2520of%2520coronary-artery%2520disease%2520in%2520type%25202%2520diabetes%253A%2520the%2520Diabetes%2520Atherosclerosis%2520Intervention%2520Study%252C%2520a%2520randomised%2520study%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D905%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rubins, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, S. J.</span><span> </span><span class="NLM_article-title">Conclutions from the VA-HIT study</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2000&pages=543-544&author=H.+B.+Rubinsauthor=S.+J.+Robins&title=Conclutions+from+the+VA-HIT+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubins%26aufirst%3DH.%2BB.%26aulast%3DRobins%26aufirst%3DS.%2BJ.%26atitle%3DConclutions%2520from%2520the%2520VA-HIT%2520study%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2000%26volume%3D86%26spage%3D543%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rubins, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fye, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elam, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faas, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schectman, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilt, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittes, J.</span><span> </span><span class="NLM_article-title">Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1056%2FNEJM199908053410604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=10438259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADyaK1MXltlyltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=410-418&author=H.+B.+Rubinsauthor=S.+J.+Robinsauthor=D.+Collinsauthor=C.+L.+Fyeauthor=J.+W.+Andersonauthor=M.+B.+Elamauthor=F.+H.+Faasauthor=E.+Linaresauthor=E.+J.+Schaeferauthor=G+Schectmanauthor=T.+J.+Wiltauthor=J.+Wittes&title=Gemfibrozil+for+the+secondary+prevention+of+coronary+heart+disease+in+men+with+low+levels+of+high-density+lipoprotein+cholesterol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol</span></div><div class="casAuthors">Rubins, Hanna Bloomfield; Robins, Sander J.; Collins, Dorothea; Fye, Carol L.; Anderson, James W.; Elam, Marshall B.; Faas, Fred H.; Linares, Esteban; Schaefer, Ernst J.; Schectman, Gordon; Wilt, Timothy J.; Wittes, Janet</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">410-418</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Although it is generally accepted that lowering elevated serum levels of low-d. lipoprotein (LDL) cholesterol in patients with coronary heart disease is beneficial, there are few data to guide decisions about therapy for patients whose primary lipid abnormality is a low level of high-d. lipoprotein (HDL) cholesterol.  We conducted a double-blind trial comparing gemfibrozil (1200 mg per day) with placebo in 2531 men with coronary heart disease, an HDL cholesterol level of 40 mg per dL (1.0 mmol per L) or less, and an LDL cholesterol level of 140 mg per dL (3.6 mmol per L) or less.  The primary study outcome was nonfatal myocardial infarction or death from coronary causes.  The median follow-up was 5.1 yr.  At one year, the mean HDL cholesterol level was 6 percent higher, the mean triglyceride level was 31 percent lower, and the mean total cholesterol level was 4 percent lower in the gemfibrozil group than in the placebo group.  LDL cholesterol levels did not differ significantly between the groups.  A primary event occurred in 275 of the 1267 patients assigned to placebo (21.7 percent) and in 219 of the 1264 patients assigned to gemfibrozil (17.3 percent).  The overall redn. in the risk of an event was 4.4 percentage points, and the redn. in relative risk was 22 percent (95 percent confidence interval, 7 to 35 percent; P=0.006).  We obsd. a 24 percent redn. in the combined outcome of death from coronary heart disease, nonfatal myocardial infarction, and stroke (P<0.001).  There were no significant differences in the rates of coronary revascularization, hospitalization for unstable angina, death from any cause, and cancer.  Gemfibrozil therapy resulted in a significant redn. in the risk of major cardiovascular events in patients with coronary disease whose primary lipid abnormality was a low HDL cholesterol level.  The findings suggest that the rate of coronary events is reduced by raising HDL cholesterol levels and lowering levels of triglycerides without lowering LDL cholesterol levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr51ZvwdsExArVg90H21EOLACvtfcHk0lh7js8kQ6FbAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlyltbw%253D&md5=ea08eff0b02e887dff1905089bbc88bf</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1056%2FNEJM199908053410604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199908053410604%26sid%3Dliteratum%253Aachs%26aulast%3DRubins%26aufirst%3DH.%2BB.%26aulast%3DRobins%26aufirst%3DS.%2BJ.%26aulast%3DCollins%26aufirst%3DD.%26aulast%3DFye%26aufirst%3DC.%2BL.%26aulast%3DAnderson%26aufirst%3DJ.%2BW.%26aulast%3DElam%26aufirst%3DM.%2BB.%26aulast%3DFaas%26aufirst%3DF.%2BH.%26aulast%3DLinares%26aufirst%3DE.%26aulast%3DSchaefer%26aufirst%3DE.%2BJ.%26aulast%3DSchectman%26aufirst%3DG%26aulast%3DWilt%26aufirst%3DT.%2BJ.%26aulast%3DWittes%26aufirst%3DJ.%26atitle%3DGemfibrozil%2520for%2520the%2520secondary%2520prevention%2520of%2520coronary%2520heart%2520disease%2520in%2520men%2520with%2520low%2520levels%2520of%2520high-density%2520lipoprotein%2520cholesterol%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D410%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullinan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saperstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibowitz, M. D.</span><span> </span><span class="NLM_article-title">Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlates with antidiabetic actions in db/db mice</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">4189</span><span class="NLM_x">–</span> <span class="NLM_lpage">4195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1996&pages=4189-4195&author=J.+Bergerauthor=P.+Baileyauthor=C.+Biswasauthor=C.+A.+Cullinanauthor=T.+W.+Doebberauthor=N.+S.+Hayesauthor=R.+Sapersteinauthor=R.+G.+Smithauthor=M.+D.+Leibowitz&title=Thiazolidinediones+produce+a+conformational+change+in+peroxisomal+proliferator-activated+receptor-%CE%B3%3A+binding+and+activation+correlates+with+antidiabetic+actions+in+db%2Fdb+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCullinan%26aufirst%3DC.%2BA.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DSaperstein%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DLeibowitz%26aufirst%3DM.%2BD.%26atitle%3DThiazolidinediones%2520produce%2520a%2520conformational%2520change%2520in%2520peroxisomal%2520proliferator-activated%2520receptor-%25CE%25B3%253A%2520binding%2520and%2520activation%2520correlates%2520with%2520antidiabetic%2520actions%2520in%2520db%252Fdb%2520mice%26jtitle%3DEndocrinology%26date%3D1996%26volume%3D137%26spage%3D4189%26epage%3D4195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Oakes, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laybutt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisholm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraegen, E. W.</span><span> </span><span class="NLM_article-title">A new antidiabtic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1994&pages=1203-1210&author=N.+D.+Oakesauthor=C.+J.+Kennedyauthor=A.+B.+Jenkinsauthor=D.+R.+Laybuttauthor=D.+J.+Chisholmauthor=E.+W.+Kraegen&title=A+new+antidiabtic+agent%2C+BRL+49653%2C+reduces+lipid+availability+and+improves+insulin+action+and+glucoregulation+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOakes%26aufirst%3DN.%2BD.%26aulast%3DKennedy%26aufirst%3DC.%2BJ.%26aulast%3DJenkins%26aufirst%3DA.%2BB.%26aulast%3DLaybutt%26aufirst%3DD.%2BR.%26aulast%3DChisholm%26aufirst%3DD.%2BJ.%26aulast%3DKraegen%26aufirst%3DE.%2BW.%26atitle%3DA%2520new%2520antidiabtic%2520agent%252C%2520BRL%252049653%252C%2520reduces%2520lipid%2520availability%2520and%2520improves%2520insulin%2520action%2520and%2520glucoregulation%2520in%2520the%2520rat%26jtitle%3DDiabetes%26date%3D1994%26volume%3D43%26spage%3D1203%26epage%3D1210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Henke, B. R.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4118</span><span class="NLM_x">–</span> <span class="NLM_lpage">4127</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030631e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4118-4127&author=B.+R.+Henke&title=Peroxisome+proliferator-activated+receptor+%CE%B1%2F%CE%B3+dual+agonists+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm030631e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030631e%26sid%3Dliteratum%253Aachs%26aulast%3DHenke%26aufirst%3DB.%2BR.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B1%252F%25CE%25B3%2520dual%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4118%26epage%3D4127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lohray, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohray, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajji, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalchar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poondra, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padakanti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vikramadithyan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juluri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamidi, N. V. S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, R.</span><span> </span><span class="NLM_article-title">(−)3-[4-[2-Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic Acid [(−)DRF2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2675</span><span class="NLM_x">–</span> <span class="NLM_lpage">2678</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010143b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2675-2678&author=B.+B.+Lohrayauthor=V.+B.+Lohrayauthor=A.+C.+Bajjiauthor=S.+Kalcharauthor=R.+R.+Poondraauthor=S.+Padakantiauthor=R.+Chakrabartiauthor=R.+K.+Vikramadithyanauthor=P.+Misraauthor=S.+Juluriauthor=N.+V.+S.+R.+Mamidiauthor=R.+Rajagopalan&title=%28%E2%88%92%293-%5B4-%5B2-Phenoxazin-10-yl%29ethoxy%5Dphenyl%5D-2-ethoxypropanoic+Acid+%5B%28%E2%88%92%29DRF2725%5D%3A+a+dual+PPAR+agonist+with+potent+antihyperglycemic+and+lipid+modulating+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm010143b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010143b%26sid%3Dliteratum%253Aachs%26aulast%3DLohray%26aufirst%3DB.%2BB.%26aulast%3DLohray%26aufirst%3DV.%2BB.%26aulast%3DBajji%26aufirst%3DA.%2BC.%26aulast%3DKalchar%26aufirst%3DS.%26aulast%3DPoondra%26aufirst%3DR.%2BR.%26aulast%3DPadakanti%26aufirst%3DS.%26aulast%3DChakrabarti%26aufirst%3DR.%26aulast%3DVikramadithyan%26aufirst%3DR.%2BK.%26aulast%3DMisra%26aufirst%3DP.%26aulast%3DJuluri%26aufirst%3DS.%26aulast%3DMamidi%26aufirst%3DN.%2BV.%2BS.%2BR.%26aulast%3DRajagopalan%26aufirst%3DR.%26atitle%3D%2528%25E2%2588%2592%25293-%255B4-%255B2-Phenoxazin-10-yl%2529ethoxy%255Dphenyl%255D-2-ethoxypropanoic%2520Acid%2520%255B%2528%25E2%2588%2592%2529DRF2725%255D%253A%2520a%2520dual%2520PPAR%2520agonist%2520with%2520potent%2520antihyperglycemic%2520and%2520lipid%2520modulating%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2675%26epage%3D2678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brooks, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etgen, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominianni, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warshawsky, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterniti, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyhonas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldham, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montrose-Rafizadeh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span> </span><span class="NLM_article-title">Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2-aryloxazol-4-yl)ethoxy]phenoxy}propionic acids: a new class of dual PPARα/γ agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2061</span><span class="NLM_x">–</span> <span class="NLM_lpage">2064</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0155188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2061-2064&author=D.+A.+Brooksauthor=G.+J.+Etgenauthor=C.+J.+Ritoauthor=A.+J.+Shukerauthor=S.+J.+Dominianniauthor=A.+W.+Warshawskyauthor=R.+Ardeckyauthor=J.+R.+Paternitiauthor=J.+Tyhonasauthor=C.+L.+Broderickauthor=B.+A.+Oldhamauthor=C.+Montrose-Rafizadehauthor=L.+L.+Winneroskiauthor=M.+M.+Faulauthor=J.+R.+McCarthy&title=Design+and+synthesis+of+2-methyl-2-%7B4-%5B2-%285-methyl-2-aryloxazol-4-yl%29ethoxy%5Dphenoxy%7Dpropionic+acids%3A+a+new+class+of+dual+PPAR%CE%B1%2F%CE%B3+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fjm0155188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0155188%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BA.%26aulast%3DEtgen%26aufirst%3DG.%2BJ.%26aulast%3DRito%26aufirst%3DC.%2BJ.%26aulast%3DShuker%26aufirst%3DA.%2BJ.%26aulast%3DDominianni%26aufirst%3DS.%2BJ.%26aulast%3DWarshawsky%26aufirst%3DA.%2BW.%26aulast%3DArdecky%26aufirst%3DR.%26aulast%3DPaterniti%26aufirst%3DJ.%2BR.%26aulast%3DTyhonas%26aufirst%3DJ.%26aulast%3DBroderick%26aufirst%3DC.%2BL.%26aulast%3DOldham%26aufirst%3DB.%2BA.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202-methyl-2-%257B4-%255B2-%25285-methyl-2-aryloxazol-4-yl%2529ethoxy%255Dphenoxy%257Dpropionic%2520acids%253A%2520a%2520new%2520class%2520of%2520dual%2520PPAR%25CE%25B1%252F%25CE%25B3%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2061%26epage%3D2064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sauerberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppesen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bury, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgensen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldike, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleckner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortensen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, l. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polivka, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindelar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panajotova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ynddal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulff, E. M.</span><span> </span><span class="NLM_article-title">Novel tricyclic-α-alkoxyphenylpropionic acids: dual PPARα/γ agonists with hypolipidemic and antidiabetic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010964g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=789-804&author=P.+Sauerbergauthor=I.+Petterssonauthor=L.+Jeppesenauthor=P.+S.+Buryauthor=J.+P.+Morgensenauthor=K.+Wassermannauthor=C.+L.+Brandauthor=J.+Sturisauthor=H.+F.+Woldikeauthor=J.+Flecknerauthor=A.+T.+Andersenauthor=S.+B.+Mortensenauthor=l.+A.+Svenssonauthor=H.+B.+Rasmussenauthor=S.+V.+Lehmannauthor=Z.+Polivkaauthor=K.+Sindelarauthor=V.+Panajotovaauthor=L.+Ynddalauthor=E.+M.+Wulff&title=Novel+tricyclic-%CE%B1-alkoxyphenylpropionic+acids%3A+dual+PPAR%CE%B1%2F%CE%B3+agonists+with+hypolipidemic+and+antidiabetic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm010964g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010964g%26sid%3Dliteratum%253Aachs%26aulast%3DSauerberg%26aufirst%3DP.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DJeppesen%26aufirst%3DL.%26aulast%3DBury%26aufirst%3DP.%2BS.%26aulast%3DMorgensen%26aufirst%3DJ.%2BP.%26aulast%3DWassermann%26aufirst%3DK.%26aulast%3DBrand%26aufirst%3DC.%2BL.%26aulast%3DSturis%26aufirst%3DJ.%26aulast%3DWoldike%26aufirst%3DH.%2BF.%26aulast%3DFleckner%26aufirst%3DJ.%26aulast%3DAndersen%26aufirst%3DA.%2BT.%26aulast%3DMortensen%26aufirst%3DS.%2BB.%26aulast%3DSvensson%26aufirst%3Dl.%2BA.%26aulast%3DRasmussen%26aufirst%3DH.%2BB.%26aulast%3DLehmann%26aufirst%3DS.%2BV.%26aulast%3DPolivka%26aufirst%3DZ.%26aulast%3DSindelar%26aufirst%3DK.%26aulast%3DPanajotova%26aufirst%3DV.%26aulast%3DYnddal%26aufirst%3DL.%26aulast%3DWulff%26aufirst%3DE.%2BM.%26atitle%3DNovel%2520tricyclic-%25CE%25B1-alkoxyphenylpropionic%2520acids%253A%2520dual%2520PPAR%25CE%25B1%252F%25CE%25B3%2520agonists%2520with%2520hypolipidemic%2520and%2520antidiabetic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D789%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cheng, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span> </span><span class="NLM_article-title">BMS-298585 is a novel, uniquely balanced dual activator of peroxisome proliferator-activated receptors (PPAR) alpha and gamma, with an excellent ADME profile</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">A94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=A94&issue=Suppl.+2&author=P.+T.+Chengauthor=G.+Chandrasenaauthor=S.+Chen&title=BMS-298585+is+a+novel%2C+uniquely+balanced+dual+activator+of+peroxisome+proliferator-activated+receptors+%28PPAR%29+alpha+and+gamma%2C+with+an+excellent+ADME+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DP.%2BT.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DBMS-298585%2520is%2520a%2520novel%252C%2520uniquely%2520balanced%2520dual%2520activator%2520of%2520peroxisome%2520proliferator-activated%2520receptors%2520%2528PPAR%2529%2520alpha%2520and%2520gamma%252C%2520with%2520an%2520excellent%2520ADME%2520profile%26jtitle%3DDiabetes%26date%3D2002%26volume%3D51%26issue%3DSuppl.%25202%26spage%3DA94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Nesto, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonow, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundy, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenkovich, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, R.</span><span> </span><span class="NLM_article-title">Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=256-263&author=R.+W.+Nestoauthor=D.+Bellauthor=R.+O.+Bonowauthor=V.+Fonsecaauthor=S.+M.+Grundyauthor=E.+S.+Hortonauthor=M.+L.+Winterauthor=D.+Porteauthor=C.+F.+Semenkovichauthor=S.+Smithauthor=L.+H.+Youngauthor=R.+Kahn&title=Thiazolidinedione+use%2C+fluid+retention%2C+and+congestive+heart+failure%3A+a+consensus+statement+from+the+American+Heart+Association+and+American+Diabetes+Association"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNesto%26aufirst%3DR.%2BW.%26aulast%3DBell%26aufirst%3DD.%26aulast%3DBonow%26aufirst%3DR.%2BO.%26aulast%3DFonseca%26aufirst%3DV.%26aulast%3DGrundy%26aufirst%3DS.%2BM.%26aulast%3DHorton%26aufirst%3DE.%2BS.%26aulast%3DWinter%26aufirst%3DM.%2BL.%26aulast%3DPorte%26aufirst%3DD.%26aulast%3DSemenkovich%26aufirst%3DC.%2BF.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DL.%2BH.%26aulast%3DKahn%26aufirst%3DR.%26atitle%3DThiazolidinedione%2520use%252C%2520fluid%2520retention%252C%2520and%2520congestive%2520heart%2520failure%253A%2520a%2520consensus%2520statement%2520from%2520the%2520American%2520Heart%2520Association%2520and%2520American%2520Diabetes%2520Association%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D256%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kahn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kravitz, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aftring, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viberti, G.</span><span> </span><span class="NLM_article-title">Rosiglitazone-associated fractures in type 2 diabetes: an analysis from a diabetes outcome progression trial (ADOPT)</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=845-851&author=S.+E.+Kahnauthor=B.+Zinmanauthor=J.+M.+Lachinauthor=S.+M.+Haffnerauthor=W.+H.+Hermanauthor=R.+R.+Holmanauthor=B.+G.+Kravitzauthor=D.+Yuauthor=M.+A.+Heiseauthor=R.+P.+Aftringauthor=G.+Viberti&title=Rosiglitazone-associated+fractures+in+type+2+diabetes%3A+an+analysis+from+a+diabetes+outcome+progression+trial+%28ADOPT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DS.%2BE.%26aulast%3DZinman%26aufirst%3DB.%26aulast%3DLachin%26aufirst%3DJ.%2BM.%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DHerman%26aufirst%3DW.%2BH.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26aulast%3DKravitz%26aufirst%3DB.%2BG.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHeise%26aufirst%3DM.%2BA.%26aulast%3DAftring%26aufirst%3DR.%2BP.%26aulast%3DViberti%26aufirst%3DG.%26atitle%3DRosiglitazone-associated%2520fractures%2520in%2520type%25202%2520diabetes%253A%2520an%2520analysis%2520from%2520a%2520diabetes%2520outcome%2520progression%2520trial%2520%2528ADOPT%2529%26jtitle%3DDiabetes%2520Care%26date%3D2008%26volume%3D31%26spage%3D845%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Burgermeister, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnoebelen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flament, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gsell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rufer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marki, H. P.</span><span> </span><span class="NLM_article-title">A novel partial agonist of peroxisome proliferator-activated receptor-(PPAR) recruits PPAR-coactivator-1, prevents triglyceride accumulation, and potentiates insulin signaling in vitro</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1210%2Fme.2005-0171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=16373399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Oqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=809-830&author=E.+Burgermeisterauthor=A.+Schnoebelenauthor=A.+Flamentauthor=J.+Benzauthor=M.+Stihleauthor=B.+Gsellauthor=A.+Ruferauthor=B.+Kuhnauthor=H.+P.+Marki&title=A+novel+partial+agonist+of+peroxisome+proliferator-activated+receptor-%28PPAR%29+recruits+PPAR-coactivator-1%2C+prevents+triglyceride+accumulation%2C+and+potentiates+insulin+signaling+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A novel partial agonist of peroxisome proliferator-activated receptor-γ (PPARγ) recruits PPARγ-coactivator-1α, prevents triglyceride accumulation, and potentiates insulin signaling in vitro</span></div><div class="casAuthors">Burgermeister, Elke; Schnoebelen, Astride; Flament, Angele; Benz, Jorg; Stihle, Martine; Gsell, Bernard; Rufer, Arne; Ruf, Armin; Kuhn, Bernd; Marki, Hans Peter; Mizrahi, Jacques; Sebokova, Elena; Niesor, Eric; Meyer, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-830</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Partial agonists of peroxisome proliferator-activated receptor-γ (PPARγ), also termed selective PPARγ modulators, are expected to uncouple insulin sensitization from triglyceride (TG) storage in patients with type 2 diabetes mellitus.  These agents shall thus avoid adverse effects, such as body wt. gain, exerted by full agonists such as thiazolidinediones.  In this context, we describe the identification and characterization of the isoquinoline deriv. PA-082, a prototype of a novel class of non-thiazolidinedione partial PPARγ ligands.  In a cocrystal with PPARγ it was bound within the ligand-binding pocket without direct contact to helix 12.  The compd. displayed partial agonism in biochem. and cell-based transactivation assays and caused preferential recruitment of PPARγ-co-activator-1α (PGC1α) to the receptor, a feature shared with other selective PPARγ modulators.  It antagonized rosiglitazone-driven transactivation and TG accumulation during de novo adipogenic differentiation of murine C3H10T1/2 mesenchymal stem cells.  The latter effect was mimicked by overexpression of wild-type PGC1α but not its LXXLL-deficient mutant.  Despite failing to promote TG loading, PA-082 induced mRNAs of genes encoding components of insulin signaling and adipogenic differentiation pathways.  It potentiated glucose uptake and inhibited the neg. cross-talk of TNFα on protein kinase B (AKT) phosphorylation in mature adipocytes and HepG2 human hepatoma cells.  PGC1α is a key regulator of energy expenditure and down-regulated in diabetics.  We thus propose that selective recruitment of PGC1α to favorable PPARγ-target genes provides a possible mol. mechanism whereby partial PPARγ agonists dissoc. TG accumulation from insulin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgK6uihTKnsLVg90H21EOLACvtfcHk0lh46r1iSiaKgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Oqu7c%253D&md5=da885be2866f262e5728fc2042e4b66f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0171%26sid%3Dliteratum%253Aachs%26aulast%3DBurgermeister%26aufirst%3DE.%26aulast%3DSchnoebelen%26aufirst%3DA.%26aulast%3DFlament%26aufirst%3DA.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DRufer%26aufirst%3DA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMarki%26aufirst%3DH.%2BP.%26atitle%3DA%2520novel%2520partial%2520agonist%2520of%2520peroxisome%2520proliferator-activated%2520receptor-%2528PPAR%2529%2520recruits%2520PPAR-coactivator-1%252C%2520prevents%2520triglyceride%2520accumulation%252C%2520and%2520potentiates%2520insulin%2520signaling%2520in%2520vitro%26jtitle%3DMol.%2520Endocrinol.%26date%3D2006%26volume%3D20%26spage%3D809%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surwit, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Distinct properties and advantages of a novel peroxisome proliferator-activated protein-selective modulator</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1210%2Fme.2002-0217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=12554792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFCksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=662-676&author=J.+P.+Bergerauthor=A.+E.+Petroauthor=K.+L.+McNaulauthor=L.+J.+Kellyauthor=B.+B.+Zhangauthor=K.+Richardsauthor=A.+Elbrechtauthor=B.+A.+Johnsonauthor=G.+Zhouauthor=T.+W.+Doebberauthor=C.+Biswasauthor=M.+Parikhauthor=N.+Sharmaauthor=M.+R.+Tanenauthor=G.+M.+Thompsonauthor=J.+Ventreauthor=A.+D.+Adamsauthor=R.+Mosleyauthor=R.+S.+Surwitauthor=D.+E.+Moller&title=Distinct+properties+and+advantages+of+a+novel+peroxisome+proliferator-activated+protein-selective+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator</span></div><div class="casAuthors">Berger, Joel P.; Petro, Ann E.; Macnaul, Karen L.; Kelly, Linda J.; Zhang, Bei B.; Richards, Karen; Elbrecht, Alex; Johnson, Bruce A.; Zhou, Gaochao; Doebber, Thomas W.; Biswas, Chhabi; Parikh, Mona; Sharma, Neelam; Tanen, Michael R.; Thompson, G. Marie; Ventre, John; Adams, Alan D.; Mosley, Ralph; Surwit, Richard S.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">662-676</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Antidiabetic thiazolidinediones (TZDs) and non-TZD compds. have been shown to serve as agonists of the peroxisome proliferator-activated receptor γ (PPARγ).  Here, we report the identification and characterization of a novel non-TZD selective PPARγ modulator (nTZDpa).  NTZDpa bound potently to PPARγ with high selectivity vs. PPARα or PPARδ.  In cell-based assays for transcriptional activation, nTZDpa served as a selective, potent PPARγ partial agonist and was able to antagonize the activity of PPARγ full agonists.  NTZDpa also displayed partial agonist effects when its ability to promote adipogenesis in 3T3-L1 cells was evaluated.  Assessment of protein conformation using protease protection or soln. NMR spectroscopy methods showed that nTZDpa produced altered PPARγ conformational stability vs. full agonists, thereby establishing a phys. basis for its obsd. partial agonism.  DNA microarray anal. of RNA from 3T3-L1 adipocytes treated with nTZDpa or several structurally diverse PPARγ full agonists demonstrated qual. differences in the affected gene expression profile for nTZDpa.  Chronic treatment of fat-fed, C57BL/6J mice with nTZDpa or a TZD full agonist ameliorated hyperglycemia and hyperinsulinemia.  However, unlike the TZD, nTZDpa caused redns. in wt. gain and adipose depot size.  Feed efficiency was also substantially diminished.  Unlike TZDs, nTZDpa did not cause cardiac hypertrophy in mice.  When a panel of PPARγ target genes was examd. in white adipose tissue, nTZDpa produced a different in vivo expression pattern vs. the full agonist.  These findings establish that novel selective PPARγ modulators can produce altered receptor conformational stability leading to distinctive gene expression profiles, reduced adipogenic cellular effects, and potentially improved in vivo biol. responses.  Such compds. may lead to preferred therapies for diabetes, obesity, or metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4wmALUo6AMrVg90H21EOLACvtfcHk0lgr9eHVvQ84Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFCksr0%253D&md5=d3f877b5b389d84034c98a54e3bbcf06</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1210%2Fme.2002-0217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2002-0217%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DPetro%26aufirst%3DA.%2BE.%26aulast%3DMcNaul%26aufirst%3DK.%2BL.%26aulast%3DKelly%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DRichards%26aufirst%3DK.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DB.%2BA.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DParikh%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DTanen%26aufirst%3DM.%2BR.%26aulast%3DThompson%26aufirst%3DG.%2BM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DA.%2BD.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DSurwit%26aufirst%3DR.%2BS.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DDistinct%2520properties%2520and%2520advantages%2520of%2520a%2520novel%2520peroxisome%2520proliferator-activated%2520protein-selective%2520modulator%26jtitle%3DMol.%2520Endocrinol.%26date%3D2003%26volume%3D17%26spage%3D662%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klatt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">L-764406 is a partial agonist of human peroxisome proliferator-activated receptor-fx1. The role of CYS313 in ligand binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">7913</span><span class="NLM_x">–</span> <span class="NLM_lpage">7922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=7913-7922&author=A.+Elbrechtauthor=Y.+Chenauthor=A+Adamsauthor=J.+P.+Bergerauthor=P.+Griffinauthor=T.+Klattauthor=B.+B.+Zhangauthor=J.+Menkeauthor=G.+Zhouauthor=R.+G.+Smithauthor=D.+E.+Moller&title=L-764406+is+a+partial+agonist+of+human+peroxisome+proliferator-activated+receptor-fx1.+The+role+of+CYS313+in+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAdams%26aufirst%3DA%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DKlatt%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DL-764406%2520is%2520a%2520partial%2520agonist%2520of%2520human%2520peroxisome%2520proliferator-activated%2520receptor-fx1.%2520The%2520role%2520of%2520CYS313%2520in%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D7913%26epage%3D7922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Shi, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dropinski, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahoo, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span> </span><span class="NLM_article-title">Novel 2-3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARα agonists with potent hypolipidemic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5589</span><span class="NLM_x">–</span> <span class="NLM_lpage">5599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050373g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5589-5599&author=G.+Q.+Shiauthor=J.+F.+Dropinskiauthor=Y.+Zhangauthor=C.+Santiniauthor=S.+P.+Sahooauthor=J.+P.+Bergerauthor=K.+L.+MacNaulauthor=G.+Zhouauthor=A.+Agrawalauthor=R.+Alvaroauthor=T.+Caiauthor=M.+Hernandezauthor=S.+D.+Wrightauthor=D.+E.+Mollerauthor=J.+V.+Heckauthor=P.+T.+Meinke&title=Novel+2-3-dihydrobenzofuran-2-carboxylic+acids%3A+highly+potent+and+subtype-selective+PPAR%CE%B1+agonists+with+potent+hypolipidemic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm050373g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050373g%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DG.%2BQ.%26aulast%3DDropinski%26aufirst%3DJ.%2BF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DAlvaro%26aufirst%3DR.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DHernandez%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26atitle%3DNovel%25202-3-dihydrobenzofuran-2-carboxylic%2520acids%253A%2520highly%2520potent%2520and%2520subtype-selective%2520PPAR%25CE%25B1%2520agonists%2520with%2520potent%2520hypolipidemic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5589%26epage%3D5599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Koyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boueres, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ippolito, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahoo, S. P.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-2-Ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3255</span><span class="NLM_x">–</span> <span class="NLM_lpage">3263</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030621d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3255-3263&author=H.+Koyamaauthor=D.+J.+Millerauthor=J.+K.+Boueresauthor=R.+C.+Desaiauthor=A.+B.+Jonesauthor=J.+P.+Bergerauthor=K.+L.+MacNaulauthor=L.+J.+Kellyauthor=T.+W.+Doebberauthor=M.+S.+Wuauthor=G.+Zhouauthor=P.+R.+Wangauthor=M.+C.+Ippolitoauthor=Y.+S.+Chaoauthor=A.+K.+Agrawalauthor=R.+Franklinauthor=J.+V.+Heckauthor=S.+D.+Wrightauthor=D.+E.+Mollerauthor=S.+P.+Sahoo&title=%282R%29-2-Ethylchromane-2-carboxylic+acids%3A+discovery+of+novel+PPARalpha%2Fgamma+dual+agonists+as+antihyperglycemic+and+hypolipidemic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm030621d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030621d%26sid%3Dliteratum%253Aachs%26aulast%3DKoyama%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DD.%2BJ.%26aulast%3DBoueres%26aufirst%3DJ.%2BK.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DKelly%26aufirst%3DL.%2BJ.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DP.%2BR.%26aulast%3DIppolito%26aufirst%3DM.%2BC.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DAgrawal%26aufirst%3DA.%2BK.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26atitle%3D%25282R%2529-2-Ethylchromane-2-carboxylic%2520acids%253A%2520discovery%2520of%2520novel%2520PPARalpha%252Fgamma%2520dual%2520agonists%2520as%2520antihyperglycemic%2520and%2520hypolipidemic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3255%26epage%3D3263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Acton, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span> </span><span class="NLM_article-title">Benzoyl 2-methyl indoles as selective PPARγ modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=357-362&author=J.+J.+Actonauthor=R.+M.+Blackauthor=A.+B.+Jonesauthor=D.+E.+Mollerauthor=L.+Colwellauthor=T.+W.+Doebberauthor=K.+L.+MacNaulauthor=J.+Bergerauthor=H.+B.+Wood&title=Benzoyl+2-methyl+indoles+as+selective+PPAR%CE%B3+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DJ.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DH.%2BB.%26atitle%3DBenzoyl%25202-methyl%2520indoles%2520as%2520selective%2520PPAR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D357%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debenham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschirret-Guth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span> </span><span class="NLM_article-title">Selective PPARγ modulators with improved pharmacological profiles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2437</span><span class="NLM_x">–</span> <span class="NLM_lpage">2440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2437-2440&author=K.+Liuauthor=R.+M.+Blackauthor=J.+A.+Actonauthor=R.+Mosleyauthor=S.+Debenhamauthor=R.+Abolaauthor=M+Yangauthor=R.+Tschirret-Guthauthor=L.+Colwellauthor=C.+Liuauthor=M.+Wuauthor=C.+F.+Wangauthor=K.+L.+MacNaulauthor=M.+E.+McCannauthor=D.+E.+Mollerauthor=J.+P.+Bergerauthor=P.+T.+Meinkeauthor=A.+B.+Jonesauthor=H.+B.+Wood&title=Selective+PPAR%CE%B3+modulators+with+improved+pharmacological+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DActon%26aufirst%3DJ.%2BA.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DDebenham%26aufirst%3DS.%26aulast%3DAbola%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DM%26aulast%3DTschirret-Guth%26aufirst%3DR.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DWood%26aufirst%3DH.%2BB.%26atitle%3DSelective%2520PPAR%25CE%25B3%2520modulators%2520with%2520improved%2520pharmacological%2520profiles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2437%26epage%3D2440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Faiola, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falls, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordelon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romach, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millar, R. T.</span><span> </span><span class="NLM_article-title">PPAR alpha, more than PPAR delta, mediates the hepatic and skeletal muscle alterations induced by the PPAR agonist GW0742</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1093%2Ftoxsci%2Fkfn130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18593727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWitL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=384-394&author=B.+Faiolaauthor=J.+G.+Fallsauthor=R.+A.+Petersonauthor=N.+R.+Bordelonauthor=T.+A.+Brodieauthor=C.+A.+Cummingsauthor=E.+H.+Romachauthor=R.+T.+Millar&title=PPAR+alpha%2C+more+than+PPAR+delta%2C+mediates+the+hepatic+and+skeletal+muscle+alterations+induced+by+the+PPAR+agonist+GW0742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR alpha, more than PPAR delta, Mediates the Hepatic and Skeletal Muscle Alterations Induced by the PPAR Agonist GW0742</span></div><div class="casAuthors">Faiola, Brenda; Falls, James Greg; Peterson, Richard A.; Bordelon, Nancy R.; Brodie, Thomas A.; Cummings, Connie A.; Romach, Elizabeth H.; Miller, Richard T.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-394</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Therapeutic use of certain peroxisome proliferator-activated receptor (PPAR) alpha agonists (fibrates) for the treatment of dyslipidemia has infrequently been assocd. with the untoward side effect of myopathy.  With interest in PPAR-δ as a therapeutic target, this study assessed whether a PPAR-δ agonist induced similar hepatic and skeletal muscle alterations as noted with some fibrates.  PPAR-α null (KO) and corresponding wild-type (WT) mice were administered toxicol. dosages of a potent PPAR-δ agonist tool ligand (GW0742; which also has weak PPAR-α agonist activity) or a potent PPAR-α agonist (WY-14,643) for 10 days.  Increases in liver wts. and clin. chem. indicators of skeletal muscle damage and/or liver injury were more pronounced in WT mice compared with KO mice administered the PPAR-δ agonist.  Likewise, the incidence and severity of skeletal myopathy were greater in WT mice given GW0742 compared with KO mice.  Ultrastructural and immunohistochem. analyses revealed significant peroxisome proliferation in muscle and liver of WT mice treated with each agonist; however, KO animals showed little or no evidence of hepatic and muscle peroxisome proliferation.  PMP-70 protein expression in liver was consistent with these results.  The hepatomegaly, hepatic and skeletal muscle peroxisome proliferation, and skeletal myopathy induced by this PPAR-δ ligand was predominantly mediated by its cross-activation of PPAR-α, though PPAR-δ agonism contributed slightly to these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAImC2zt51nLVg90H21EOLACvtfcHk0lgTVUNBn9cI4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWitL7O&md5=b20d2cd53d71878883bb573192bd87b3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfn130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfn130%26sid%3Dliteratum%253Aachs%26aulast%3DFaiola%26aufirst%3DB.%26aulast%3DFalls%26aufirst%3DJ.%2BG.%26aulast%3DPeterson%26aufirst%3DR.%2BA.%26aulast%3DBordelon%26aufirst%3DN.%2BR.%26aulast%3DBrodie%26aufirst%3DT.%2BA.%26aulast%3DCummings%26aufirst%3DC.%2BA.%26aulast%3DRomach%26aufirst%3DE.%2BH.%26aulast%3DMillar%26aufirst%3DR.%2BT.%26atitle%3DPPAR%2520alpha%252C%2520more%2520than%2520PPAR%2520delta%252C%2520mediates%2520the%2520hepatic%2520and%2520skeletal%2520muscle%2520alterations%2520induced%2520by%2520the%2520PPAR%2520agonist%2520GW0742%26jtitle%3DToxicol.%2520Sci.%26date%3D2008%26volume%3D105%26spage%3D384%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malgres, P. E.; Mumphrey, G. R.; Marcoux, J-.F.; Hillier, M.; Zhao, D.; Krska, S.; Grabowski, E. J. J.</span><span> </span><span class="NLM_article-title">Practical, highly convergent, asymmetric synthesis of a selecive PPARγ modulator</span>.  <span class="citation_source-journal">Org. Process Res. Dev.</span>, in press. </span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Malgres%2C+P.+E.%3B+Mumphrey%2C+G.+R.%3B+Marcoux%2C+J-.F.%3B+Hillier%2C+M.%3B+Zhao%2C+D.%3B+Krska%2C+S.%3B+Grabowski%2C+E.+J.+J.+Practical%2C+highly+convergent%2C+asymmetric+synthesis+of+a+selecive+PPAR%CE%B3+modulator.+Org.+Process+Res.+Dev.%2C+in+press.+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalgres%26aufirst%3DP.%2BE.%26atitle%3DPractical%252C%2520highly%2520convergent%252C%2520asymmetric%2520synthesis%2520of%2520a%2520selecive%2520PPAR%25CE%25B3%2520modulator%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Acton, J. J.; Akiyama, T. E.; Chang, C. H.; Colwell, L.; Debenham, S.; Doebber, T.; Einstein, M.; Liu, K.; McCann, M. E.; Moller, D. E.; Muise, E. S.; Tan, Y.; Thompson, J. R.; Wong, K. K.; Wu, M.; Xu, L.; Meinke, P. T.; Berger, J. P.; Wood, H. B.</span><span> </span><span class="NLM_article-title">Discovery of MK-0533: a novel SPPARgM for the treatment of T2MD with a reduced potential to increase plasma volume and extracellular fluid</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Acton%2C+J.+J.%3B+Akiyama%2C+T.+E.%3B+Chang%2C+C.+H.%3B+Colwell%2C+L.%3B+Debenham%2C+S.%3B+Doebber%2C+T.%3B+Einstein%2C+M.%3B+Liu%2C+K.%3B+McCann%2C+M.+E.%3B+Moller%2C+D.+E.%3B+Muise%2C+E.+S.%3B+Tan%2C+Y.%3B+Thompson%2C+J.+R.%3B+Wong%2C+K.+K.%3B+Wu%2C+M.%3B+Xu%2C+L.%3B+Meinke%2C+P.+T.%3B+Berger%2C+J.+P.%3B+Wood%2C+H.+B.+Discovery+of+MK-0533%3A+a+novel+SPPARgM+for+the+treatment+of+T2MD+with+a+reduced+potential+to+increase+plasma+volume+and+extracellular+fluid.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-0533%253A%2520a%2520novel%2520SPPARgM%2520for%2520the%2520treatment%2520of%2520T2MD%2520with%2520a%2520reduced%2520potential%2520to%2520increase%2520plasma%2520volume%2520and%2520extracellular%2520fluid" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">For the binding assay procedure, see the following: </p></div><span class="NLM_contrib-group">Adams, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Amphipathic 3-phenyl-7-propylbenzisoxazoles; human PPARγ, δ and α agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=931-936&author=A.+D.+Adamsauthor=W.+Yuenauthor=Z.+Huauthor=C.+Santiniauthor=A.+B.+Jonesauthor=K.+L.+MacNaulauthor=J.+P.+Bergerauthor=T.+W.+Doebberauthor=D.+E.+Moller&title=Amphipathic+3-phenyl-7-propylbenzisoxazoles%3B+human+PPAR%CE%B3%2C+%CE%B4+and+%CE%B1+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DA.%2BD.%26aulast%3DYuen%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DAmphipathic%25203-phenyl-7-propylbenzisoxazoles%253B%2520human%2520PPAR%25CE%25B3%252C%2520%25CE%25B4%2520and%2520%25CE%25B1%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D931%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Berger, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cillinana, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saperstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebowitz, M. D.</span><span> </span><span class="NLM_article-title">Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">4189</span><span class="NLM_x">–</span> <span class="NLM_lpage">4195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1996&pages=4189-4195&author=J.+B.+Bergerauthor=P.+Baileyauthor=C.+Biswasauthor=C.+A.+Cillinanaauthor=T.+W.+Doebberauthor=N.+S.+Hayesauthor=R.+Sapersteinauthor=R.+G.+Smithauthor=M.+D.+Liebowitz&title=Thiazolidinediones+produce+a+conformational+change+in+peroxisomal+proliferator-activated+receptor-gamma%3A+binding+and+activation+correlate+with+antidiabetic+actions+in+db%2Fdb+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BB.%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCillinana%26aufirst%3DC.%2BA.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DSaperstein%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DLiebowitz%26aufirst%3DM.%2BD.%26atitle%3DThiazolidinediones%2520produce%2520a%2520conformational%2520change%2520in%2520peroxisomal%2520proliferator-activated%2520receptor-gamma%253A%2520binding%2520and%2520activation%2520correlate%2520with%2520antidiabetic%2520actions%2520in%2520db%252Fdb%2520mice%26jtitle%3DEndocrinology%26date%3D1996%26volume%3D137%26spage%3D4189%26epage%3D4195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bergeron, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zycband, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: a comparison with PPAR gamma agonism</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">4252</span><span class="NLM_x">–</span> <span class="NLM_lpage">4262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=4252-4262&author=R+Bergeronauthor=J.+Yaoauthor=J.+W.+Woodsauthor=E.+I.+Zycbandauthor=C.+Liuauthor=Z.+Liauthor=A.+Adamsauthor=J.+P.+Bergerauthor=B.+B.+Zhangauthor=D.+E.+Mollerauthor=T.+W.+Doebber&title=Peroxisome+proliferator-activated+receptor+%28PPAR%29-alpha+agonism+prevents+the+onset+of+type+2+diabetes+in+Zucker+diabetic+fatty+rats%3A+a+comparison+with+PPAR+gamma+agonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DWoods%26aufirst%3DJ.%2BW.%26aulast%3DZycband%26aufirst%3DE.%2BI.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DAdams%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520%2528PPAR%2529-alpha%2520agonism%2520prevents%2520the%2520onset%2520of%2520type%25202%2520diabetes%2520in%2520Zucker%2520diabetic%2520fatty%2520rats%253A%2520a%2520comparison%2520with%2520PPAR%2520gamma%2520agonism%26jtitle%3DEndocrinology%26date%3D2006%26volume%3D147%26spage%3D4252%26epage%3D4262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Tsunoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span> </span><span class="NLM_article-title">A novel PPARα agonist ameliorates insulin resistance in dogs fed a high-fat diet</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">E833</span><span class="NLM_x">–</span> <span class="NLM_lpage">E840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=E833-E840&author=M.+Tsunodaauthor=N.+Kobayashiauthor=T.+Ideauthor=M.+Utsumiauthor=M.+Nagasawaauthor=K.+Murakami&title=A+novel+PPAR%CE%B1+agonist+ameliorates+insulin+resistance+in+dogs+fed+a+high-fat+diet"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsunoda%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DN.%26aulast%3DIde%26aufirst%3DT.%26aulast%3DUtsumi%26aufirst%3DM.%26aulast%3DNagasawa%26aufirst%3DM.%26aulast%3DMurakami%26aufirst%3DK.%26atitle%3DA%2520novel%2520PPAR%25CE%25B1%2520agonist%2520ameliorates%2520insulin%2520resistance%2520in%2520dogs%2520fed%2520a%2520high-fat%2520diet%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2008%26volume%3D294%26spage%3DE833%26epage%3DE840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Malinowski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolesta, S.</span><span> </span><span class="NLM_article-title">Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1151</span><span class="NLM_x">–</span> <span class="NLM_lpage">1168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1016%2FS0149-2918%2800%2983060-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=11110228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosFygtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2000&pages=1151-1168&issue=10&author=J.+M.+Malinowskiauthor=S.+Bolesta&title=Rosiglitazone+in+the+treatment+of+type+2+diabetes+mellitus%3A+a+critical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review</span></div><div class="casAuthors">Malinowski, Jennifer M.; Bolesta, Scott</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1151-1168</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review with 47 refs.  This article reviews the pharmacol., pharmacokinetics, clin. efficacy, adverse effects, drug interactions, and dosing of rosiglitazone, the second thiazolidinedione approved for the treatment of type 2 diabetes mellitus.  Background information for this article was obtained from searches of MEDLINE, Iowa Drug Information Service, and International Pharmaceutical Abstrs., as well as from data on file with the manufacturer of rosiglitazone.  Rosiglitazone is indicated for use alone or in combination with metformin or sulfonylureas for the maintenance of glycemic control in patients with type 2 diabetes mellitus.  Rather than stimulation of insulin secretion, rosiglitazone's primary mechanism of action is sensitization of tissues to insulin through activation of the peroxisome proliferator-activated receptor gamma and increasing expression of the glucose transporter-4 receptor.  Rosiglitazone is administered orally, is absorbed almost completely, and is 99.8% bound to plasma proteins.  The majority of a dose is metabolized by the cytochrome P 450 2C8 isoenzyme, with the inactive metabolites excreted primarily in the urine.  Four to 8 mg/d of rosiglitazone given alone or in combination with metformin, sulfonylureas, or insulin has produced redns. in baseline fasting plasma glucose and glycosylated Hb in studies of up to 1 yr's duration.  Common adverse effects (occurring in ≥5.0% of patients) include upper respiratory tract infection, injury, and headache.  Edema, wt. gain, and increased low-d. lipoprotein cholesterol concns. have also been obsd.  It is recommended that rosiglitazone be avoided in patients with alanine aminotransferase levels >2.5 times normal.  No clin. relevant drug interactions have been documented with rosiglitazone to date.  The initial starting daily dose of rosiglitazone is 4 mg in single or divided doses, without regard to meals, to a max. of 8 mg.  No direct comparative trials of the efficacy and safety of rosiglitazone vs. those of the other available thiazolidinedione, pioglitazone, have yet been performed.  The role of rosiglitazone as a single agent and in combination with other antidiabetic agents remains to be clarified as addnl. comparative and long-term data become available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3oWEWYd51dLVg90H21EOLACvtfcHk0lj_VEQKdfMMAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosFygtrg%253D&md5=a21a16943b1889f027b2ddd65206a871</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2800%2983060-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252800%252983060-X%26sid%3Dliteratum%253Aachs%26aulast%3DMalinowski%26aufirst%3DJ.%2BM.%26aulast%3DBolesta%26aufirst%3DS.%26atitle%3DRosiglitazone%2520in%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%253A%2520a%2520critical%2520review%26jtitle%3DClin.%2520Ther.%26date%3D2000%26volume%3D22%26issue%3D10%26spage%3D1151%26epage%3D1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Davidson, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. H.</span><span> </span><span class="NLM_article-title">Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet</span> <span class="citation_source-journal">Clin. Drug Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.2165%2F00044011-200828100-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18783300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GqsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=615-623&issue=10&author=M.+H.+Davidsonauthor=P.+H.+Jones&title=Retrospective+comparison+of+the+effectiveness+of+a+fenofibrate+145+mg+formulation+compared+with+the+standard+160+mg+tablet"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet</span></div><div class="casAuthors">Davidson, Michael H.; Jones, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Drug Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">615-623</span>CODEN:
                <span class="NLM_cas:coden">CDINFR</span>;
        ISSN:<span class="NLM_cas:issn">1173-2563</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">Objective: To compare changes in lipid levels (total cholesterol [total-C], low-d. lipoprotein cholesterol [LDL-C], triglycerides [TG], and high-d. lipoprotein cholesterol [HDL-C]) for patients who switched from std. fenofibrate 160 mg (requiring dosing with food) to fenofibrate 145 mg with no food effect (NFE).  Methods: The analyses were performed using an electronic medical records dataset from 1 Jan. 2003 to 31 July 2005.  Patients were eligible for the anal. if they had a diagnosis of hypertension, dyslipidemia or diabetes mellitus, were written a prescription for std. fenofibrate 160 mg during the period 1 May 2004 to 30 Apr. 2005, and were written a subsequent prescription for fenofibrate 145 mg NFE at least 60 days after first receiving the 160 mg dose.  The outcomes measured were lipid levels: total-C, LDL-C, HDL-C and TG.  Results: 491 patients who switched from std. fenofibrate 160 mg to fenofibrate 145 mg NFE met all of the inclusion criteria.  Patients who changed therapy to fenofibrate 145 mg NFE from std. fenofibrate 160 mg showed a beneficial response in lipid levels.  Statistically significant patient-specific changes in lipid levels were obsd. for the change from baseline to std. fenofibrate 160 mg for three lipid levels (total-C, HDL-C and TG).  Statistically significant changes were obsd. for the switch to fenofibrate 145 mg NFE for three lipid levels (total-C, LDL-C and TG).  Conclusions: More patients treated in an outpatient clin. practice had better lipid results when prescribed fenofibrate 145 mg NFE than those prescribed std. fenofibrate 160 mg, suggesting that a less restrictive dosing regimen improves lipid outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR27nfzpzHT7Vg90H21EOLACvtfcHk0lj_VEQKdfMMAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GqsL%252FP&md5=4a6612c4eaa360ebd2f8c7830be360a5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2165%2F00044011-200828100-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00044011-200828100-00002%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DM.%2BH.%26aulast%3DJones%26aufirst%3DP.%2BH.%26atitle%3DRetrospective%2520comparison%2520of%2520the%2520effectiveness%2520of%2520a%2520fenofibrate%2520145%2520mg%2520formulation%2520compared%2520with%2520the%2520standard%2520160%2520mg%2520tablet%26jtitle%3DClin.%2520Drug%2520Invest.%26date%3D2008%26volume%3D28%26issue%3D10%26spage%3D615%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Debenham, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemme, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span> </span><span class="NLM_article-title">Highly functionalized 7-azaindoles as selective PPARγ modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4798</span><span class="NLM_x">–</span> <span class="NLM_lpage">4801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4798-4801&author=S.+D.+Debenhamauthor=A.+Chanauthor=F.+W.+Lauauthor=W.+Liuauthor=H.+B.+Woodauthor=K.+Lemmeauthor=L.+Colwellauthor=B.+Habulihazauthor=T.+E.+Akiyamaauthor=M.+Einsteinauthor=T.+W.+Doebberauthor=N.+Sharmaauthor=C.+F.+Wangauthor=M.+Wuauthor=J.+P.+Bergerauthor=P.+T.+Meinke&title=Highly+functionalized+7-azaindoles+as+selective+PPAR%CE%B3+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDebenham%26aufirst%3DS.%2BD.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DLau%26aufirst%3DF.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DLemme%26aufirst%3DK.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DEinstein%26aufirst%3DM.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26atitle%3DHighly%2520functionalized%25207-azaindoles%2520as%2520selective%2520PPAR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4798%26epage%3D4801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiethe, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J. M.</span><span> </span><span class="NLM_article-title">The structure−activity relationship between peroxisome proliferator-activated receptor γ agonism and the anti-hyperglycemic activity of thiazolidinediones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950395a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=665-668&issue=3&author=T.+M.+Willsonauthor=J.+E.+Cobbauthor=D.+J.+Cowanauthor=R.+W.+Wietheauthor=I.+D.+Correaauthor=S.+R.+Prakashauthor=K.+D.+Beckauthor=L.+B.+Mooreauthor=S.+A.+Kliewerauthor=J.+M.+Lehmann&title=The+structure%E2%88%92activity+relationship+between+peroxisome+proliferator-activated+receptor+%CE%B3+agonism+and+the+anti-hyperglycemic+activity+of+thiazolidinediones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm950395a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950395a%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DCobb%26aufirst%3DJ.%2BE.%26aulast%3DCowan%26aufirst%3DD.%2BJ.%26aulast%3DWiethe%26aufirst%3DR.%2BW.%26aulast%3DCorrea%26aufirst%3DI.%2BD.%26aulast%3DPrakash%26aufirst%3DS.%2BR.%26aulast%3DBeck%26aufirst%3DK.%2BD.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520structure%25E2%2588%2592activity%2520relationship%2520between%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520agonism%2520and%2520the%2520anti-hyperglycemic%2520activity%2520of%2520thiazolidinediones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26issue%3D3%26spage%3D665%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Mu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zycband, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span> </span><span class="NLM_article-title">Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1695</span><span class="NLM_x">–</span> <span class="NLM_lpage">1704</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=1695-1704&issue=6&author=J.+Muauthor=J.+Woodsauthor=+Zhouauthor=R.+S.+Royauthor=Z.+Liauthor=E.+Zycbandauthor=Y.+Fengauthor=L.+Zhuauthor=C.+Liauthor=A.+D.+Howardauthor=D.+E.+Mollerauthor=N.+A.+Thornberryauthor=B.+B.+Zhang&title=Chronic+inhibition+of+dipeptidyl+peptidase-4+with+a+sitagliptin+analog+preserves+pancreatic+%CE%B2-cell+mass+and+function+in+a+rodent+model+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DZhou%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZycband%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26atitle%3DChronic%2520inhibition%2520of%2520dipeptidyl%2520peptidase-4%2520with%2520a%2520sitagliptin%2520analog%2520preserves%2520pancreatic%2520%25CE%25B2-cell%2520mass%2520and%2520function%2520in%2520a%2520rodent%2520model%2520of%2520type%25202%2520diabetes%26jtitle%3DDiabetes%26date%3D2006%26volume%3D55%26issue%3D6%26spage%3D1695%26epage%3D1704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Chang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muise, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span> </span><span class="NLM_article-title">A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1016%2Fj.ejphar.2007.12.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18346728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVKrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2008&pages=192-201&author=C.+H.+Changauthor=L.+A.+McNamaraauthor=M.+S.+Wuauthor=E.+S.+Muiseauthor=Y.+Tanauthor=H.+B.+Woodauthor=P.+T.+Meinkeauthor=J.+R.+Thompsonauthor=T.+W.+Doebberauthor=J.+P.+Bergerauthor=M.+E.+McCann&title=A+novel+selective+peroxisome+proliferator-activator+receptor-gamma+modulator-SPPAR%CE%B3M5+improves+insulin+sensitivity+with+diminished+adverse+cardiovascular+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective peroxisome proliferator-activator receptor-γ modulator-SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects</span></div><div class="casAuthors">Chang, Ching H.; McNamara, Lesley A.; Wu, Margaret S.; Muise, Eric S.; Tan, Yejun; Wood, Harold B.; Meinke, Peter T.; Thompson, John R.; Doebber, Tom W.; Berger, Joel P.; McCann, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">584</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-201</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The use of the thiazolidinedione insulin sensitizers rosiglitazone and pioglitazone for the treatment of type 2 diabetes mellitus in recent years has proven to be effective in helping patients resume normal glycemic control.  However, their use is often assocd. with undesirable side effects including peripheral edema, congestive heart failure and wt. gain.  Here, we report the identification and characterization of a novel selective PPARγ modulator, SPPARγM5 ((2S)-2-(2-chloro-5-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl} phenoxy)propionic acid), which has notable insulin sensitizing properties and a superior tolerability profile to that of rosiglitazone.  SPPARγM5 is a potent ligand of human PPARγ with high selectivity vs. PPARα or PPARδ in receptor competitive binding assays.  In cell-based transcriptional activation assays, SPPARγM5 was a potent partial agonist of human PPARγ in comparison to the PPARγ full agonist rosiglitazone.  Compared to rosiglitazone or the PPARγ full agonist COOH (2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid), SPPARγM5 induced an attenuated PPARγ-regulated gene expression profile in fully differentiated 3T3-L1 adipocytes and white adipose tissue of chronically treated db/db mice.  SPPARγM5 treatment also reduced the insulin resistance index by homeostasis model assessment (HOMA), suggesting an improvement in insulin resistance in these db/db mice.  Treatment of obese Zucker rats with either rosiglitazone or SPPARγM5 resulted in an improvement in selected parameters that serve as surrogate indicators of insulin resistance and hyperlipidemia.  However, unlike rosiglitazone, SPPARγM5 did not cause significant fluid retention or cardiac hypertrophy in these rats.  Thus, compds. such as SPPARγM5 may offer beneficial effects on glycemic control with significantly attenuated adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxeoOWfrT3IbVg90H21EOLACvtfcHk0lhPByi817sNjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVKrsb0%253D&md5=68ac4e15e57b5d7e97807c80ae823b3b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.12.036%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BH.%26aulast%3DMcNamara%26aufirst%3DL.%2BA.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DMuise%26aufirst%3DE.%2BS.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DThompson%26aufirst%3DJ.%2BR.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26atitle%3DA%2520novel%2520selective%2520peroxisome%2520proliferator-activator%2520receptor-gamma%2520modulator-SPPAR%25CE%25B3M5%2520improves%2520insulin%2520sensitivity%2520with%2520diminished%2520adverse%2520cardiovascular%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D584%26spage%3D192%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Spady, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietschy, J. M.</span><span> </span><span class="NLM_article-title">Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1172%2FJCI113321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=2448340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADyaL1cXit1Sktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1988&pages=300-309&author=D.+K.+Spadyauthor=J.+M.+Dietschy&title=Interaction+of+dietary+cholesterol+and+triglycerides+in+the+regulation+of+hepatic+low+density+lipoprotein+transport+in+the+hamster"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster</span></div><div class="casAuthors">Spady, David K.; Dietschy, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-9</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">The effects of dietary cholesterol and triglyceride on rates of receptor-dependent and receptor-independent low-d. lipoprotein (LDL) transport were studied in the liver of the hamster.  In animals fed diets enriched with 0.1, 0.25, or 1% cholesterol for 1 mo., receptor-dependent LDL transport in the liver was suppressed by 43, 63, and 77%, resp., and there were reciprocal changes in plasma LDL-cholesterol concns.  In addn., dietary triglycerides modified the effect of dietary cholesterol on hepatic LDL transport and plasma LDL concns., so that at each level of cholesterol intake, polyunsatd. triglycerides diminished and satd. triglycerides accentuated the effect of dietary cholesterol.  When animals were raised from weaning on diets contg. small amts. of cholesterol, the decline in receptor-dependent LDL transport was nearly abolished by the addn. of polyunsatd. or monounsatd. triglycerides, but was markedly augmented by the addn. of satd. lipids.  When animals raised on diets contg. cholesterol and satd. triglycerides were returned to the low cholesterol, low triglyceride control diet, hepatic receptor-dependent LDL transport and plasma LDL-cholesterol concns. returned essentially to normal within 2 wk.  Neither receptor-independent LDL transport nor the receptor-dependent uptake of asialofetuin was significantly altered by dietary cholesterol or triglyceride, suggesting that the effect of these lipids on hepatic LDL receptor activity was specific and not due to a generalized alteration in the physiochem. properties of hepatic membranes.  These studies demonstrate the important role of satd. triglycerides in augmenting the effect of cholesterol in suppressing hepatic LDL receptor activity and elevating LDL-cholesterol levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrweWNHU1WSVLVg90H21EOLACvtfcHk0lhPByi817sNjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXit1Sktb4%253D&md5=a5e37ea4d3846780c0566f63bde233c1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1172%2FJCI113321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI113321%26sid%3Dliteratum%253Aachs%26aulast%3DSpady%26aufirst%3DD.%2BK.%26aulast%3DDietschy%26aufirst%3DJ.%2BM.%26atitle%3DInteraction%2520of%2520dietary%2520cholesterol%2520and%2520triglycerides%2520in%2520the%2520regulation%2520of%2520hepatic%2520low%2520density%2520lipoprotein%2520transport%2520in%2520the%2520hamster%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1988%26volume%3D81%26spage%3D300%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Shunji, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumiyoshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masanobu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isao, T.</span><span> </span><span class="NLM_article-title">Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice and beagle dogs</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1254%2Fjphs.FP0072346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18776709" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=40-48&issue=1&author=K+Shunjiauthor=I.+Takashiauthor=Y.+Hidekiauthor=H.+Taroauthor=M.+Fumiyoshiauthor=H.+Hitoshiauthor=S.+Masanobuauthor=T.+Isao&title=Antidiabetic+and+hypolipidemic+effects+of+a+novel+dual+peroxisome+proliferator-activated+receptor+%28PPAR%29+alpha%2Fgamma+agonist%2C+E3030%2C+in+db%2Fdb+mice+and+beagle+dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0072346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0072346%26sid%3Dliteratum%253Aachs%26aulast%3DShunji%26aufirst%3DK%26aulast%3DTakashi%26aufirst%3DI.%26aulast%3DHideki%26aufirst%3DY.%26aulast%3DTaro%26aufirst%3DH.%26aulast%3DFumiyoshi%26aufirst%3DM.%26aulast%3DHitoshi%26aufirst%3DH.%26aulast%3DMasanobu%26aufirst%3DS.%26aulast%3DIsao%26aufirst%3DT.%26atitle%3DAntidiabetic%2520and%2520hypolipidemic%2520effects%2520of%2520a%2520novel%2520dual%2520peroxisome%2520proliferator-activated%2520receptor%2520%2528PPAR%2529%2520alpha%252Fgamma%2520agonist%252C%2520E3030%252C%2520in%2520db%252Fdb%2520mice%2520and%2520beagle%2520dogs%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D108%26issue%3D1%26spage%3D40%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nedergaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, B.</span><span> </span><span class="NLM_article-title">PPAR.γ in the control of brown adipocyte differentiation</span> <span class="citation_source-journal">Biochim. Biophy. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1740</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=15949696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFCrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1740&publication_year=2005&pages=293-304&issue=2&author=J.+Nedergaardauthor=N.+Petrovicauthor=E.+M.+Lindgrenauthor=A.+Jacobssonauthor=B.+Cannon&title=PPAR.%CE%B3+in+the+control+of+brown+adipocyte+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">PPARγ in the control of brown adipocyte differentiation</span></div><div class="casAuthors">Nedergaard, Jan; Petrovic, Natasa; Lindgren, Eva M.; Jacobsson, Anders; Cannon, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1740</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The effects of fatty acids and retinoic acid (carotene) on brown adipose tissue differentiation are mediated by activation of the transcription factors PPARγ and PPARα in combination with RXR.  There is good support for the idea that activated PPARγ promotes adipogenesis also in brown adipose tissue.  However, the issue is more complex concerning the full differentiation to the brown adipocyte phenotype, particularly the expression of the brown-fat-specific marker UCP1.  The effect of norepinephrine on PPARγ gene expression, at least in-vitro, is neg., PPARγ-ablated brown adipose tissue can express UCP1, and PGC-1α coactivates other transcription factors (including PPARα); thus, the significance of PPARγ for the physiol. control of UCP1 gene expression is not settled.  However, importantly, the effects of PPAR agonists demonstrate the existence of a pathway for brown adipose tissue recruitment that is not dependent on chronic adrenergic stimulation and may be active in recruitment conditions such as prenatal and prehibernation recruitment.  The ability of chronic PPARγ agonist treatment to promote the occurrence of brown-fat features in white adipose tissue-like depots implies a role in anti-obesity treatment, but this will only be effective if the extra thermogenic capacity is activated by adrenergic stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq50Y-B5q0pnrVg90H21EOLACvtfcHk0ljveHh9JhCnPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFCrur4%253D&md5=53c3fae82de466090a5b6286a5125545</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNedergaard%26aufirst%3DJ.%26aulast%3DPetrovic%26aufirst%3DN.%26aulast%3DLindgren%26aufirst%3DE.%2BM.%26aulast%3DJacobsson%26aufirst%3DA.%26aulast%3DCannon%26aufirst%3DB.%26atitle%3DPPAR.%25CE%25B3%2520in%2520the%2520control%2520of%2520brown%2520adipocyte%2520differentiation%26jtitle%3DBiochim.%2520Biophy.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2005%26volume%3D1740%26issue%3D2%26spage%3D293%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Buckingham, R E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, A.</span><span> </span><span class="NLM_article-title">Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?</span> <span class="citation_source-journal">Diabetes, obesity & metabolism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltVyktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=312-328&issue=4&author=R+E+Buckinghamauthor=A.+Hanna&title=Thiazolidinedione+insulin+sensitizers+and+the+heart%3A+a+tale+of+two+organs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?</span></div><div class="casAuthors">Buckingham, R. E.; Hanna, A.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-328</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Thiazolidinediones (TZDs) are relatively new agents for the treatment of type 2 diabetes.  They act as agonists at the PPAR-γ nuclear receptor and their therapeutic effects include decreased insulin resistance and hyperglycemia, an improved plasma lipid, inflammation and pro-coagulant profile, and amelioration of hypertension, microalbuminuria and hepatic steatosis.  The most common side effects of TZDs include wt. gain and edema, with occasional reports of congestive heart failure (CHF).  This review discusses the benefit-risk profile of TZDs in treating patients with type 2 diabetes, with particular ref. to the heart.  To provide context, we explore briefly the epidemiol. and pathophysiol. of heart failure in patients with type 2 diabetes, touch on the assocn. of heart disease and cardiovascular mortality with antihyperglycemic treatment modalities other than TZDs, and then focus on the effects of TZDs on the heart, cardiovascular risk factors and outcomes.  We describe the cluster of host factors, which seems to predispose patients with type 2 diabetes to TZD-induced or TZD-exacerbated edema and CHF and then provide an overview of the putative mechanisms of these TZD-related side effects.  We also propose that certain diuretics (amiloride and spironolactone), by targeting the distal nephron that expresses PPARγ in collecting duct cells, might be of benefit in ameliorating the fluid retention and edema assocd. with TZDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGAeTz4d5x7Vg90H21EOLACvtfcHk0ljveHh9JhCnPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltVyktL8%253D&md5=8c5caf438d501ecfec6e97a703ad3a4d</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuckingham%26aufirst%3DR%2BE%26aulast%3DHanna%26aufirst%3DA.%26atitle%3DThiazolidinedione%2520insulin%2520sensitizers%2520and%2520the%2520heart%253A%2520a%2520tale%2520of%2520two%2520organs%253F%26jtitle%3DDiabetes%252C%2520obesity%2520%2526%2520metabolism%26date%3D2008%26volume%3D10%26issue%3D4%26spage%3D312%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rosen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallanat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waalkes, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corton, J. C.</span><span> </span><span class="NLM_article-title">Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR.α and CAR</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1093%2Ftoxsci%2Fkfn025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18281256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksF2ls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2008&pages=46-56&issue=1&author=M.+B.+Rosenauthor=J.+S.+Leeauthor=H.+Renauthor=B.+Vallanatauthor=J.+Liuauthor=M.+P.+Waalkesauthor=B.+D.+Abbottauthor=C.+Lauauthor=J.+C.+Corton&title=Toxicogenomic+dissection+of+the+perfluorooctanoic+acid+transcript+profile+in+mouse+liver%3A+evidence+for+the+involvement+of+nuclear+receptors+PPAR.%CE%B1+and+CAR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicogenomic Dissection of the Perfluorooctanoic Acid Transcript Profile in Mouse Liver: Evidence for the Involvement of Nuclear Receptors PPARα and CAR</span></div><div class="casAuthors">Rosen, Mitchell B.; Lee, Janice S.; Ren, Hongzu; Vallanat, Beena; Liu, Jie; Waalkes, Michael P.; Abbott, Barbara D.; Lau, Christopher; Corton, J. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-56</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A no. of perfluorinated alkyl acids including perfluorooctanoic acid (PFOA) elicit effects similar to peroxisome proliferator chems. (PPC) in mouse and rat liver.  There is strong evidence that PPC cause many of their effects linked to liver cancer through the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARα).  To det. the role of PPARα in mediating PFOA transcriptional events, we compared the transcript profiles of the livers of wild-type or PPARα-null mice exposed to PFOA or the PPARα agonist WY-14,643 (WY).  After 7 days of exposure, 85% or 99.7% of the genes altered by PFOA or WY exposure, resp. were dependent on PPARα.  The PPARα-independent genes regulated by PFOA included those involved in lipid homeostasis and xenobiotic metab.  Many of the lipid homeostasis genes including acyl-CoA oxidase (Acox1) were also regulated by WY in a PPARα-dependent manner.  The increased expression of these genes in PPARα-null mice may be partly due to increases in PPARγ expression upon PFOA exposure.  Many of the identified xenobiotic metab. genes are known to be under control of the nuclear receptor CAR (constitutive activated/androstane receptor) and the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2).  There was excellent correlation between the transcript profile of PPARα-independent PFOA genes and those of activators of CAR including phenobarbital and 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene but not those regulated by the Nrf2 activator, dithiol-3-thione.  These results indicate that PFOA alters most genes in wild-type mouse liver through PPARα, but that a subset of genes are regulated by CAR and possibly PPARγ in the PPARα-null mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo3r_LpRhJJrVg90H21EOLACvtfcHk0ljveHh9JhCnPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksF2ls78%253D&md5=41ead5fdb07fa84ac1e8d1b9f9eda1fa</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfn025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfn025%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DM.%2BB.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DVallanat%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWaalkes%26aufirst%3DM.%2BP.%26aulast%3DAbbott%26aufirst%3DB.%2BD.%26aulast%3DLau%26aufirst%3DC.%26aulast%3DCorton%26aufirst%3DJ.%2BC.%26atitle%3DToxicogenomic%2520dissection%2520of%2520the%2520perfluorooctanoic%2520acid%2520transcript%2520profile%2520in%2520mouse%2520liver%253A%2520evidence%2520for%2520the%2520involvement%2520of%2520nuclear%2520receptors%2520PPAR.%25CE%25B1%2520and%2520CAR%26jtitle%3DToxicol.%2520Sci.%26date%3D2008%26volume%3D103%26issue%3D1%26spage%3D46%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Einstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castriota, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span> </span><span class="NLM_article-title">The differential interactions of peroxisome proliferator-activator receptor γ ligands with Tyr473 is a physical basis for their unique biological activities</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=62-74&issue=1&author=M.+Einsteinauthor=T.+E.+Akiyamaauthor=G.+A.+Castriotaauthor=C.+F.+Wangauthor=B.+McKeeverauthor=R.+T.+Mosleyauthor=J.+W.+Beckerauthor=D.+E.+Mollerauthor=P.+T.+Meinkeauthor=H.+B.+Woodauthor=J.+P.+Berger&title=The+differential+interactions+of+peroxisome+proliferator-activator+receptor+%CE%B3+ligands+with+Tyr473+is+a+physical+basis+for+their+unique+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEinstein%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DCastriota%26aufirst%3DG.%2BA.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DMcKeever%26aufirst%3DB.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520differential%2520interactions%2520of%2520peroxisome%2520proliferator-activator%2520receptor%2520%25CE%25B3%2520ligands%2520with%2520Tyr473%2520is%2520a%2520physical%2520basis%2520for%2520their%2520unique%2520biological%2520activities%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26issue%3D1%26spage%3D62%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Belcher, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriss, E. B.</span><span> </span><span class="NLM_article-title">Studies of plasma volume, red cell volume and total blood volume in young growing rats</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=13481897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A280%3ADyaG1c%252FisVGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1957&pages=64-78&author=E.+H.+Belcherauthor=E.+B.+Harriss&title=Studies+of+plasma+volume%2C+red+cell+volume+and+total+blood+volume+in+young+growing+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Studies of plasma volume, red cell volume and total blood volume in young growing rats</span></div><div class="casAuthors">BELCHER E H; HARRISS E B</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of physiology</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-78</span>
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4s_zNGAgMIC6Ufuk_1xoTfW6udTcc2eZ1G2NTDeSC-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG1c%252FisVGqsA%253D%253D&md5=dd122772ec2175d6f23b9b3c758bddb3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelcher%26aufirst%3DE.%2BH.%26aulast%3DHarriss%26aufirst%3DE.%2BB.%26atitle%3DStudies%2520of%2520plasma%2520volume%252C%2520red%2520cell%2520volume%2520and%2520total%2520blood%2520volume%2520in%2520young%2520growing%2520rats%26jtitle%3DJ.%2520Physiol.%26date%3D1957%26volume%3D139%26spage%3D64%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c','cit12d'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Liang Dai, Zhiqi Feng, Rili Zha, Keguang Cheng, Xiaoan Wen, Hongbin Sun, <span class="NLM_string-name hlFld-ContribAuthor">Haoliang Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Peroxisome Proliferator-Activated Receptor α (PPARα) Agonists by Virtual Screening and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (3)
                                     , 1717-1727. <a href="https://doi.org/10.1021/acs.jcim.9b00838" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00838%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BNovel%252BPeroxisome%252BProliferator-Activated%252BReceptor%252B%2525CE%2525B1%252B%252528PPAR%2525CE%2525B1%252529%252BAgonists%252Bby%252BVirtual%252BScreening%252Band%252BBiological%252BEvaluation%26aulast%3DDai%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26092019%26date%3D20022020%26date%3D06022020%26volume%3D60%26issue%3D3%26spage%3D1717%26epage%3D1727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Song  Song</span>, <span class="hlFld-ContribAuthor ">Shou-Fei  Zhu</span>, <span class="hlFld-ContribAuthor ">Yu  Li</span>, and <span class="hlFld-ContribAuthor ">Qi-Lin  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Iridium-Catalyzed Enantioselective Hydrogenation of α,β-Unsaturated Carboxylic Acids with Tetrasubstituted Olefins. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (14)
                                     , 3722-3725. <a href="https://doi.org/10.1021/ol401593a" title="DOI URL">https://doi.org/10.1021/ol401593a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol401593a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol401593a%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIridium-Catalyzed%252BEnantioselective%252BHydrogenation%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BCarboxylic%252BAcids%252Bwith%252BTetrasubstituted%252BOlefins%26aulast%3DSong%26aufirst%3DSong%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06062013%26date%3D03072013%26date%3D19072013%26volume%3D15%26issue%3D14%26spage%3D3722%26epage%3D3725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Céline  Pirat</span>, <span class="hlFld-ContribAuthor ">Amaury  Farce</span>, <span class="hlFld-ContribAuthor ">Nicolas  Lebègue</span>, <span class="hlFld-ContribAuthor ">Nicolas  Renault</span>, <span class="hlFld-ContribAuthor ">Christophe  Furman</span>, <span class="hlFld-ContribAuthor ">Régis  Millet</span>, <span class="hlFld-ContribAuthor ">Saı̈d  Yous</span>, <span class="hlFld-ContribAuthor ">Silvia  Speca</span>, <span class="hlFld-ContribAuthor ">Pascal  Berthelot</span>, <span class="hlFld-ContribAuthor ">Pierre  Desreumaux</span>, and <span class="hlFld-ContribAuthor ">Philippe  Chavatte</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (9)
                                     , 4027-4061. <a href="https://doi.org/10.1021/jm101360s" title="DOI URL">https://doi.org/10.1021/jm101360s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101360s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101360s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BPeroxisome%252BProliferator-Activated%252BReceptors%252B%252528PPARs%252529%25253A%252BDevelopment%252Bof%252BModulators%26aulast%3DPirat%26aufirst%3DC%25C3%25A9line%26date%3D2012%26date%3D2012%26date%3D2010%26date%3D19102010%26date%3D27022012%26date%3D10052012%26date%3D19012012%26volume%3D55%26issue%3D9%26spage%3D4027%26epage%3D4061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabetta  Brenna</span>, <span class="hlFld-ContribAuthor ">Francesco G.  Gatti</span>, <span class="hlFld-ContribAuthor ">Alessia  Manfredi</span>, <span class="hlFld-ContribAuthor ">Daniela  Monti</span>, and <span class="hlFld-ContribAuthor ">Fabio  Parmeggiani</span>  . </span><span class="cited-content_cbyCitation_article-title">Enoate Reductase-Mediated Preparation of Methyl (S)-2-Bromobutanoate, a Useful Key Intermediate for the Synthesis of Chiral Active Pharmaceutical Ingredients. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2012,</strong> <em>16 </em>
                                    (2)
                                     , 262-268. <a href="https://doi.org/10.1021/op200086t" title="DOI URL">https://doi.org/10.1021/op200086t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op200086t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop200086t%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEnoate%252BReductase-Mediated%252BPreparation%252Bof%252BMethyl%252B%252528S%252529-2-Bromobutanoate%25252C%252Ba%252BUseful%252BKey%252BIntermediate%252Bfor%252Bthe%252BSynthesis%252Bof%252BChiral%252BActive%252BPharmaceutical%252BIngredients%26aulast%3DBrenna%26aufirst%3DElisabetta%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D31032011%26date%3D06092011%26date%3D17022012%26date%3D22072011%26volume%3D16%26issue%3D2%26spage%3D262%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Mendgen</span>, <span class="hlFld-ContribAuthor ">Christian  Steuer</span>, and <span class="hlFld-ContribAuthor ">Christian D.  Klein</span>  . </span><span class="cited-content_cbyCitation_article-title">Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (2)
                                     , 743-753. <a href="https://doi.org/10.1021/jm201243p" title="DOI URL">https://doi.org/10.1021/jm201243p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201243p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201243p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPrivileged%252BScaffolds%252Bor%252BPromiscuous%252BBinders%25253A%252BA%252BComparative%252BStudy%252Bon%252BRhodanines%252Band%252BRelated%252BHeterocycles%252Bin%252BMedicinal%252BChemistry%26aulast%3DMendgen%26aufirst%3DThomas%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D19092011%26date%3D11012012%26date%3D26012012%26date%3D14112011%26volume%3D55%26issue%3D2%26spage%3D743%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Fiona  Lau</span>, <span class="hlFld-ContribAuthor ">Kun  Liu</span>, <span class="hlFld-ContribAuthor ">Harold B.  Wood</span>, <span class="hlFld-ContribAuthor ">Gaochao  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuli  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Taro E.  Akiyama</span>, <span class="hlFld-ContribAuthor ">Gino  Castriota</span>, <span class="hlFld-ContribAuthor ">Monica  Einstein</span>, <span class="hlFld-ContribAuthor ">Chualin  Wang</span>, <span class="hlFld-ContribAuthor ">Margaret E.  McCann</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Doebber</span>, <span class="hlFld-ContribAuthor ">Margaret  Wu</span>, <span class="hlFld-ContribAuthor ">Ching H.  Chang</span>, <span class="hlFld-ContribAuthor ">Lesley  McNamara</span>, <span class="hlFld-ContribAuthor ">Brian  McKeever</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Mosley</span>, <span class="hlFld-ContribAuthor ">Joel P.  Berger</span>, and <span class="hlFld-ContribAuthor ">Peter T.  Meinke</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8541-8554. <a href="https://doi.org/10.1021/jm201061j" title="DOI URL">https://doi.org/10.1021/jm201061j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201061j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201061j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazolones%25253A%252BA%252BNew%252BClass%252Bof%252BSelective%252BPeroxisome%252BProliferator-Activated%252BReceptor%252B%2525CE%2525B3%252B%252528PPAR%2525CE%2525B3%252529%252BModulators%26aulast%3DLiu%26aufirst%3DWeiguo%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D07082011%26date%3D28112011%26date%3D22122011%26date%3D09112011%26volume%3D54%26issue%3D24%26spage%3D8541%26epage%3D8554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shigeki  Seto</span>, <span class="hlFld-ContribAuthor ">Kyoko  Okada</span>, <span class="hlFld-ContribAuthor ">Koichi  Kiyota</span>, <span class="hlFld-ContribAuthor ">Shigeki  Isogai</span>, <span class="hlFld-ContribAuthor ">Maki  Iwago</span>, <span class="hlFld-ContribAuthor ">Takehiro  Shinozaki</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Kitamura</span>, <span class="hlFld-ContribAuthor ">Yasushi  Kohno</span> and <span class="hlFld-ContribAuthor ">Koji  Murakami</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structure−Activity Relationship Studies of Novel 2,4,6-Trisubstituted-5-pyrimidinecarboxylic Acids as Peroxisome Proliferator-Activated Receptor γ (PPARγ) Partial Agonists with Comparable Antidiabetic Efficacy to Rosiglitazone. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (13)
                                     , 5012-5024. <a href="https://doi.org/10.1021/jm100443s" title="DOI URL">https://doi.org/10.1021/jm100443s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100443s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100443s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructure%2525E2%252588%252592Activity%252BRelationship%252BStudies%252Bof%252BNovel%252B2%25252C4%25252C6-Trisubstituted-5-pyrimidinecarboxylic%252BAcids%252Bas%252BPeroxisome%252BProliferator-Activated%252BReceptor%252B%2525CE%2525B3%252B%252528PPAR%2525CE%2525B3%252529%252BPartial%252BAgonists%252Bwith%252BComparable%252BAntidiabetic%252BEfficacy%252Bto%252BRosiglitazone%26aulast%3DSeto%26aufirst%3DShigeki%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D11042010%26date%3D09062010%26date%3D08072010%26volume%3D53%26issue%3D13%26spage%3D5012%26epage%3D5024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter T.W.  Cheng</span>, <span class="hlFld-ContribAuthor ">Ellen  Kick</span>, <span class="hlFld-ContribAuthor ">Ranjan  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Nuclear Hormone Receptor Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-117. <a href="https://doi.org/10.1002/0471266949.bmc191.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc191.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc191.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc191.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DNuclear%252BHormone%252BReceptor%252BMedicinal%252BChemistry%26aulast%3DCheng%26aufirst%3DPeter%2BT.W.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D117%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Letizia  Giampietro</span>, <span class="hlFld-ContribAuthor ">Alessandra  Ammazzalorso</span>, <span class="hlFld-ContribAuthor ">Rosa  Amoroso</span>, <span class="hlFld-ContribAuthor ">Barbara  De Filippis</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Fibrates as Important Scaffolds in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (11)
                                     , 1051-1066. <a href="https://doi.org/10.1002/cmdc.201900128" title="DOI URL">https://doi.org/10.1002/cmdc.201900128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900128%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDevelopment%252Bof%252BFibrates%252Bas%252BImportant%252BScaffolds%252Bin%252BMedicinal%252BChemistry%26aulast%3DGiampietro%26aufirst%3DLetizia%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D11%26spage%3D1051%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina M.  Alcántara</span>, <span class="hlFld-ContribAuthor ">Andrés R.  Alcántara</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalyzed synthesis of antidiabetic drugs: A review. </span><span class="cited-content_cbyCitation_journal-name">Biocatalysis and Biotransformation</span><span> <strong>2018,</strong> <em>36 </em>
                                    (1)
                                     , 12-46. <a href="https://doi.org/10.1080/10242422.2017.1323887" title="DOI URL">https://doi.org/10.1080/10242422.2017.1323887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10242422.2017.1323887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10242422.2017.1323887%26sid%3Dliteratum%253Aachs%26jtitle%3DBiocatalysis%2520and%2520Biotransformation%26atitle%3DBiocatalyzed%252Bsynthesis%252Bof%252Bantidiabetic%252Bdrugs%25253A%252BA%252Breview%26aulast%3DAlc%25C3%25A1ntara%26aufirst%3DCristina%2BM.%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D1%26spage%3D12%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nuggehally R.  Srinivas</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Drug Metabolism and Pharmacokinetics</span><span> <strong>2015,</strong> <em>40 </em>
                                    (1)
                                     , 1-12. <a href="https://doi.org/10.1007/s13318-014-0186-9" title="DOI URL">https://doi.org/10.1007/s13318-014-0186-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13318-014-0186-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13318-014-0186-9%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Drug%2520Metabolism%2520and%2520Pharmacokinetics%26atitle%3DStrategies%252Bfor%252Bpreclinical%252Bpharmacokinetic%252Binvestigation%252Bin%252Bstreptozotocin-induced%252Bdiabetes%252Bmellitus%252B%252528DMIS%252529%252Band%252Balloxan-induced%252Bdiabetes%252Bmellitus%252B%252528DMIA%252529%252Brat%252Bmodels%25253A%252Bcase%252Bstudies%252Band%252Bperspectives%26aulast%3DSrinivas%26aufirst%3DNuggehally%2BR.%26date%3D2015%26date%3D2014%26volume%3D40%26issue%3D1%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Vrontaki</span>, <span class="hlFld-ContribAuthor ">Georgia  Melagraki</span>, <span class="hlFld-ContribAuthor ">Thomas  Mavromoustakos</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Methods</span><span> <strong>2015,</strong> <em>71 </em>, 4-13. <a href="https://doi.org/10.1016/j.ymeth.2014.03.021" title="DOI URL">https://doi.org/10.1016/j.ymeth.2014.03.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ymeth.2014.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ymeth.2014.03.021%26sid%3Dliteratum%253Aachs%26jtitle%3DMethods%26atitle%3DExploiting%252BChEMBL%252Bdatabase%252Bto%252Bidentify%252Bindole%252Banalogs%252Bas%252BHCV%252Breplication%252Binhibitors%26aulast%3DVrontaki%26aufirst%3DEleni%26date%3D2015%26volume%3D71%26spage%3D4%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-Bing  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Dan-Dan  Zhu</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Three-component domino reaction synthesis of highly functionalized bicyclic pyrrole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (5)
                                     , 1047-1054. <a href="https://doi.org/10.1016/j.tet.2013.12.062" title="DOI URL">https://doi.org/10.1016/j.tet.2013.12.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.12.062%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DThree-component%252Bdomino%252Breaction%252Bsynthesis%252Bof%252Bhighly%252Bfunctionalized%252Bbicyclic%252Bpyrrole%252Bderivatives%26aulast%3DChen%26aufirst%3DXue-Bing%26date%3D2014%26volume%3D70%26issue%3D5%26spage%3D1047%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gábor  Tasnádi</span>, <span class="hlFld-ContribAuthor ">Mélanie  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">Relevant Practical Applications of Bioreduction Processes in the Synthesis of Active Pharmaceutical Ingredients. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 329-374. <a href="https://doi.org/10.1002/9783527665785.ch13" title="DOI URL">https://doi.org/10.1002/9783527665785.ch13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527665785.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527665785.ch13%26sid%3Dliteratum%253Aachs%26atitle%3DRelevant%252BPractical%252BApplications%252Bof%252BBioreduction%252BProcesses%252Bin%252Bthe%252BSynthesis%252Bof%252BActive%252BPharmaceutical%252BIngredients%26aulast%3DTasn%25C3%25A1di%26aufirst%3DG%25C3%25A1bor%26date%3D2013%26date%3D2013%26spage%3D329%26epage%3D374%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DSynthetic%252BMethods%252Bfor%252BBiologically%252BActive%252BMolecules%26aulast%3DBrenna%26aufirst%3DElisabetta%26date%3D2013%26volume%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gábor  Tasnádi</span>, <span class="hlFld-ContribAuthor ">Christoph K.  Winkler</span>, <span class="hlFld-ContribAuthor ">Dorina  Clay</span>, <span class="hlFld-ContribAuthor ">Nargis  Sultana</span>, <span class="hlFld-ContribAuthor ">Walter M. F.  Fabian</span>, <span class="hlFld-ContribAuthor ">Mélanie  Hall</span>, <span class="hlFld-ContribAuthor ">Klaus  Ditrich</span>, <span class="hlFld-ContribAuthor ">Kurt  Faber</span>. </span><span class="cited-content_cbyCitation_article-title">A Substrate-Driven Approach to Determine Reactivities of α,β-Unsaturated Carboxylic Esters Towards Asymmetric Bioreduction. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2012,</strong> <em>18 </em>
                                    (33)
                                     , 10362-10367. <a href="https://doi.org/10.1002/chem.201200990" title="DOI URL">https://doi.org/10.1002/chem.201200990</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201200990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201200990%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DA%252BSubstrate-Driven%252BApproach%252Bto%252BDetermine%252BReactivities%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BCarboxylic%252BEsters%252BTowards%252BAsymmetric%252BBioreduction%26aulast%3DTasn%25C3%25A1di%26aufirst%3DG%25C3%25A1bor%26date%3D2012%26date%3D2012%26volume%3D18%26issue%3D33%26spage%3D10362%26epage%3D10367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Guasch</span>, <span class="hlFld-ContribAuthor ">Esther  Sala</span>, <span class="hlFld-ContribAuthor ">Cristina  Valls</span>, <span class="hlFld-ContribAuthor ">Mayte  Blay</span>, <span class="hlFld-ContribAuthor ">Miquel  Mulero</span>, <span class="hlFld-ContribAuthor ">Lluís  Arola</span>, <span class="hlFld-ContribAuthor ">Gerard  Pujadas</span>, <span class="hlFld-ContribAuthor ">Santiago  Garcia-Vallvé</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights for the design of new PPARgamma partial agonists with high binding affinity and low transactivation activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2011,</strong> <em>25 </em>
                                    (8)
                                     , 717-728. <a href="https://doi.org/10.1007/s10822-011-9446-9" title="DOI URL">https://doi.org/10.1007/s10822-011-9446-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-011-9446-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-011-9446-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DStructural%252Binsights%252Bfor%252Bthe%252Bdesign%252Bof%252Bnew%252BPPARgamma%252Bpartial%252Bagonists%252Bwith%252Bhigh%252Bbinding%252Baffinity%252Band%252Blow%252Btransactivation%252Bactivity%26aulast%3DGuasch%26aufirst%3DLaura%26date%3D2011%26date%3D2011%26volume%3D25%26issue%3D8%26spage%3D717%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj  Makadia</span>, <span class="hlFld-ContribAuthor ">Shailesh R.  Shah</span>, <span class="hlFld-ContribAuthor ">Harikishore  Pingali</span>, <span class="hlFld-ContribAuthor ">Pandurang  Zaware</span>, <span class="hlFld-ContribAuthor ">Darshit  Patel</span>, <span class="hlFld-ContribAuthor ">Suresh  Pola</span>, <span class="hlFld-ContribAuthor ">Baban  Thube</span>, <span class="hlFld-ContribAuthor ">Priyanka  Priyadarshini</span>, <span class="hlFld-ContribAuthor ">Dinesh  Suthar</span>, <span class="hlFld-ContribAuthor ">Maanan  Shah</span>, <span class="hlFld-ContribAuthor ">Suresh  Giri</span>, <span class="hlFld-ContribAuthor ">Chitrang  Trivedi</span>, <span class="hlFld-ContribAuthor ">Mukul  Jain</span>, <span class="hlFld-ContribAuthor ">Pankaj  Patel</span>, <span class="hlFld-ContribAuthor ">Rajesh  Bahekar</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of structurally constrained oxime–ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (2)
                                     , 771-782. <a href="https://doi.org/10.1016/j.bmc.2010.12.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2010.12.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2010.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2010.12.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DEffect%252Bof%252Bstructurally%252Bconstrained%252Boxime%2525E2%252580%252593ether%252Blinker%252Bon%252BPPAR%252Bsubtype%252Bselectivity%25253A%252BDiscovery%252Bof%252Ba%252Bnovel%252Band%252Bpotent%252Bseries%252Bof%252BPPAR-pan%252Bagonists%26aulast%3DMakadia%26aufirst%3DPankaj%26date%3D2011%26volume%3D19%26issue%3D2%26spage%3D771%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter T.W.  Cheng</span>, <span class="hlFld-ContribAuthor ">Ellen  Kick</span>, <span class="hlFld-ContribAuthor ">Ranjan  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Nuclear Hormone Receptor Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 77-188. <a href="https://doi.org/10.1002/0471266949.bmc191" title="DOI URL">https://doi.org/10.1002/0471266949.bmc191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc191%26sid%3Dliteratum%253Aachs%26atitle%3DNuclear%252BHormone%252BReceptor%252BMedicinal%252BChemistry%26aulast%3DCheng%26aufirst%3DPeter%2BT.W.%26date%3D2010%26date%3D2010%26spage%3D77%26epage%3D188%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lalit S  Doshi</span>, <span class="hlFld-ContribAuthor ">Manoja Kumar  Brahma</span>, <span class="hlFld-ContribAuthor ">Umakant A  Bahirat</span>, <span class="hlFld-ContribAuthor ">Amol V  Dixit</span>, <span class="hlFld-ContribAuthor ">Kumar VS  Nemmani</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2010,</strong> <em>19 </em>
                                    (4)
                                     , 489-512. <a href="https://doi.org/10.1517/13543781003640169" title="DOI URL">https://doi.org/10.1517/13543781003640169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543781003640169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543781003640169%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252Bselective%252BPPAR%2525CE%2525B3%252Bmodulators%252Bas%252Bsafe%252Band%252Beffective%252Bantidiabetic%252Bagents%26aulast%3DDoshi%26aufirst%3DLalit%2BS%26date%3D2010%26date%3D2010%26volume%3D19%26issue%3D4%26spage%3D489%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. 1-Benzoyl-3-benzylindolecarboxylic Acid vs 3-Acyl-1-benzylindolecarboxylic Acid</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AcOH, 110 °C, flash SiO<sub>2</sub> column separation to obtain <b>6</b>; (b) TFA, 50 °C; (c) ZnCl<sub>2</sub>, EtMgCl, CH<sub>2</sub>Cl<sub>2</sub>, AlCl<sub>3,</sub> room temp; (d) Cs<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (e) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (f) PPh<sub>3</sub>, DIAD, THF, 0 °C, X = OH; or Cs<sub>2</sub>CO<sub>3</sub>, DMF, room temp, X = Br; (g) NaOH, MeOH, room temp.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (b) LDA, MeI, THF, −78 °C; (c) NBS, AIBN, CCl<sub>4</sub>, reflux; (d) Ce<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (e) chiral HPLC resolution; (f) NaOH, MeOH, room temp.</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Evaluation of compound <b>12d</b> in fa/fa Zucker rat for plasma volume and cardiac effects. Animals (<i>n</i> = 8) were treated daily for 7 days with vehicle, rosiglitazone (1, 10, and 100 mpk), or <b>12d</b> (0.03, 0.3, 3, 15 mpk). Circulating drug and insulin levels, plasma volume, and heart weight were determined as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. The drug exposure levels that caused a 50% reduction in plasma insulin (ED<sub>50</sub>) for rosiglitazone and <b>12d</b> were 125 and 10 μM·h, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/medium/jm-2009-00367w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Percentage reduction of serum total cholesterol levels in mature beagle dogs. Dogs were housed individually and dosed daily by oral gavage with <b>12d</b>, simvastatin (Simva), fenofibrate, or vehicle, respectively. Serum cholesterol reductions were calculated as percent correction of vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900367w/production/images/large/jm-2009-00367w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900367w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kopelman, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitman, G. A.</span><span> </span><span class="NLM_article-title">Diabetes, exploding type II</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">SIV5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=SIV5&issue=Suppl.+4&author=P.+G.+Kopelmanauthor=G.+A.+Hitman&title=Diabetes%2C+exploding+type+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopelman%26aufirst%3DP.%2BG.%26aulast%3DHitman%26aufirst%3DG.%2BA.%26atitle%3DDiabetes%252C%2520exploding%2520type%2520II%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26issue%3DSuppl.%25204%26spage%3DSIV5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Amos, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmet, P.</span><span> </span><span class="NLM_article-title">The rising global burden of diabetes and its complications: estimates and projections by 2010</span> <span class="citation_source-journal">Diabet. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 5</span><span class="NLM_x">) </span> <span class="NLM_fpage">S5</span><span class="NLM_x">–</span> <span class="NLM_lpage">S85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=S5-S85&issue=Suppl.+5&author=A.+F.+Amosauthor=D.+J.+McCarthyauthor=P.+Zimmet&title=The+rising+global+burden+of+diabetes+and+its+complications%3A+estimates+and+projections+by+2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmos%26aufirst%3DA.%2BF.%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DZimmet%26aufirst%3DP.%26atitle%3DThe%2520rising%2520global%2520burden%2520of%2520diabetes%2520and%2520its%2520complications%253A%2520estimates%2520and%2520projections%2520by%25202010%26jtitle%3DDiabet.%2520Med.%26date%3D1997%26volume%3D14%26issue%3DSuppl.%25205%26spage%3DS5%26epage%3DS85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronnemaa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyorala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakso, M.</span><span> </span><span class="NLM_article-title">Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with or without prior myocardial infarction</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1056%2FNEJM199807233390404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=9673301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A280%3ADyaK1czivVKgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=229-234&author=S.+M.+Haffnerauthor=S.+Lehtoauthor=T.+Ronnemaaauthor=K.+Pyoralaauthor=M.+Laakso&title=Mortality+from+coronary+heart+disease+in+subjects+with+type+2+diabetes+and+in+non-diabetic+subjects+with+or+without+prior+myocardial+infarction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction</span></div><div class="casAuthors">Haffner S M; Lehto S; Ronnemaa T; Pyorala K; Laakso M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-34</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Type 2 (non-insulin-dependent) diabetes is associated with a marked increase in the risk of coronary heart disease.  It has been debated whether patients with diabetes who have not had myocardial infarctions should be treated as aggressively for cardiovascular risk factors as patients who have had myocardial infarctions.  METHODS:  To address this issue, we compared the seven-year incidence of myocardial infarction (fatal and nonfatal) among 1373 nondiabetic subjects with the incidence among 1059 diabetic subjects, all from a Finnish population-based study.  RESULTS:  The seven-year incidence rates of myocardial infarction in nondiabetic subjects with and without prior myocardial infarction at base line were 18.8 percent and 3.5 percent, respectively (P<0.001).  The seven-year incidence rates of myocardial infarction in diabetic subjects with and without prior myocardial infarction at base line were 45.0 percent and 20.2 percent, respectively (P<0.001).  The hazard ratio for death from coronary heart disease for diabetic subjects without prior myocardial infarction as compared with nondiabetic subjects with prior myocardial infarction was not significantly different from 1.0 (hazard ratio, 1.4; 95 percent confidence interval, 0.7 to 2.6) after adjustment for age and sex, suggesting similar risks of infarction in the two groups.  After further adjustment for total cholesterol, hypertension, and smoking, this hazard ratio remained close to 1.0 (hazard ratio, 1.2; 95 percent confidence interval, 0.6 to 2.4).  CONCLUSIONS:  Our data suggest that diabetic patients without previous myocardial infarction have as high a risk of myocardial infarction as nondiabetic patients with previous myocardial infarction.  These data provide a rationale for treating cardiovascular risk factors in diabetic patients as aggressively as in nondiabetic patients with prior myocardial infarction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqrTVfkG4mzSM8MEzWGjS9fW6udTcc2eYFBe0g035OF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czivVKgsg%253D%253D&md5=b11e317a0a8cb2eaf90f80a72e746416</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJM199807233390404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199807233390404%26sid%3Dliteratum%253Aachs%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DLehto%26aufirst%3DS.%26aulast%3DRonnemaa%26aufirst%3DT.%26aulast%3DPyorala%26aufirst%3DK.%26aulast%3DLaakso%26aufirst%3DM.%26atitle%3DMortality%2520from%2520coronary%2520heart%2520disease%2520in%2520subjects%2520with%2520type%25202%2520diabetes%2520and%2520in%2520non-diabetic%2520subjects%2520with%2520or%2520without%2520prior%2520myocardial%2520infarction%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D229%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">UKPDS.</span><span> </span><span class="NLM_article-title">UK prospective diabetes study 33: intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications with type 2 diabetes</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=837-853&author=UKPDS.&title=UK+prospective+diabetes+study+33%3A+intensive+blood+glucose+control+with+sulfonylureas+or+insulin+compared+with+conventional+treatment+and+risk+of+complications+with+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DUK%2520prospective%2520diabetes%2520study%252033%253A%2520intensive%2520blood%2520glucose%2520control%2520with%2520sulfonylureas%2520or%2520insulin%2520compared%2520with%2520conventional%2520treatment%2520and%2520risk%2520of%2520complications%2520with%2520type%25202%2520diabetes%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26spage%3D837%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternbach, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, B. R.</span><span> </span><span class="NLM_article-title">The PPARs: from orphan receptor to drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990554g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=527-550&author=T.+M.+Willsonauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=B.+R.+Henke&title=The+PPARs%3A+from+orphan+receptor+to+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm990554g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990554g%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DHenke%26aufirst%3DB.%2BR.%26atitle%3DThe%2520PPARs%253A%2520from%2520orphan%2520receptor%2520to%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D527%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kersten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desvergne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahli, W.</span><span> </span><span class="NLM_article-title">Roles of PPARs in health and disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1038%2F35013000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=10839530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=421-424&author=S.+Kerstenauthor=B.+Desvergneauthor=W.+Wahli&title=Roles+of+PPARs+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of PPARs in health and disease</span></div><div class="casAuthors">Kersten, Sander; Desvergne, Beatrice; Wahli, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6785</span>),
    <span class="NLM_cas:pages">421-424</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 30 refs.  In developed societies, chronic diseases such as diabetes, obesity, atherosclerosis and cancer are responsible for most deaths.  These ailments have complex causes involving genetic, environmental and nutritional factors.  There is evidence that a group of closely related nuclear receptors, called peroxisome proliferator-activated receptors (PPARs), may be involved in these diseases.  This, together with the fact that PPAR activity can be modulated by drugs such as thiazolidinediones and fibrates, has instigated a huge research effort into PPARs.  Here the authors present the latest developments in the PPAR field, with particular emphasis on the physiol. function of PPARs during various nutritional states, and the possible role of PPARs in several chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PXJCpyB84rVg90H21EOLACvtfcHk0lgwi_RAn6UEow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslymsb4%253D&md5=239dd875e8860da8fa12d6a0e0fc0dfd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F35013000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35013000%26sid%3Dliteratum%253Aachs%26aulast%3DKersten%26aufirst%3DS.%26aulast%3DDesvergne%26aufirst%3DB.%26aulast%3DWahli%26aufirst%3DW.%26atitle%3DRoles%2520of%2520PPARs%2520in%2520health%2520and%2520disease%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D421%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span>Nuclear Receptors Nomenclature Committee, 1999. <span> </span><span class="NLM_article-title">A unified nomenclature system for the nuclear receptor superfamily</span>.  <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span>− <span class="NLM_lpage">163</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nuclear+Receptors+Nomenclature+Committee%2C+1999.+A+unified+nomenclature+system+for+the+nuclear+receptor+superfamily.+Cell+1999%2C+97%2C+161%E2%88%92163."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520unified%2520nomenclature%2520system%2520for%2520the%2520nuclear%2520receptor%2520superfamily%26jtitle%3DCell%26date%3D1999%26volume%3D97%26spage%3D161%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallongeville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoonjans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitersdorf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruchart, J. C.</span><span> </span><span class="NLM_article-title">Mechanism of action of fibrates on lipid and lipoprotein metabolism</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">2088</span><span class="NLM_x">–</span> <span class="NLM_lpage">2093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1161%2F01.CIR.98.19.2088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=9808609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFCisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1998&pages=2088-2093&author=B.+Staelsauthor=J.+Dallongevilleauthor=J.+Auwerxauthor=K.+Schoonjansauthor=E.+Leitersdorfauthor=J.+C.+Fruchart&title=Mechanism+of+action+of+fibrates+on+lipid+and+lipoprotein+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of fibrates on lipid and lipoprotein metabolism</span></div><div class="casAuthors">Staels, Bart; Dallongeville, Jean; Auwerx, Johan; Schoonjans, Kristina; Leitersdorf, Eran; Fruchart, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2088-2093</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 78 refs.  Treatment with fibrates, a widely used class of lipid-modifying agents, results in a substantial decrease in plasma triglycerides and is usually assocd. with a moderate decrease in LDL cholesterol and an increase in HDL cholesterol concns.  Recent investigations indicate that the effects of fibrates are mediated, at least in part, through alterations in transcription of genes encoding for proteins that control lipoprotein metab.  Fibrates activate specific transcription factors belonging to the nuclear hormone receptor superfamily, termed peroxisome proliferator-activated receptors (PPARs).  The PPAR-α form mediates fibrate action on HDL cholesterol levels via transcriptional induction of synthesis of the major HDL apolipoproteins, apoA-I and apoA-II.  Fibrates lower hepatic apoC-III prodn. and increase lipoprotein lipase-mediated lipolysis via PPAR.  Fibrates stimulate cellular fatty acid uptake, conversion to acyl-CoA derivs., and catabolism by the β-oxidn. pathways, which, combined with a redn. in fatty acid and triglyceride synthesis, results in a decrease in VLDL prodn.  In summary, both enhanced catabolism of triglyceride-rich particles and reduced secretion of VLDL underlie the hypotriglyceridemic effect of fibrates, whereas their effect on HDL metab. is assocd. with changes in HDL apolipoprotein expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohY0hG-dzaaLVg90H21EOLACvtfcHk0lgta9dtsGBn4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFCisr8%253D&md5=79c83a6524388cfa813c633fdbffc720</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.98.19.2088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.98.19.2088%26sid%3Dliteratum%253Aachs%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDallongeville%26aufirst%3DJ.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DLeitersdorf%26aufirst%3DE.%26aulast%3DFruchart%26aufirst%3DJ.%2BC.%26atitle%3DMechanism%2520of%2520action%2520of%2520fibrates%2520on%2520lipid%2520and%2520lipoprotein%2520metabolism%26jtitle%3DCirculation%26date%3D1998%26volume%3D98%26spage%3D2088%26epage%3D2093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schoonjans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span> </span><span class="NLM_article-title">Role of the peroxisome proliferators-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=907-925&author=K.+Schoonjansauthor=B.+Staelsauthor=J.+Auwerx&title=Role+of+the+peroxisome+proliferators-activated+receptor+%28PPAR%29+in+mediating+the+effects+of+fibrates+and+fatty+acids+on+gene+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DRole%2520of%2520the%2520peroxisome%2520proliferators-activated%2520receptor%2520%2528PPAR%2529%2520in%2520mediating%2520the%2520effects%2520of%2520fibrates%2520and%2520fatty%2520acids%2520on%2520gene%2520expression%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1996%26volume%3D37%26spage%3D907%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Steiner, G.</span><span> </span><span class="NLM_article-title">Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=905-910&author=G.+Steiner&title=Effect+of+fenofibrate+on+progression+of+coronary-artery+disease+in+type+2+diabetes%3A+the+Diabetes+Atherosclerosis+Intervention+Study%2C+a+randomised+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteiner%26aufirst%3DG.%26atitle%3DEffect%2520of%2520fenofibrate%2520on%2520progression%2520of%2520coronary-artery%2520disease%2520in%2520type%25202%2520diabetes%253A%2520the%2520Diabetes%2520Atherosclerosis%2520Intervention%2520Study%252C%2520a%2520randomised%2520study%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D905%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rubins, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, S. J.</span><span> </span><span class="NLM_article-title">Conclutions from the VA-HIT study</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2000&pages=543-544&author=H.+B.+Rubinsauthor=S.+J.+Robins&title=Conclutions+from+the+VA-HIT+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubins%26aufirst%3DH.%2BB.%26aulast%3DRobins%26aufirst%3DS.%2BJ.%26atitle%3DConclutions%2520from%2520the%2520VA-HIT%2520study%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2000%26volume%3D86%26spage%3D543%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rubins, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fye, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elam, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faas, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schectman, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilt, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittes, J.</span><span> </span><span class="NLM_article-title">Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1056%2FNEJM199908053410604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=10438259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADyaK1MXltlyltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=410-418&author=H.+B.+Rubinsauthor=S.+J.+Robinsauthor=D.+Collinsauthor=C.+L.+Fyeauthor=J.+W.+Andersonauthor=M.+B.+Elamauthor=F.+H.+Faasauthor=E.+Linaresauthor=E.+J.+Schaeferauthor=G+Schectmanauthor=T.+J.+Wiltauthor=J.+Wittes&title=Gemfibrozil+for+the+secondary+prevention+of+coronary+heart+disease+in+men+with+low+levels+of+high-density+lipoprotein+cholesterol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol</span></div><div class="casAuthors">Rubins, Hanna Bloomfield; Robins, Sander J.; Collins, Dorothea; Fye, Carol L.; Anderson, James W.; Elam, Marshall B.; Faas, Fred H.; Linares, Esteban; Schaefer, Ernst J.; Schectman, Gordon; Wilt, Timothy J.; Wittes, Janet</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">410-418</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Although it is generally accepted that lowering elevated serum levels of low-d. lipoprotein (LDL) cholesterol in patients with coronary heart disease is beneficial, there are few data to guide decisions about therapy for patients whose primary lipid abnormality is a low level of high-d. lipoprotein (HDL) cholesterol.  We conducted a double-blind trial comparing gemfibrozil (1200 mg per day) with placebo in 2531 men with coronary heart disease, an HDL cholesterol level of 40 mg per dL (1.0 mmol per L) or less, and an LDL cholesterol level of 140 mg per dL (3.6 mmol per L) or less.  The primary study outcome was nonfatal myocardial infarction or death from coronary causes.  The median follow-up was 5.1 yr.  At one year, the mean HDL cholesterol level was 6 percent higher, the mean triglyceride level was 31 percent lower, and the mean total cholesterol level was 4 percent lower in the gemfibrozil group than in the placebo group.  LDL cholesterol levels did not differ significantly between the groups.  A primary event occurred in 275 of the 1267 patients assigned to placebo (21.7 percent) and in 219 of the 1264 patients assigned to gemfibrozil (17.3 percent).  The overall redn. in the risk of an event was 4.4 percentage points, and the redn. in relative risk was 22 percent (95 percent confidence interval, 7 to 35 percent; P=0.006).  We obsd. a 24 percent redn. in the combined outcome of death from coronary heart disease, nonfatal myocardial infarction, and stroke (P<0.001).  There were no significant differences in the rates of coronary revascularization, hospitalization for unstable angina, death from any cause, and cancer.  Gemfibrozil therapy resulted in a significant redn. in the risk of major cardiovascular events in patients with coronary disease whose primary lipid abnormality was a low HDL cholesterol level.  The findings suggest that the rate of coronary events is reduced by raising HDL cholesterol levels and lowering levels of triglycerides without lowering LDL cholesterol levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr51ZvwdsExArVg90H21EOLACvtfcHk0lgta9dtsGBn4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlyltbw%253D&md5=ea08eff0b02e887dff1905089bbc88bf</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1056%2FNEJM199908053410604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199908053410604%26sid%3Dliteratum%253Aachs%26aulast%3DRubins%26aufirst%3DH.%2BB.%26aulast%3DRobins%26aufirst%3DS.%2BJ.%26aulast%3DCollins%26aufirst%3DD.%26aulast%3DFye%26aufirst%3DC.%2BL.%26aulast%3DAnderson%26aufirst%3DJ.%2BW.%26aulast%3DElam%26aufirst%3DM.%2BB.%26aulast%3DFaas%26aufirst%3DF.%2BH.%26aulast%3DLinares%26aufirst%3DE.%26aulast%3DSchaefer%26aufirst%3DE.%2BJ.%26aulast%3DSchectman%26aufirst%3DG%26aulast%3DWilt%26aufirst%3DT.%2BJ.%26aulast%3DWittes%26aufirst%3DJ.%26atitle%3DGemfibrozil%2520for%2520the%2520secondary%2520prevention%2520of%2520coronary%2520heart%2520disease%2520in%2520men%2520with%2520low%2520levels%2520of%2520high-density%2520lipoprotein%2520cholesterol%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D410%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullinan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saperstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibowitz, M. D.</span><span> </span><span class="NLM_article-title">Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlates with antidiabetic actions in db/db mice</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">4189</span><span class="NLM_x">–</span> <span class="NLM_lpage">4195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1996&pages=4189-4195&author=J.+Bergerauthor=P.+Baileyauthor=C.+Biswasauthor=C.+A.+Cullinanauthor=T.+W.+Doebberauthor=N.+S.+Hayesauthor=R.+Sapersteinauthor=R.+G.+Smithauthor=M.+D.+Leibowitz&title=Thiazolidinediones+produce+a+conformational+change+in+peroxisomal+proliferator-activated+receptor-%CE%B3%3A+binding+and+activation+correlates+with+antidiabetic+actions+in+db%2Fdb+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCullinan%26aufirst%3DC.%2BA.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DSaperstein%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DLeibowitz%26aufirst%3DM.%2BD.%26atitle%3DThiazolidinediones%2520produce%2520a%2520conformational%2520change%2520in%2520peroxisomal%2520proliferator-activated%2520receptor-%25CE%25B3%253A%2520binding%2520and%2520activation%2520correlates%2520with%2520antidiabetic%2520actions%2520in%2520db%252Fdb%2520mice%26jtitle%3DEndocrinology%26date%3D1996%26volume%3D137%26spage%3D4189%26epage%3D4195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Oakes, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laybutt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisholm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraegen, E. W.</span><span> </span><span class="NLM_article-title">A new antidiabtic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1994&pages=1203-1210&author=N.+D.+Oakesauthor=C.+J.+Kennedyauthor=A.+B.+Jenkinsauthor=D.+R.+Laybuttauthor=D.+J.+Chisholmauthor=E.+W.+Kraegen&title=A+new+antidiabtic+agent%2C+BRL+49653%2C+reduces+lipid+availability+and+improves+insulin+action+and+glucoregulation+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOakes%26aufirst%3DN.%2BD.%26aulast%3DKennedy%26aufirst%3DC.%2BJ.%26aulast%3DJenkins%26aufirst%3DA.%2BB.%26aulast%3DLaybutt%26aufirst%3DD.%2BR.%26aulast%3DChisholm%26aufirst%3DD.%2BJ.%26aulast%3DKraegen%26aufirst%3DE.%2BW.%26atitle%3DA%2520new%2520antidiabtic%2520agent%252C%2520BRL%252049653%252C%2520reduces%2520lipid%2520availability%2520and%2520improves%2520insulin%2520action%2520and%2520glucoregulation%2520in%2520the%2520rat%26jtitle%3DDiabetes%26date%3D1994%26volume%3D43%26spage%3D1203%26epage%3D1210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Henke, B. R.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4118</span><span class="NLM_x">–</span> <span class="NLM_lpage">4127</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030631e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4118-4127&author=B.+R.+Henke&title=Peroxisome+proliferator-activated+receptor+%CE%B1%2F%CE%B3+dual+agonists+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm030631e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030631e%26sid%3Dliteratum%253Aachs%26aulast%3DHenke%26aufirst%3DB.%2BR.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B1%252F%25CE%25B3%2520dual%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4118%26epage%3D4127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lohray, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohray, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajji, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalchar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poondra, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padakanti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vikramadithyan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juluri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamidi, N. V. S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, R.</span><span> </span><span class="NLM_article-title">(−)3-[4-[2-Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic Acid [(−)DRF2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2675</span><span class="NLM_x">–</span> <span class="NLM_lpage">2678</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010143b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2675-2678&author=B.+B.+Lohrayauthor=V.+B.+Lohrayauthor=A.+C.+Bajjiauthor=S.+Kalcharauthor=R.+R.+Poondraauthor=S.+Padakantiauthor=R.+Chakrabartiauthor=R.+K.+Vikramadithyanauthor=P.+Misraauthor=S.+Juluriauthor=N.+V.+S.+R.+Mamidiauthor=R.+Rajagopalan&title=%28%E2%88%92%293-%5B4-%5B2-Phenoxazin-10-yl%29ethoxy%5Dphenyl%5D-2-ethoxypropanoic+Acid+%5B%28%E2%88%92%29DRF2725%5D%3A+a+dual+PPAR+agonist+with+potent+antihyperglycemic+and+lipid+modulating+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm010143b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010143b%26sid%3Dliteratum%253Aachs%26aulast%3DLohray%26aufirst%3DB.%2BB.%26aulast%3DLohray%26aufirst%3DV.%2BB.%26aulast%3DBajji%26aufirst%3DA.%2BC.%26aulast%3DKalchar%26aufirst%3DS.%26aulast%3DPoondra%26aufirst%3DR.%2BR.%26aulast%3DPadakanti%26aufirst%3DS.%26aulast%3DChakrabarti%26aufirst%3DR.%26aulast%3DVikramadithyan%26aufirst%3DR.%2BK.%26aulast%3DMisra%26aufirst%3DP.%26aulast%3DJuluri%26aufirst%3DS.%26aulast%3DMamidi%26aufirst%3DN.%2BV.%2BS.%2BR.%26aulast%3DRajagopalan%26aufirst%3DR.%26atitle%3D%2528%25E2%2588%2592%25293-%255B4-%255B2-Phenoxazin-10-yl%2529ethoxy%255Dphenyl%255D-2-ethoxypropanoic%2520Acid%2520%255B%2528%25E2%2588%2592%2529DRF2725%255D%253A%2520a%2520dual%2520PPAR%2520agonist%2520with%2520potent%2520antihyperglycemic%2520and%2520lipid%2520modulating%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2675%26epage%3D2678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brooks, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etgen, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominianni, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warshawsky, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterniti, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyhonas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldham, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montrose-Rafizadeh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span> </span><span class="NLM_article-title">Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2-aryloxazol-4-yl)ethoxy]phenoxy}propionic acids: a new class of dual PPARα/γ agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2061</span><span class="NLM_x">–</span> <span class="NLM_lpage">2064</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0155188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2061-2064&author=D.+A.+Brooksauthor=G.+J.+Etgenauthor=C.+J.+Ritoauthor=A.+J.+Shukerauthor=S.+J.+Dominianniauthor=A.+W.+Warshawskyauthor=R.+Ardeckyauthor=J.+R.+Paternitiauthor=J.+Tyhonasauthor=C.+L.+Broderickauthor=B.+A.+Oldhamauthor=C.+Montrose-Rafizadehauthor=L.+L.+Winneroskiauthor=M.+M.+Faulauthor=J.+R.+McCarthy&title=Design+and+synthesis+of+2-methyl-2-%7B4-%5B2-%285-methyl-2-aryloxazol-4-yl%29ethoxy%5Dphenoxy%7Dpropionic+acids%3A+a+new+class+of+dual+PPAR%CE%B1%2F%CE%B3+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fjm0155188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0155188%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BA.%26aulast%3DEtgen%26aufirst%3DG.%2BJ.%26aulast%3DRito%26aufirst%3DC.%2BJ.%26aulast%3DShuker%26aufirst%3DA.%2BJ.%26aulast%3DDominianni%26aufirst%3DS.%2BJ.%26aulast%3DWarshawsky%26aufirst%3DA.%2BW.%26aulast%3DArdecky%26aufirst%3DR.%26aulast%3DPaterniti%26aufirst%3DJ.%2BR.%26aulast%3DTyhonas%26aufirst%3DJ.%26aulast%3DBroderick%26aufirst%3DC.%2BL.%26aulast%3DOldham%26aufirst%3DB.%2BA.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202-methyl-2-%257B4-%255B2-%25285-methyl-2-aryloxazol-4-yl%2529ethoxy%255Dphenoxy%257Dpropionic%2520acids%253A%2520a%2520new%2520class%2520of%2520dual%2520PPAR%25CE%25B1%252F%25CE%25B3%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2061%26epage%3D2064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sauerberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppesen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bury, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgensen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldike, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleckner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortensen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, l. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polivka, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindelar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panajotova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ynddal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulff, E. M.</span><span> </span><span class="NLM_article-title">Novel tricyclic-α-alkoxyphenylpropionic acids: dual PPARα/γ agonists with hypolipidemic and antidiabetic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010964g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=789-804&author=P.+Sauerbergauthor=I.+Petterssonauthor=L.+Jeppesenauthor=P.+S.+Buryauthor=J.+P.+Morgensenauthor=K.+Wassermannauthor=C.+L.+Brandauthor=J.+Sturisauthor=H.+F.+Woldikeauthor=J.+Flecknerauthor=A.+T.+Andersenauthor=S.+B.+Mortensenauthor=l.+A.+Svenssonauthor=H.+B.+Rasmussenauthor=S.+V.+Lehmannauthor=Z.+Polivkaauthor=K.+Sindelarauthor=V.+Panajotovaauthor=L.+Ynddalauthor=E.+M.+Wulff&title=Novel+tricyclic-%CE%B1-alkoxyphenylpropionic+acids%3A+dual+PPAR%CE%B1%2F%CE%B3+agonists+with+hypolipidemic+and+antidiabetic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm010964g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010964g%26sid%3Dliteratum%253Aachs%26aulast%3DSauerberg%26aufirst%3DP.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DJeppesen%26aufirst%3DL.%26aulast%3DBury%26aufirst%3DP.%2BS.%26aulast%3DMorgensen%26aufirst%3DJ.%2BP.%26aulast%3DWassermann%26aufirst%3DK.%26aulast%3DBrand%26aufirst%3DC.%2BL.%26aulast%3DSturis%26aufirst%3DJ.%26aulast%3DWoldike%26aufirst%3DH.%2BF.%26aulast%3DFleckner%26aufirst%3DJ.%26aulast%3DAndersen%26aufirst%3DA.%2BT.%26aulast%3DMortensen%26aufirst%3DS.%2BB.%26aulast%3DSvensson%26aufirst%3Dl.%2BA.%26aulast%3DRasmussen%26aufirst%3DH.%2BB.%26aulast%3DLehmann%26aufirst%3DS.%2BV.%26aulast%3DPolivka%26aufirst%3DZ.%26aulast%3DSindelar%26aufirst%3DK.%26aulast%3DPanajotova%26aufirst%3DV.%26aulast%3DYnddal%26aufirst%3DL.%26aulast%3DWulff%26aufirst%3DE.%2BM.%26atitle%3DNovel%2520tricyclic-%25CE%25B1-alkoxyphenylpropionic%2520acids%253A%2520dual%2520PPAR%25CE%25B1%252F%25CE%25B3%2520agonists%2520with%2520hypolipidemic%2520and%2520antidiabetic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D789%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cheng, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span> </span><span class="NLM_article-title">BMS-298585 is a novel, uniquely balanced dual activator of peroxisome proliferator-activated receptors (PPAR) alpha and gamma, with an excellent ADME profile</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">A94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=A94&issue=Suppl.+2&author=P.+T.+Chengauthor=G.+Chandrasenaauthor=S.+Chen&title=BMS-298585+is+a+novel%2C+uniquely+balanced+dual+activator+of+peroxisome+proliferator-activated+receptors+%28PPAR%29+alpha+and+gamma%2C+with+an+excellent+ADME+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DP.%2BT.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DBMS-298585%2520is%2520a%2520novel%252C%2520uniquely%2520balanced%2520dual%2520activator%2520of%2520peroxisome%2520proliferator-activated%2520receptors%2520%2528PPAR%2529%2520alpha%2520and%2520gamma%252C%2520with%2520an%2520excellent%2520ADME%2520profile%26jtitle%3DDiabetes%26date%3D2002%26volume%3D51%26issue%3DSuppl.%25202%26spage%3DA94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Nesto, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonow, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundy, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenkovich, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, R.</span><span> </span><span class="NLM_article-title">Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=256-263&author=R.+W.+Nestoauthor=D.+Bellauthor=R.+O.+Bonowauthor=V.+Fonsecaauthor=S.+M.+Grundyauthor=E.+S.+Hortonauthor=M.+L.+Winterauthor=D.+Porteauthor=C.+F.+Semenkovichauthor=S.+Smithauthor=L.+H.+Youngauthor=R.+Kahn&title=Thiazolidinedione+use%2C+fluid+retention%2C+and+congestive+heart+failure%3A+a+consensus+statement+from+the+American+Heart+Association+and+American+Diabetes+Association"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNesto%26aufirst%3DR.%2BW.%26aulast%3DBell%26aufirst%3DD.%26aulast%3DBonow%26aufirst%3DR.%2BO.%26aulast%3DFonseca%26aufirst%3DV.%26aulast%3DGrundy%26aufirst%3DS.%2BM.%26aulast%3DHorton%26aufirst%3DE.%2BS.%26aulast%3DWinter%26aufirst%3DM.%2BL.%26aulast%3DPorte%26aufirst%3DD.%26aulast%3DSemenkovich%26aufirst%3DC.%2BF.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DL.%2BH.%26aulast%3DKahn%26aufirst%3DR.%26atitle%3DThiazolidinedione%2520use%252C%2520fluid%2520retention%252C%2520and%2520congestive%2520heart%2520failure%253A%2520a%2520consensus%2520statement%2520from%2520the%2520American%2520Heart%2520Association%2520and%2520American%2520Diabetes%2520Association%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D256%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kahn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kravitz, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aftring, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viberti, G.</span><span> </span><span class="NLM_article-title">Rosiglitazone-associated fractures in type 2 diabetes: an analysis from a diabetes outcome progression trial (ADOPT)</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=845-851&author=S.+E.+Kahnauthor=B.+Zinmanauthor=J.+M.+Lachinauthor=S.+M.+Haffnerauthor=W.+H.+Hermanauthor=R.+R.+Holmanauthor=B.+G.+Kravitzauthor=D.+Yuauthor=M.+A.+Heiseauthor=R.+P.+Aftringauthor=G.+Viberti&title=Rosiglitazone-associated+fractures+in+type+2+diabetes%3A+an+analysis+from+a+diabetes+outcome+progression+trial+%28ADOPT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DS.%2BE.%26aulast%3DZinman%26aufirst%3DB.%26aulast%3DLachin%26aufirst%3DJ.%2BM.%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DHerman%26aufirst%3DW.%2BH.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26aulast%3DKravitz%26aufirst%3DB.%2BG.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHeise%26aufirst%3DM.%2BA.%26aulast%3DAftring%26aufirst%3DR.%2BP.%26aulast%3DViberti%26aufirst%3DG.%26atitle%3DRosiglitazone-associated%2520fractures%2520in%2520type%25202%2520diabetes%253A%2520an%2520analysis%2520from%2520a%2520diabetes%2520outcome%2520progression%2520trial%2520%2528ADOPT%2529%26jtitle%3DDiabetes%2520Care%26date%3D2008%26volume%3D31%26spage%3D845%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Burgermeister, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnoebelen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flament, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gsell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rufer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marki, H. P.</span><span> </span><span class="NLM_article-title">A novel partial agonist of peroxisome proliferator-activated receptor-(PPAR) recruits PPAR-coactivator-1, prevents triglyceride accumulation, and potentiates insulin signaling in vitro</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1210%2Fme.2005-0171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=16373399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Oqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=809-830&author=E.+Burgermeisterauthor=A.+Schnoebelenauthor=A.+Flamentauthor=J.+Benzauthor=M.+Stihleauthor=B.+Gsellauthor=A.+Ruferauthor=B.+Kuhnauthor=H.+P.+Marki&title=A+novel+partial+agonist+of+peroxisome+proliferator-activated+receptor-%28PPAR%29+recruits+PPAR-coactivator-1%2C+prevents+triglyceride+accumulation%2C+and+potentiates+insulin+signaling+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A novel partial agonist of peroxisome proliferator-activated receptor-γ (PPARγ) recruits PPARγ-coactivator-1α, prevents triglyceride accumulation, and potentiates insulin signaling in vitro</span></div><div class="casAuthors">Burgermeister, Elke; Schnoebelen, Astride; Flament, Angele; Benz, Jorg; Stihle, Martine; Gsell, Bernard; Rufer, Arne; Ruf, Armin; Kuhn, Bernd; Marki, Hans Peter; Mizrahi, Jacques; Sebokova, Elena; Niesor, Eric; Meyer, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-830</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Partial agonists of peroxisome proliferator-activated receptor-γ (PPARγ), also termed selective PPARγ modulators, are expected to uncouple insulin sensitization from triglyceride (TG) storage in patients with type 2 diabetes mellitus.  These agents shall thus avoid adverse effects, such as body wt. gain, exerted by full agonists such as thiazolidinediones.  In this context, we describe the identification and characterization of the isoquinoline deriv. PA-082, a prototype of a novel class of non-thiazolidinedione partial PPARγ ligands.  In a cocrystal with PPARγ it was bound within the ligand-binding pocket without direct contact to helix 12.  The compd. displayed partial agonism in biochem. and cell-based transactivation assays and caused preferential recruitment of PPARγ-co-activator-1α (PGC1α) to the receptor, a feature shared with other selective PPARγ modulators.  It antagonized rosiglitazone-driven transactivation and TG accumulation during de novo adipogenic differentiation of murine C3H10T1/2 mesenchymal stem cells.  The latter effect was mimicked by overexpression of wild-type PGC1α but not its LXXLL-deficient mutant.  Despite failing to promote TG loading, PA-082 induced mRNAs of genes encoding components of insulin signaling and adipogenic differentiation pathways.  It potentiated glucose uptake and inhibited the neg. cross-talk of TNFα on protein kinase B (AKT) phosphorylation in mature adipocytes and HepG2 human hepatoma cells.  PGC1α is a key regulator of energy expenditure and down-regulated in diabetics.  We thus propose that selective recruitment of PGC1α to favorable PPARγ-target genes provides a possible mol. mechanism whereby partial PPARγ agonists dissoc. TG accumulation from insulin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgK6uihTKnsLVg90H21EOLACvtfcHk0lg4LPe9G0MNIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Oqu7c%253D&md5=da885be2866f262e5728fc2042e4b66f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0171%26sid%3Dliteratum%253Aachs%26aulast%3DBurgermeister%26aufirst%3DE.%26aulast%3DSchnoebelen%26aufirst%3DA.%26aulast%3DFlament%26aufirst%3DA.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DRufer%26aufirst%3DA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMarki%26aufirst%3DH.%2BP.%26atitle%3DA%2520novel%2520partial%2520agonist%2520of%2520peroxisome%2520proliferator-activated%2520receptor-%2528PPAR%2529%2520recruits%2520PPAR-coactivator-1%252C%2520prevents%2520triglyceride%2520accumulation%252C%2520and%2520potentiates%2520insulin%2520signaling%2520in%2520vitro%26jtitle%3DMol.%2520Endocrinol.%26date%3D2006%26volume%3D20%26spage%3D809%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surwit, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Distinct properties and advantages of a novel peroxisome proliferator-activated protein-selective modulator</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1210%2Fme.2002-0217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=12554792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFCksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=662-676&author=J.+P.+Bergerauthor=A.+E.+Petroauthor=K.+L.+McNaulauthor=L.+J.+Kellyauthor=B.+B.+Zhangauthor=K.+Richardsauthor=A.+Elbrechtauthor=B.+A.+Johnsonauthor=G.+Zhouauthor=T.+W.+Doebberauthor=C.+Biswasauthor=M.+Parikhauthor=N.+Sharmaauthor=M.+R.+Tanenauthor=G.+M.+Thompsonauthor=J.+Ventreauthor=A.+D.+Adamsauthor=R.+Mosleyauthor=R.+S.+Surwitauthor=D.+E.+Moller&title=Distinct+properties+and+advantages+of+a+novel+peroxisome+proliferator-activated+protein-selective+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator</span></div><div class="casAuthors">Berger, Joel P.; Petro, Ann E.; Macnaul, Karen L.; Kelly, Linda J.; Zhang, Bei B.; Richards, Karen; Elbrecht, Alex; Johnson, Bruce A.; Zhou, Gaochao; Doebber, Thomas W.; Biswas, Chhabi; Parikh, Mona; Sharma, Neelam; Tanen, Michael R.; Thompson, G. Marie; Ventre, John; Adams, Alan D.; Mosley, Ralph; Surwit, Richard S.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">662-676</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Antidiabetic thiazolidinediones (TZDs) and non-TZD compds. have been shown to serve as agonists of the peroxisome proliferator-activated receptor γ (PPARγ).  Here, we report the identification and characterization of a novel non-TZD selective PPARγ modulator (nTZDpa).  NTZDpa bound potently to PPARγ with high selectivity vs. PPARα or PPARδ.  In cell-based assays for transcriptional activation, nTZDpa served as a selective, potent PPARγ partial agonist and was able to antagonize the activity of PPARγ full agonists.  NTZDpa also displayed partial agonist effects when its ability to promote adipogenesis in 3T3-L1 cells was evaluated.  Assessment of protein conformation using protease protection or soln. NMR spectroscopy methods showed that nTZDpa produced altered PPARγ conformational stability vs. full agonists, thereby establishing a phys. basis for its obsd. partial agonism.  DNA microarray anal. of RNA from 3T3-L1 adipocytes treated with nTZDpa or several structurally diverse PPARγ full agonists demonstrated qual. differences in the affected gene expression profile for nTZDpa.  Chronic treatment of fat-fed, C57BL/6J mice with nTZDpa or a TZD full agonist ameliorated hyperglycemia and hyperinsulinemia.  However, unlike the TZD, nTZDpa caused redns. in wt. gain and adipose depot size.  Feed efficiency was also substantially diminished.  Unlike TZDs, nTZDpa did not cause cardiac hypertrophy in mice.  When a panel of PPARγ target genes was examd. in white adipose tissue, nTZDpa produced a different in vivo expression pattern vs. the full agonist.  These findings establish that novel selective PPARγ modulators can produce altered receptor conformational stability leading to distinctive gene expression profiles, reduced adipogenic cellular effects, and potentially improved in vivo biol. responses.  Such compds. may lead to preferred therapies for diabetes, obesity, or metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4wmALUo6AMrVg90H21EOLACvtfcHk0lg4LPe9G0MNIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFCksr0%253D&md5=d3f877b5b389d84034c98a54e3bbcf06</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1210%2Fme.2002-0217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2002-0217%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DPetro%26aufirst%3DA.%2BE.%26aulast%3DMcNaul%26aufirst%3DK.%2BL.%26aulast%3DKelly%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DRichards%26aufirst%3DK.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DB.%2BA.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DParikh%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DTanen%26aufirst%3DM.%2BR.%26aulast%3DThompson%26aufirst%3DG.%2BM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DA.%2BD.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DSurwit%26aufirst%3DR.%2BS.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DDistinct%2520properties%2520and%2520advantages%2520of%2520a%2520novel%2520peroxisome%2520proliferator-activated%2520protein-selective%2520modulator%26jtitle%3DMol.%2520Endocrinol.%26date%3D2003%26volume%3D17%26spage%3D662%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klatt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">L-764406 is a partial agonist of human peroxisome proliferator-activated receptor-fx1. The role of CYS313 in ligand binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">7913</span><span class="NLM_x">–</span> <span class="NLM_lpage">7922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=7913-7922&author=A.+Elbrechtauthor=Y.+Chenauthor=A+Adamsauthor=J.+P.+Bergerauthor=P.+Griffinauthor=T.+Klattauthor=B.+B.+Zhangauthor=J.+Menkeauthor=G.+Zhouauthor=R.+G.+Smithauthor=D.+E.+Moller&title=L-764406+is+a+partial+agonist+of+human+peroxisome+proliferator-activated+receptor-fx1.+The+role+of+CYS313+in+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAdams%26aufirst%3DA%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DKlatt%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DL-764406%2520is%2520a%2520partial%2520agonist%2520of%2520human%2520peroxisome%2520proliferator-activated%2520receptor-fx1.%2520The%2520role%2520of%2520CYS313%2520in%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D7913%26epage%3D7922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Shi, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dropinski, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahoo, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span> </span><span class="NLM_article-title">Novel 2-3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARα agonists with potent hypolipidemic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5589</span><span class="NLM_x">–</span> <span class="NLM_lpage">5599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050373g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5589-5599&author=G.+Q.+Shiauthor=J.+F.+Dropinskiauthor=Y.+Zhangauthor=C.+Santiniauthor=S.+P.+Sahooauthor=J.+P.+Bergerauthor=K.+L.+MacNaulauthor=G.+Zhouauthor=A.+Agrawalauthor=R.+Alvaroauthor=T.+Caiauthor=M.+Hernandezauthor=S.+D.+Wrightauthor=D.+E.+Mollerauthor=J.+V.+Heckauthor=P.+T.+Meinke&title=Novel+2-3-dihydrobenzofuran-2-carboxylic+acids%3A+highly+potent+and+subtype-selective+PPAR%CE%B1+agonists+with+potent+hypolipidemic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm050373g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050373g%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DG.%2BQ.%26aulast%3DDropinski%26aufirst%3DJ.%2BF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DAlvaro%26aufirst%3DR.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DHernandez%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26atitle%3DNovel%25202-3-dihydrobenzofuran-2-carboxylic%2520acids%253A%2520highly%2520potent%2520and%2520subtype-selective%2520PPAR%25CE%25B1%2520agonists%2520with%2520potent%2520hypolipidemic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5589%26epage%3D5599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Koyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boueres, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ippolito, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahoo, S. P.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-2-Ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3255</span><span class="NLM_x">–</span> <span class="NLM_lpage">3263</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030621d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3255-3263&author=H.+Koyamaauthor=D.+J.+Millerauthor=J.+K.+Boueresauthor=R.+C.+Desaiauthor=A.+B.+Jonesauthor=J.+P.+Bergerauthor=K.+L.+MacNaulauthor=L.+J.+Kellyauthor=T.+W.+Doebberauthor=M.+S.+Wuauthor=G.+Zhouauthor=P.+R.+Wangauthor=M.+C.+Ippolitoauthor=Y.+S.+Chaoauthor=A.+K.+Agrawalauthor=R.+Franklinauthor=J.+V.+Heckauthor=S.+D.+Wrightauthor=D.+E.+Mollerauthor=S.+P.+Sahoo&title=%282R%29-2-Ethylchromane-2-carboxylic+acids%3A+discovery+of+novel+PPARalpha%2Fgamma+dual+agonists+as+antihyperglycemic+and+hypolipidemic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm030621d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030621d%26sid%3Dliteratum%253Aachs%26aulast%3DKoyama%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DD.%2BJ.%26aulast%3DBoueres%26aufirst%3DJ.%2BK.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DKelly%26aufirst%3DL.%2BJ.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DP.%2BR.%26aulast%3DIppolito%26aufirst%3DM.%2BC.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DAgrawal%26aufirst%3DA.%2BK.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DHeck%26aufirst%3DJ.%2BV.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26atitle%3D%25282R%2529-2-Ethylchromane-2-carboxylic%2520acids%253A%2520discovery%2520of%2520novel%2520PPARalpha%252Fgamma%2520dual%2520agonists%2520as%2520antihyperglycemic%2520and%2520hypolipidemic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3255%26epage%3D3263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Acton, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span> </span><span class="NLM_article-title">Benzoyl 2-methyl indoles as selective PPARγ modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=357-362&author=J.+J.+Actonauthor=R.+M.+Blackauthor=A.+B.+Jonesauthor=D.+E.+Mollerauthor=L.+Colwellauthor=T.+W.+Doebberauthor=K.+L.+MacNaulauthor=J.+Bergerauthor=H.+B.+Wood&title=Benzoyl+2-methyl+indoles+as+selective+PPAR%CE%B3+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DJ.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DH.%2BB.%26atitle%3DBenzoyl%25202-methyl%2520indoles%2520as%2520selective%2520PPAR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D357%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debenham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschirret-Guth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span> </span><span class="NLM_article-title">Selective PPARγ modulators with improved pharmacological profiles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2437</span><span class="NLM_x">–</span> <span class="NLM_lpage">2440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2437-2440&author=K.+Liuauthor=R.+M.+Blackauthor=J.+A.+Actonauthor=R.+Mosleyauthor=S.+Debenhamauthor=R.+Abolaauthor=M+Yangauthor=R.+Tschirret-Guthauthor=L.+Colwellauthor=C.+Liuauthor=M.+Wuauthor=C.+F.+Wangauthor=K.+L.+MacNaulauthor=M.+E.+McCannauthor=D.+E.+Mollerauthor=J.+P.+Bergerauthor=P.+T.+Meinkeauthor=A.+B.+Jonesauthor=H.+B.+Wood&title=Selective+PPAR%CE%B3+modulators+with+improved+pharmacological+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DActon%26aufirst%3DJ.%2BA.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DDebenham%26aufirst%3DS.%26aulast%3DAbola%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DM%26aulast%3DTschirret-Guth%26aufirst%3DR.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DWood%26aufirst%3DH.%2BB.%26atitle%3DSelective%2520PPAR%25CE%25B3%2520modulators%2520with%2520improved%2520pharmacological%2520profiles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2437%26epage%3D2440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Faiola, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falls, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordelon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romach, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millar, R. T.</span><span> </span><span class="NLM_article-title">PPAR alpha, more than PPAR delta, mediates the hepatic and skeletal muscle alterations induced by the PPAR agonist GW0742</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1093%2Ftoxsci%2Fkfn130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18593727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWitL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=384-394&author=B.+Faiolaauthor=J.+G.+Fallsauthor=R.+A.+Petersonauthor=N.+R.+Bordelonauthor=T.+A.+Brodieauthor=C.+A.+Cummingsauthor=E.+H.+Romachauthor=R.+T.+Millar&title=PPAR+alpha%2C+more+than+PPAR+delta%2C+mediates+the+hepatic+and+skeletal+muscle+alterations+induced+by+the+PPAR+agonist+GW0742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR alpha, more than PPAR delta, Mediates the Hepatic and Skeletal Muscle Alterations Induced by the PPAR Agonist GW0742</span></div><div class="casAuthors">Faiola, Brenda; Falls, James Greg; Peterson, Richard A.; Bordelon, Nancy R.; Brodie, Thomas A.; Cummings, Connie A.; Romach, Elizabeth H.; Miller, Richard T.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-394</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Therapeutic use of certain peroxisome proliferator-activated receptor (PPAR) alpha agonists (fibrates) for the treatment of dyslipidemia has infrequently been assocd. with the untoward side effect of myopathy.  With interest in PPAR-δ as a therapeutic target, this study assessed whether a PPAR-δ agonist induced similar hepatic and skeletal muscle alterations as noted with some fibrates.  PPAR-α null (KO) and corresponding wild-type (WT) mice were administered toxicol. dosages of a potent PPAR-δ agonist tool ligand (GW0742; which also has weak PPAR-α agonist activity) or a potent PPAR-α agonist (WY-14,643) for 10 days.  Increases in liver wts. and clin. chem. indicators of skeletal muscle damage and/or liver injury were more pronounced in WT mice compared with KO mice administered the PPAR-δ agonist.  Likewise, the incidence and severity of skeletal myopathy were greater in WT mice given GW0742 compared with KO mice.  Ultrastructural and immunohistochem. analyses revealed significant peroxisome proliferation in muscle and liver of WT mice treated with each agonist; however, KO animals showed little or no evidence of hepatic and muscle peroxisome proliferation.  PMP-70 protein expression in liver was consistent with these results.  The hepatomegaly, hepatic and skeletal muscle peroxisome proliferation, and skeletal myopathy induced by this PPAR-δ ligand was predominantly mediated by its cross-activation of PPAR-α, though PPAR-δ agonism contributed slightly to these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAImC2zt51nLVg90H21EOLACvtfcHk0lg357Mp_ZpGzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWitL7O&md5=b20d2cd53d71878883bb573192bd87b3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfn130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfn130%26sid%3Dliteratum%253Aachs%26aulast%3DFaiola%26aufirst%3DB.%26aulast%3DFalls%26aufirst%3DJ.%2BG.%26aulast%3DPeterson%26aufirst%3DR.%2BA.%26aulast%3DBordelon%26aufirst%3DN.%2BR.%26aulast%3DBrodie%26aufirst%3DT.%2BA.%26aulast%3DCummings%26aufirst%3DC.%2BA.%26aulast%3DRomach%26aufirst%3DE.%2BH.%26aulast%3DMillar%26aufirst%3DR.%2BT.%26atitle%3DPPAR%2520alpha%252C%2520more%2520than%2520PPAR%2520delta%252C%2520mediates%2520the%2520hepatic%2520and%2520skeletal%2520muscle%2520alterations%2520induced%2520by%2520the%2520PPAR%2520agonist%2520GW0742%26jtitle%3DToxicol.%2520Sci.%26date%3D2008%26volume%3D105%26spage%3D384%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malgres, P. E.; Mumphrey, G. R.; Marcoux, J-.F.; Hillier, M.; Zhao, D.; Krska, S.; Grabowski, E. J. J.</span><span> </span><span class="NLM_article-title">Practical, highly convergent, asymmetric synthesis of a selecive PPARγ modulator</span>.  <span class="citation_source-journal">Org. Process Res. Dev.</span>, in press. </span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Malgres%2C+P.+E.%3B+Mumphrey%2C+G.+R.%3B+Marcoux%2C+J-.F.%3B+Hillier%2C+M.%3B+Zhao%2C+D.%3B+Krska%2C+S.%3B+Grabowski%2C+E.+J.+J.+Practical%2C+highly+convergent%2C+asymmetric+synthesis+of+a+selecive+PPAR%CE%B3+modulator.+Org.+Process+Res.+Dev.%2C+in+press.+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalgres%26aufirst%3DP.%2BE.%26atitle%3DPractical%252C%2520highly%2520convergent%252C%2520asymmetric%2520synthesis%2520of%2520a%2520selecive%2520PPAR%25CE%25B3%2520modulator%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Acton, J. J.; Akiyama, T. E.; Chang, C. H.; Colwell, L.; Debenham, S.; Doebber, T.; Einstein, M.; Liu, K.; McCann, M. E.; Moller, D. E.; Muise, E. S.; Tan, Y.; Thompson, J. R.; Wong, K. K.; Wu, M.; Xu, L.; Meinke, P. T.; Berger, J. P.; Wood, H. B.</span><span> </span><span class="NLM_article-title">Discovery of MK-0533: a novel SPPARgM for the treatment of T2MD with a reduced potential to increase plasma volume and extracellular fluid</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Acton%2C+J.+J.%3B+Akiyama%2C+T.+E.%3B+Chang%2C+C.+H.%3B+Colwell%2C+L.%3B+Debenham%2C+S.%3B+Doebber%2C+T.%3B+Einstein%2C+M.%3B+Liu%2C+K.%3B+McCann%2C+M.+E.%3B+Moller%2C+D.+E.%3B+Muise%2C+E.+S.%3B+Tan%2C+Y.%3B+Thompson%2C+J.+R.%3B+Wong%2C+K.+K.%3B+Wu%2C+M.%3B+Xu%2C+L.%3B+Meinke%2C+P.+T.%3B+Berger%2C+J.+P.%3B+Wood%2C+H.+B.+Discovery+of+MK-0533%3A+a+novel+SPPARgM+for+the+treatment+of+T2MD+with+a+reduced+potential+to+increase+plasma+volume+and+extracellular+fluid.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-0533%253A%2520a%2520novel%2520SPPARgM%2520for%2520the%2520treatment%2520of%2520T2MD%2520with%2520a%2520reduced%2520potential%2520to%2520increase%2520plasma%2520volume%2520and%2520extracellular%2520fluid" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">For the binding assay procedure, see the following: </p></div><span class="NLM_contrib-group">Adams, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Amphipathic 3-phenyl-7-propylbenzisoxazoles; human PPARγ, δ and α agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=931-936&author=A.+D.+Adamsauthor=W.+Yuenauthor=Z.+Huauthor=C.+Santiniauthor=A.+B.+Jonesauthor=K.+L.+MacNaulauthor=J.+P.+Bergerauthor=T.+W.+Doebberauthor=D.+E.+Moller&title=Amphipathic+3-phenyl-7-propylbenzisoxazoles%3B+human+PPAR%CE%B3%2C+%CE%B4+and+%CE%B1+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DA.%2BD.%26aulast%3DYuen%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DAmphipathic%25203-phenyl-7-propylbenzisoxazoles%253B%2520human%2520PPAR%25CE%25B3%252C%2520%25CE%25B4%2520and%2520%25CE%25B1%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D931%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Berger, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cillinana, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saperstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebowitz, M. D.</span><span> </span><span class="NLM_article-title">Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">4189</span><span class="NLM_x">–</span> <span class="NLM_lpage">4195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1996&pages=4189-4195&author=J.+B.+Bergerauthor=P.+Baileyauthor=C.+Biswasauthor=C.+A.+Cillinanaauthor=T.+W.+Doebberauthor=N.+S.+Hayesauthor=R.+Sapersteinauthor=R.+G.+Smithauthor=M.+D.+Liebowitz&title=Thiazolidinediones+produce+a+conformational+change+in+peroxisomal+proliferator-activated+receptor-gamma%3A+binding+and+activation+correlate+with+antidiabetic+actions+in+db%2Fdb+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BB.%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCillinana%26aufirst%3DC.%2BA.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DSaperstein%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DLiebowitz%26aufirst%3DM.%2BD.%26atitle%3DThiazolidinediones%2520produce%2520a%2520conformational%2520change%2520in%2520peroxisomal%2520proliferator-activated%2520receptor-gamma%253A%2520binding%2520and%2520activation%2520correlate%2520with%2520antidiabetic%2520actions%2520in%2520db%252Fdb%2520mice%26jtitle%3DEndocrinology%26date%3D1996%26volume%3D137%26spage%3D4189%26epage%3D4195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bergeron, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zycband, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: a comparison with PPAR gamma agonism</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">4252</span><span class="NLM_x">–</span> <span class="NLM_lpage">4262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=4252-4262&author=R+Bergeronauthor=J.+Yaoauthor=J.+W.+Woodsauthor=E.+I.+Zycbandauthor=C.+Liuauthor=Z.+Liauthor=A.+Adamsauthor=J.+P.+Bergerauthor=B.+B.+Zhangauthor=D.+E.+Mollerauthor=T.+W.+Doebber&title=Peroxisome+proliferator-activated+receptor+%28PPAR%29-alpha+agonism+prevents+the+onset+of+type+2+diabetes+in+Zucker+diabetic+fatty+rats%3A+a+comparison+with+PPAR+gamma+agonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DWoods%26aufirst%3DJ.%2BW.%26aulast%3DZycband%26aufirst%3DE.%2BI.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DAdams%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520%2528PPAR%2529-alpha%2520agonism%2520prevents%2520the%2520onset%2520of%2520type%25202%2520diabetes%2520in%2520Zucker%2520diabetic%2520fatty%2520rats%253A%2520a%2520comparison%2520with%2520PPAR%2520gamma%2520agonism%26jtitle%3DEndocrinology%26date%3D2006%26volume%3D147%26spage%3D4252%26epage%3D4262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Tsunoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span> </span><span class="NLM_article-title">A novel PPARα agonist ameliorates insulin resistance in dogs fed a high-fat diet</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">E833</span><span class="NLM_x">–</span> <span class="NLM_lpage">E840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=E833-E840&author=M.+Tsunodaauthor=N.+Kobayashiauthor=T.+Ideauthor=M.+Utsumiauthor=M.+Nagasawaauthor=K.+Murakami&title=A+novel+PPAR%CE%B1+agonist+ameliorates+insulin+resistance+in+dogs+fed+a+high-fat+diet"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsunoda%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DN.%26aulast%3DIde%26aufirst%3DT.%26aulast%3DUtsumi%26aufirst%3DM.%26aulast%3DNagasawa%26aufirst%3DM.%26aulast%3DMurakami%26aufirst%3DK.%26atitle%3DA%2520novel%2520PPAR%25CE%25B1%2520agonist%2520ameliorates%2520insulin%2520resistance%2520in%2520dogs%2520fed%2520a%2520high-fat%2520diet%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2008%26volume%3D294%26spage%3DE833%26epage%3DE840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Malinowski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolesta, S.</span><span> </span><span class="NLM_article-title">Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1151</span><span class="NLM_x">–</span> <span class="NLM_lpage">1168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1016%2FS0149-2918%2800%2983060-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=11110228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosFygtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2000&pages=1151-1168&issue=10&author=J.+M.+Malinowskiauthor=S.+Bolesta&title=Rosiglitazone+in+the+treatment+of+type+2+diabetes+mellitus%3A+a+critical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review</span></div><div class="casAuthors">Malinowski, Jennifer M.; Bolesta, Scott</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1151-1168</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review with 47 refs.  This article reviews the pharmacol., pharmacokinetics, clin. efficacy, adverse effects, drug interactions, and dosing of rosiglitazone, the second thiazolidinedione approved for the treatment of type 2 diabetes mellitus.  Background information for this article was obtained from searches of MEDLINE, Iowa Drug Information Service, and International Pharmaceutical Abstrs., as well as from data on file with the manufacturer of rosiglitazone.  Rosiglitazone is indicated for use alone or in combination with metformin or sulfonylureas for the maintenance of glycemic control in patients with type 2 diabetes mellitus.  Rather than stimulation of insulin secretion, rosiglitazone's primary mechanism of action is sensitization of tissues to insulin through activation of the peroxisome proliferator-activated receptor gamma and increasing expression of the glucose transporter-4 receptor.  Rosiglitazone is administered orally, is absorbed almost completely, and is 99.8% bound to plasma proteins.  The majority of a dose is metabolized by the cytochrome P 450 2C8 isoenzyme, with the inactive metabolites excreted primarily in the urine.  Four to 8 mg/d of rosiglitazone given alone or in combination with metformin, sulfonylureas, or insulin has produced redns. in baseline fasting plasma glucose and glycosylated Hb in studies of up to 1 yr's duration.  Common adverse effects (occurring in ≥5.0% of patients) include upper respiratory tract infection, injury, and headache.  Edema, wt. gain, and increased low-d. lipoprotein cholesterol concns. have also been obsd.  It is recommended that rosiglitazone be avoided in patients with alanine aminotransferase levels >2.5 times normal.  No clin. relevant drug interactions have been documented with rosiglitazone to date.  The initial starting daily dose of rosiglitazone is 4 mg in single or divided doses, without regard to meals, to a max. of 8 mg.  No direct comparative trials of the efficacy and safety of rosiglitazone vs. those of the other available thiazolidinedione, pioglitazone, have yet been performed.  The role of rosiglitazone as a single agent and in combination with other antidiabetic agents remains to be clarified as addnl. comparative and long-term data become available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3oWEWYd51dLVg90H21EOLACvtfcHk0liPEEnpw0QPzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosFygtrg%253D&md5=a21a16943b1889f027b2ddd65206a871</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2800%2983060-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252800%252983060-X%26sid%3Dliteratum%253Aachs%26aulast%3DMalinowski%26aufirst%3DJ.%2BM.%26aulast%3DBolesta%26aufirst%3DS.%26atitle%3DRosiglitazone%2520in%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%253A%2520a%2520critical%2520review%26jtitle%3DClin.%2520Ther.%26date%3D2000%26volume%3D22%26issue%3D10%26spage%3D1151%26epage%3D1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Davidson, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. H.</span><span> </span><span class="NLM_article-title">Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet</span> <span class="citation_source-journal">Clin. Drug Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.2165%2F00044011-200828100-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18783300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GqsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=615-623&issue=10&author=M.+H.+Davidsonauthor=P.+H.+Jones&title=Retrospective+comparison+of+the+effectiveness+of+a+fenofibrate+145+mg+formulation+compared+with+the+standard+160+mg+tablet"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet</span></div><div class="casAuthors">Davidson, Michael H.; Jones, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Drug Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">615-623</span>CODEN:
                <span class="NLM_cas:coden">CDINFR</span>;
        ISSN:<span class="NLM_cas:issn">1173-2563</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">Objective: To compare changes in lipid levels (total cholesterol [total-C], low-d. lipoprotein cholesterol [LDL-C], triglycerides [TG], and high-d. lipoprotein cholesterol [HDL-C]) for patients who switched from std. fenofibrate 160 mg (requiring dosing with food) to fenofibrate 145 mg with no food effect (NFE).  Methods: The analyses were performed using an electronic medical records dataset from 1 Jan. 2003 to 31 July 2005.  Patients were eligible for the anal. if they had a diagnosis of hypertension, dyslipidemia or diabetes mellitus, were written a prescription for std. fenofibrate 160 mg during the period 1 May 2004 to 30 Apr. 2005, and were written a subsequent prescription for fenofibrate 145 mg NFE at least 60 days after first receiving the 160 mg dose.  The outcomes measured were lipid levels: total-C, LDL-C, HDL-C and TG.  Results: 491 patients who switched from std. fenofibrate 160 mg to fenofibrate 145 mg NFE met all of the inclusion criteria.  Patients who changed therapy to fenofibrate 145 mg NFE from std. fenofibrate 160 mg showed a beneficial response in lipid levels.  Statistically significant patient-specific changes in lipid levels were obsd. for the change from baseline to std. fenofibrate 160 mg for three lipid levels (total-C, HDL-C and TG).  Statistically significant changes were obsd. for the switch to fenofibrate 145 mg NFE for three lipid levels (total-C, LDL-C and TG).  Conclusions: More patients treated in an outpatient clin. practice had better lipid results when prescribed fenofibrate 145 mg NFE than those prescribed std. fenofibrate 160 mg, suggesting that a less restrictive dosing regimen improves lipid outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR27nfzpzHT7Vg90H21EOLACvtfcHk0liPEEnpw0QPzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GqsL%252FP&md5=4a6612c4eaa360ebd2f8c7830be360a5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2165%2F00044011-200828100-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00044011-200828100-00002%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DM.%2BH.%26aulast%3DJones%26aufirst%3DP.%2BH.%26atitle%3DRetrospective%2520comparison%2520of%2520the%2520effectiveness%2520of%2520a%2520fenofibrate%2520145%2520mg%2520formulation%2520compared%2520with%2520the%2520standard%2520160%2520mg%2520tablet%26jtitle%3DClin.%2520Drug%2520Invest.%26date%3D2008%26volume%3D28%26issue%3D10%26spage%3D615%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Debenham, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemme, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span> </span><span class="NLM_article-title">Highly functionalized 7-azaindoles as selective PPARγ modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4798</span><span class="NLM_x">–</span> <span class="NLM_lpage">4801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4798-4801&author=S.+D.+Debenhamauthor=A.+Chanauthor=F.+W.+Lauauthor=W.+Liuauthor=H.+B.+Woodauthor=K.+Lemmeauthor=L.+Colwellauthor=B.+Habulihazauthor=T.+E.+Akiyamaauthor=M.+Einsteinauthor=T.+W.+Doebberauthor=N.+Sharmaauthor=C.+F.+Wangauthor=M.+Wuauthor=J.+P.+Bergerauthor=P.+T.+Meinke&title=Highly+functionalized+7-azaindoles+as+selective+PPAR%CE%B3+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDebenham%26aufirst%3DS.%2BD.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DLau%26aufirst%3DF.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DLemme%26aufirst%3DK.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DEinstein%26aufirst%3DM.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26atitle%3DHighly%2520functionalized%25207-azaindoles%2520as%2520selective%2520PPAR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4798%26epage%3D4801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiethe, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J. M.</span><span> </span><span class="NLM_article-title">The structure−activity relationship between peroxisome proliferator-activated receptor γ agonism and the anti-hyperglycemic activity of thiazolidinediones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950395a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=665-668&issue=3&author=T.+M.+Willsonauthor=J.+E.+Cobbauthor=D.+J.+Cowanauthor=R.+W.+Wietheauthor=I.+D.+Correaauthor=S.+R.+Prakashauthor=K.+D.+Beckauthor=L.+B.+Mooreauthor=S.+A.+Kliewerauthor=J.+M.+Lehmann&title=The+structure%E2%88%92activity+relationship+between+peroxisome+proliferator-activated+receptor+%CE%B3+agonism+and+the+anti-hyperglycemic+activity+of+thiazolidinediones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm950395a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950395a%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DCobb%26aufirst%3DJ.%2BE.%26aulast%3DCowan%26aufirst%3DD.%2BJ.%26aulast%3DWiethe%26aufirst%3DR.%2BW.%26aulast%3DCorrea%26aufirst%3DI.%2BD.%26aulast%3DPrakash%26aufirst%3DS.%2BR.%26aulast%3DBeck%26aufirst%3DK.%2BD.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520structure%25E2%2588%2592activity%2520relationship%2520between%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520agonism%2520and%2520the%2520anti-hyperglycemic%2520activity%2520of%2520thiazolidinediones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26issue%3D3%26spage%3D665%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Mu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zycband, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span> </span><span class="NLM_article-title">Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1695</span><span class="NLM_x">–</span> <span class="NLM_lpage">1704</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=1695-1704&issue=6&author=J.+Muauthor=J.+Woodsauthor=+Zhouauthor=R.+S.+Royauthor=Z.+Liauthor=E.+Zycbandauthor=Y.+Fengauthor=L.+Zhuauthor=C.+Liauthor=A.+D.+Howardauthor=D.+E.+Mollerauthor=N.+A.+Thornberryauthor=B.+B.+Zhang&title=Chronic+inhibition+of+dipeptidyl+peptidase-4+with+a+sitagliptin+analog+preserves+pancreatic+%CE%B2-cell+mass+and+function+in+a+rodent+model+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DZhou%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZycband%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26atitle%3DChronic%2520inhibition%2520of%2520dipeptidyl%2520peptidase-4%2520with%2520a%2520sitagliptin%2520analog%2520preserves%2520pancreatic%2520%25CE%25B2-cell%2520mass%2520and%2520function%2520in%2520a%2520rodent%2520model%2520of%2520type%25202%2520diabetes%26jtitle%3DDiabetes%26date%3D2006%26volume%3D55%26issue%3D6%26spage%3D1695%26epage%3D1704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Chang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muise, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span> </span><span class="NLM_article-title">A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1016%2Fj.ejphar.2007.12.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18346728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVKrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2008&pages=192-201&author=C.+H.+Changauthor=L.+A.+McNamaraauthor=M.+S.+Wuauthor=E.+S.+Muiseauthor=Y.+Tanauthor=H.+B.+Woodauthor=P.+T.+Meinkeauthor=J.+R.+Thompsonauthor=T.+W.+Doebberauthor=J.+P.+Bergerauthor=M.+E.+McCann&title=A+novel+selective+peroxisome+proliferator-activator+receptor-gamma+modulator-SPPAR%CE%B3M5+improves+insulin+sensitivity+with+diminished+adverse+cardiovascular+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective peroxisome proliferator-activator receptor-γ modulator-SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects</span></div><div class="casAuthors">Chang, Ching H.; McNamara, Lesley A.; Wu, Margaret S.; Muise, Eric S.; Tan, Yejun; Wood, Harold B.; Meinke, Peter T.; Thompson, John R.; Doebber, Tom W.; Berger, Joel P.; McCann, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">584</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-201</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The use of the thiazolidinedione insulin sensitizers rosiglitazone and pioglitazone for the treatment of type 2 diabetes mellitus in recent years has proven to be effective in helping patients resume normal glycemic control.  However, their use is often assocd. with undesirable side effects including peripheral edema, congestive heart failure and wt. gain.  Here, we report the identification and characterization of a novel selective PPARγ modulator, SPPARγM5 ((2S)-2-(2-chloro-5-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl} phenoxy)propionic acid), which has notable insulin sensitizing properties and a superior tolerability profile to that of rosiglitazone.  SPPARγM5 is a potent ligand of human PPARγ with high selectivity vs. PPARα or PPARδ in receptor competitive binding assays.  In cell-based transcriptional activation assays, SPPARγM5 was a potent partial agonist of human PPARγ in comparison to the PPARγ full agonist rosiglitazone.  Compared to rosiglitazone or the PPARγ full agonist COOH (2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid), SPPARγM5 induced an attenuated PPARγ-regulated gene expression profile in fully differentiated 3T3-L1 adipocytes and white adipose tissue of chronically treated db/db mice.  SPPARγM5 treatment also reduced the insulin resistance index by homeostasis model assessment (HOMA), suggesting an improvement in insulin resistance in these db/db mice.  Treatment of obese Zucker rats with either rosiglitazone or SPPARγM5 resulted in an improvement in selected parameters that serve as surrogate indicators of insulin resistance and hyperlipidemia.  However, unlike rosiglitazone, SPPARγM5 did not cause significant fluid retention or cardiac hypertrophy in these rats.  Thus, compds. such as SPPARγM5 may offer beneficial effects on glycemic control with significantly attenuated adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxeoOWfrT3IbVg90H21EOLACvtfcHk0lgcPZsarapJXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVKrsb0%253D&md5=68ac4e15e57b5d7e97807c80ae823b3b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.12.036%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BH.%26aulast%3DMcNamara%26aufirst%3DL.%2BA.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DMuise%26aufirst%3DE.%2BS.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DThompson%26aufirst%3DJ.%2BR.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26atitle%3DA%2520novel%2520selective%2520peroxisome%2520proliferator-activator%2520receptor-gamma%2520modulator-SPPAR%25CE%25B3M5%2520improves%2520insulin%2520sensitivity%2520with%2520diminished%2520adverse%2520cardiovascular%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D584%26spage%3D192%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Spady, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietschy, J. M.</span><span> </span><span class="NLM_article-title">Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1172%2FJCI113321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=2448340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADyaL1cXit1Sktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1988&pages=300-309&author=D.+K.+Spadyauthor=J.+M.+Dietschy&title=Interaction+of+dietary+cholesterol+and+triglycerides+in+the+regulation+of+hepatic+low+density+lipoprotein+transport+in+the+hamster"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster</span></div><div class="casAuthors">Spady, David K.; Dietschy, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-9</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">The effects of dietary cholesterol and triglyceride on rates of receptor-dependent and receptor-independent low-d. lipoprotein (LDL) transport were studied in the liver of the hamster.  In animals fed diets enriched with 0.1, 0.25, or 1% cholesterol for 1 mo., receptor-dependent LDL transport in the liver was suppressed by 43, 63, and 77%, resp., and there were reciprocal changes in plasma LDL-cholesterol concns.  In addn., dietary triglycerides modified the effect of dietary cholesterol on hepatic LDL transport and plasma LDL concns., so that at each level of cholesterol intake, polyunsatd. triglycerides diminished and satd. triglycerides accentuated the effect of dietary cholesterol.  When animals were raised from weaning on diets contg. small amts. of cholesterol, the decline in receptor-dependent LDL transport was nearly abolished by the addn. of polyunsatd. or monounsatd. triglycerides, but was markedly augmented by the addn. of satd. lipids.  When animals raised on diets contg. cholesterol and satd. triglycerides were returned to the low cholesterol, low triglyceride control diet, hepatic receptor-dependent LDL transport and plasma LDL-cholesterol concns. returned essentially to normal within 2 wk.  Neither receptor-independent LDL transport nor the receptor-dependent uptake of asialofetuin was significantly altered by dietary cholesterol or triglyceride, suggesting that the effect of these lipids on hepatic LDL receptor activity was specific and not due to a generalized alteration in the physiochem. properties of hepatic membranes.  These studies demonstrate the important role of satd. triglycerides in augmenting the effect of cholesterol in suppressing hepatic LDL receptor activity and elevating LDL-cholesterol levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrweWNHU1WSVLVg90H21EOLACvtfcHk0lgjJPYesO6tkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXit1Sktb4%253D&md5=a5e37ea4d3846780c0566f63bde233c1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1172%2FJCI113321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI113321%26sid%3Dliteratum%253Aachs%26aulast%3DSpady%26aufirst%3DD.%2BK.%26aulast%3DDietschy%26aufirst%3DJ.%2BM.%26atitle%3DInteraction%2520of%2520dietary%2520cholesterol%2520and%2520triglycerides%2520in%2520the%2520regulation%2520of%2520hepatic%2520low%2520density%2520lipoprotein%2520transport%2520in%2520the%2520hamster%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1988%26volume%3D81%26spage%3D300%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Shunji, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumiyoshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masanobu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isao, T.</span><span> </span><span class="NLM_article-title">Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice and beagle dogs</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1254%2Fjphs.FP0072346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18776709" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=40-48&issue=1&author=K+Shunjiauthor=I.+Takashiauthor=Y.+Hidekiauthor=H.+Taroauthor=M.+Fumiyoshiauthor=H.+Hitoshiauthor=S.+Masanobuauthor=T.+Isao&title=Antidiabetic+and+hypolipidemic+effects+of+a+novel+dual+peroxisome+proliferator-activated+receptor+%28PPAR%29+alpha%2Fgamma+agonist%2C+E3030%2C+in+db%2Fdb+mice+and+beagle+dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0072346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0072346%26sid%3Dliteratum%253Aachs%26aulast%3DShunji%26aufirst%3DK%26aulast%3DTakashi%26aufirst%3DI.%26aulast%3DHideki%26aufirst%3DY.%26aulast%3DTaro%26aufirst%3DH.%26aulast%3DFumiyoshi%26aufirst%3DM.%26aulast%3DHitoshi%26aufirst%3DH.%26aulast%3DMasanobu%26aufirst%3DS.%26aulast%3DIsao%26aufirst%3DT.%26atitle%3DAntidiabetic%2520and%2520hypolipidemic%2520effects%2520of%2520a%2520novel%2520dual%2520peroxisome%2520proliferator-activated%2520receptor%2520%2528PPAR%2529%2520alpha%252Fgamma%2520agonist%252C%2520E3030%252C%2520in%2520db%252Fdb%2520mice%2520and%2520beagle%2520dogs%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D108%26issue%3D1%26spage%3D40%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nedergaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, B.</span><span> </span><span class="NLM_article-title">PPAR.γ in the control of brown adipocyte differentiation</span> <span class="citation_source-journal">Biochim. Biophy. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1740</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=15949696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFCrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1740&publication_year=2005&pages=293-304&issue=2&author=J.+Nedergaardauthor=N.+Petrovicauthor=E.+M.+Lindgrenauthor=A.+Jacobssonauthor=B.+Cannon&title=PPAR.%CE%B3+in+the+control+of+brown+adipocyte+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">PPARγ in the control of brown adipocyte differentiation</span></div><div class="casAuthors">Nedergaard, Jan; Petrovic, Natasa; Lindgren, Eva M.; Jacobsson, Anders; Cannon, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1740</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The effects of fatty acids and retinoic acid (carotene) on brown adipose tissue differentiation are mediated by activation of the transcription factors PPARγ and PPARα in combination with RXR.  There is good support for the idea that activated PPARγ promotes adipogenesis also in brown adipose tissue.  However, the issue is more complex concerning the full differentiation to the brown adipocyte phenotype, particularly the expression of the brown-fat-specific marker UCP1.  The effect of norepinephrine on PPARγ gene expression, at least in-vitro, is neg., PPARγ-ablated brown adipose tissue can express UCP1, and PGC-1α coactivates other transcription factors (including PPARα); thus, the significance of PPARγ for the physiol. control of UCP1 gene expression is not settled.  However, importantly, the effects of PPAR agonists demonstrate the existence of a pathway for brown adipose tissue recruitment that is not dependent on chronic adrenergic stimulation and may be active in recruitment conditions such as prenatal and prehibernation recruitment.  The ability of chronic PPARγ agonist treatment to promote the occurrence of brown-fat features in white adipose tissue-like depots implies a role in anti-obesity treatment, but this will only be effective if the extra thermogenic capacity is activated by adrenergic stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq50Y-B5q0pnrVg90H21EOLACvtfcHk0lgjJPYesO6tkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFCrur4%253D&md5=53c3fae82de466090a5b6286a5125545</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNedergaard%26aufirst%3DJ.%26aulast%3DPetrovic%26aufirst%3DN.%26aulast%3DLindgren%26aufirst%3DE.%2BM.%26aulast%3DJacobsson%26aufirst%3DA.%26aulast%3DCannon%26aufirst%3DB.%26atitle%3DPPAR.%25CE%25B3%2520in%2520the%2520control%2520of%2520brown%2520adipocyte%2520differentiation%26jtitle%3DBiochim.%2520Biophy.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2005%26volume%3D1740%26issue%3D2%26spage%3D293%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Buckingham, R E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, A.</span><span> </span><span class="NLM_article-title">Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?</span> <span class="citation_source-journal">Diabetes, obesity & metabolism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltVyktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=312-328&issue=4&author=R+E+Buckinghamauthor=A.+Hanna&title=Thiazolidinedione+insulin+sensitizers+and+the+heart%3A+a+tale+of+two+organs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?</span></div><div class="casAuthors">Buckingham, R. E.; Hanna, A.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-328</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Thiazolidinediones (TZDs) are relatively new agents for the treatment of type 2 diabetes.  They act as agonists at the PPAR-γ nuclear receptor and their therapeutic effects include decreased insulin resistance and hyperglycemia, an improved plasma lipid, inflammation and pro-coagulant profile, and amelioration of hypertension, microalbuminuria and hepatic steatosis.  The most common side effects of TZDs include wt. gain and edema, with occasional reports of congestive heart failure (CHF).  This review discusses the benefit-risk profile of TZDs in treating patients with type 2 diabetes, with particular ref. to the heart.  To provide context, we explore briefly the epidemiol. and pathophysiol. of heart failure in patients with type 2 diabetes, touch on the assocn. of heart disease and cardiovascular mortality with antihyperglycemic treatment modalities other than TZDs, and then focus on the effects of TZDs on the heart, cardiovascular risk factors and outcomes.  We describe the cluster of host factors, which seems to predispose patients with type 2 diabetes to TZD-induced or TZD-exacerbated edema and CHF and then provide an overview of the putative mechanisms of these TZD-related side effects.  We also propose that certain diuretics (amiloride and spironolactone), by targeting the distal nephron that expresses PPARγ in collecting duct cells, might be of benefit in ameliorating the fluid retention and edema assocd. with TZDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGAeTz4d5x7Vg90H21EOLACvtfcHk0lgjJPYesO6tkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltVyktL8%253D&md5=8c5caf438d501ecfec6e97a703ad3a4d</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuckingham%26aufirst%3DR%2BE%26aulast%3DHanna%26aufirst%3DA.%26atitle%3DThiazolidinedione%2520insulin%2520sensitizers%2520and%2520the%2520heart%253A%2520a%2520tale%2520of%2520two%2520organs%253F%26jtitle%3DDiabetes%252C%2520obesity%2520%2526%2520metabolism%26date%3D2008%26volume%3D10%26issue%3D4%26spage%3D312%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rosen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallanat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waalkes, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corton, J. C.</span><span> </span><span class="NLM_article-title">Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR.α and CAR</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm900367w&amp;key=10.1093%2Ftoxsci%2Fkfn025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=18281256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksF2ls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2008&pages=46-56&issue=1&author=M.+B.+Rosenauthor=J.+S.+Leeauthor=H.+Renauthor=B.+Vallanatauthor=J.+Liuauthor=M.+P.+Waalkesauthor=B.+D.+Abbottauthor=C.+Lauauthor=J.+C.+Corton&title=Toxicogenomic+dissection+of+the+perfluorooctanoic+acid+transcript+profile+in+mouse+liver%3A+evidence+for+the+involvement+of+nuclear+receptors+PPAR.%CE%B1+and+CAR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicogenomic Dissection of the Perfluorooctanoic Acid Transcript Profile in Mouse Liver: Evidence for the Involvement of Nuclear Receptors PPARα and CAR</span></div><div class="casAuthors">Rosen, Mitchell B.; Lee, Janice S.; Ren, Hongzu; Vallanat, Beena; Liu, Jie; Waalkes, Michael P.; Abbott, Barbara D.; Lau, Christopher; Corton, J. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-56</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A no. of perfluorinated alkyl acids including perfluorooctanoic acid (PFOA) elicit effects similar to peroxisome proliferator chems. (PPC) in mouse and rat liver.  There is strong evidence that PPC cause many of their effects linked to liver cancer through the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARα).  To det. the role of PPARα in mediating PFOA transcriptional events, we compared the transcript profiles of the livers of wild-type or PPARα-null mice exposed to PFOA or the PPARα agonist WY-14,643 (WY).  After 7 days of exposure, 85% or 99.7% of the genes altered by PFOA or WY exposure, resp. were dependent on PPARα.  The PPARα-independent genes regulated by PFOA included those involved in lipid homeostasis and xenobiotic metab.  Many of the lipid homeostasis genes including acyl-CoA oxidase (Acox1) were also regulated by WY in a PPARα-dependent manner.  The increased expression of these genes in PPARα-null mice may be partly due to increases in PPARγ expression upon PFOA exposure.  Many of the identified xenobiotic metab. genes are known to be under control of the nuclear receptor CAR (constitutive activated/androstane receptor) and the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2).  There was excellent correlation between the transcript profile of PPARα-independent PFOA genes and those of activators of CAR including phenobarbital and 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene but not those regulated by the Nrf2 activator, dithiol-3-thione.  These results indicate that PFOA alters most genes in wild-type mouse liver through PPARα, but that a subset of genes are regulated by CAR and possibly PPARγ in the PPARα-null mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo3r_LpRhJJrVg90H21EOLACvtfcHk0lg8TmYxLwsbpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksF2ls78%253D&md5=41ead5fdb07fa84ac1e8d1b9f9eda1fa</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfn025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfn025%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DM.%2BB.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DVallanat%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWaalkes%26aufirst%3DM.%2BP.%26aulast%3DAbbott%26aufirst%3DB.%2BD.%26aulast%3DLau%26aufirst%3DC.%26aulast%3DCorton%26aufirst%3DJ.%2BC.%26atitle%3DToxicogenomic%2520dissection%2520of%2520the%2520perfluorooctanoic%2520acid%2520transcript%2520profile%2520in%2520mouse%2520liver%253A%2520evidence%2520for%2520the%2520involvement%2520of%2520nuclear%2520receptors%2520PPAR.%25CE%25B1%2520and%2520CAR%26jtitle%3DToxicol.%2520Sci.%26date%3D2008%26volume%3D103%26issue%3D1%26spage%3D46%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Einstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castriota, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span> </span><span class="NLM_article-title">The differential interactions of peroxisome proliferator-activator receptor γ ligands with Tyr473 is a physical basis for their unique biological activities</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=62-74&issue=1&author=M.+Einsteinauthor=T.+E.+Akiyamaauthor=G.+A.+Castriotaauthor=C.+F.+Wangauthor=B.+McKeeverauthor=R.+T.+Mosleyauthor=J.+W.+Beckerauthor=D.+E.+Mollerauthor=P.+T.+Meinkeauthor=H.+B.+Woodauthor=J.+P.+Berger&title=The+differential+interactions+of+peroxisome+proliferator-activator+receptor+%CE%B3+ligands+with+Tyr473+is+a+physical+basis+for+their+unique+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEinstein%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DCastriota%26aufirst%3DG.%2BA.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DMcKeever%26aufirst%3DB.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520differential%2520interactions%2520of%2520peroxisome%2520proliferator-activator%2520receptor%2520%25CE%25B3%2520ligands%2520with%2520Tyr473%2520is%2520a%2520physical%2520basis%2520for%2520their%2520unique%2520biological%2520activities%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26issue%3D1%26spage%3D62%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Belcher, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriss, E. B.</span><span> </span><span class="NLM_article-title">Studies of plasma volume, red cell volume and total blood volume in young growing rats</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900367w&amp;key=13481897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900367w&amp;key=1%3ACAS%3A280%3ADyaG1c%252FisVGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1957&pages=64-78&author=E.+H.+Belcherauthor=E.+B.+Harriss&title=Studies+of+plasma+volume%2C+red+cell+volume+and+total+blood+volume+in+young+growing+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Studies of plasma volume, red cell volume and total blood volume in young growing rats</span></div><div class="casAuthors">BELCHER E H; HARRISS E B</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of physiology</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-78</span>
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4s_zNGAgMIC6Ufuk_1xoTfW6udTcc2eY34ani2BdRGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG1c%252FisVGqsA%253D%253D&md5=dd122772ec2175d6f23b9b3c758bddb3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelcher%26aufirst%3DE.%2BH.%26aulast%3DHarriss%26aufirst%3DE.%2BB.%26atitle%3DStudies%2520of%2520plasma%2520volume%252C%2520red%2520cell%2520volume%2520and%2520total%2520blood%2520volume%2520in%2520young%2520growing%2520rats%26jtitle%3DJ.%2520Physiol.%26date%3D1957%26volume%3D139%26spage%3D64%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a href="/doi/suppl/10.1021/jm900367w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_35510"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures for synthesis of 2-bromoamino acids; elemental analysis results of <b>12c</b>, <b>12d</b>, <b>12g</b>, and <b>12h</b>; spectral data of compounds <b>15</b>, <b>16</b>, and <b>17</b>; and chiral HPLC traces of selected compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900367w/suppl_file/jm900367w_si_001.pdf">jm900367w_si_001.pdf (372.56 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900367w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm900367w%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-14" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900367w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679982a0b9d83d7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
